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ABSTRACT
HL60 is a human promyelocytic, leukaemic cell line. The cells are 
bipotent in culture; treatment with retinoic acid (RA) or dimethyl
sulphoxide (DMSO) induces HL60 cells to differentiate to granulocytes 
whereas treatment with 12-0-tetradecanoyl 13-phorbol acetate (TPA) 
induces these cells to differentiate to monocytes / macrophages.
Differential screening of a cDNA library representing poly(A)+ RNA 
from RA induced HL60 cells led to the selection of three different 
probes for sequences which change in abundance following 
differentiation of HL60 cells (F6, F10, C6). F6 RNA is highly
abundant in uninduced cells but not in induced HL60 cells. Sequencing
of F6 cDNA revealed that it consisted of an Alu repetitive element.
Both F10 and C6 RNAs increase in abundance during differentiation of 
HL60 cells to granulocytes. In situ hybridisation indicated that F10 
RNA represents a differentiation stage-specific transcript of the 
myeloid lineage. A probe for C6 RNA detected two transcripts. 
Analysis of the distribution of these RNAs between nuclear and total
RNA isolated from RA induced HL60 cells suggested that the larger
transcript is an unprocessed precursor of the smaller C6 RNA.
The timing of changes in expression of these three genes, together 
with c-myc and lysozyme, has been determined during the induced 
differentiation of HL60 cells. This has been compared to the timing
of the commitment event, as determined by examination of parameters
which assess the cell's potential to self-renew and their
differentiation status. It appears that c-myc expression bears a 
direct relationship to proliferation and differentiation of TPA 
induced HL60 cells. However, no such relationship was observed during 
DMSO and RA induction. A direct relationship was also observed 
between C6 and F10 expression and differentiation of HL60 cells to 
granulocytes.
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1 CELLULAR DIFFERENTIATION
A) Stem Cells and Commitment to Differentiation
The process of differentiation generates heterogeneous cell 
populations, crucial to the survival of the multicellular organism. 
These cell populations are characterised by their unique protein 
content or phenotype which is essential to the specific functions 
they perform. For example, in muscle cells the presence of actin, 
myosin and other proteins contributing to the cytoskeletal and muscle 
fibres give the cells contractile properties. Similarly, haemoglobin 
in mature erythrocytes enables these cells to implement oxygen / 
carbon dioxide gaseous exchange throughout every tissue.
All cells from an individual organism contain the same genetically 
encoded information. The unique phenotypes displayed by mature, 
differentiated cells are therefore brought about by differential gene 
expression. For this to occur in the highly organised manner observed 
during embryonic development and throughout adult life, strict, 
intracellular control of gene expression must operate. Determination 
of the mechanisms for the regulation of differentiation programmes is 
therefore of vital importance to our understanding of both normal and 
aberrant development, as it is believed that neoplastic 
transformation is the result of disruption of normal regulatory 
processes of differentiation (Sachs, 1980).
i) Stem Cells
The life span of an individual cell is almost always shorter than 
that of the multicellular organism. Some tissues such as epithelium 
and blood consist of short-lived cells and therefore to maintain a 
normal tissue architecture, the loss of cells through natural wastage 
or damage must be compensated. Most mature cells are incapable of 
proliferationtherefore to meet this demand a relatively small 
population of primitive stem cells exist. Other cell types are much 
longer lived such as brain cells. These cells exist throughout the 
life-span of the multicellular organism. It is believed that these 
cells also arise from stem cells during the process of development. 
Stem cells were originally demonstrated in the bone marrow. In 1961,
13
Till and McCulloch observed that following total body irradiation of 
mice, causing the destruction of bone marrow cells, an inoculum of 
marrow cells from a donor could rescue the animal from death. From 
analysis of the cells that formed colonies in the spleens of the 
recipient mice it was proposed that the initial inoculum contained 
primitive cells capable of self-renewal and differentiation processes 
which enabled the full restoration of the haematopoietic system (Till 
and McCulloch, 1961).
Recently, stem cell existence has also been demonstrated in other 
tissues. Ponder et al (1985) used chromosomal markers to show that 
adult mouse intestinal epithelium originates from a single stem cell
at the base of each intestinal crypt. Stem cells have also been
demonstrated in muscle cell populations (Smith Quinn et al, 1985). 
Difficulties in culturing early progenitor cells and the problem of 
identifying them has made the search for stem cells from other 
tissues more complex.
Stem cells are pluripotent; they possess the ability to self renew 
but also produce progeny capable of development into specialised, 
differentiated cells. It is believed that early in embryonic
development embryonic cells become determined or committed and are 
laid down as lineages of pluripotent stem cells from which all
tissues of the organism are derived. These stem cells proliferate and 
their progeny differentiate, gradually activating genes that encode
the specific proteins of that cell type. Stem cells are
differentiated in the sense that the developmental options open to
their progeny are restricted to specific lineages of development.
Hence a haematopoietic stem cell is committed to produce progeny 
which differentiate down the haematopoietic differentiation pathway 
only. Little is known about the process resulting in the conversion 
of embryonic cells to stem cells. However^all stem cells address the 
same problem during embryonic development; each must migrate to its 
final destination in the embryo, and once there it must proliferate 
and its progeny differentiate into terminally differentiated cells 
(Hall, 1983). From very small numbers of stem cells the tens of
thousands of cells found in the adult are produced through
proliferation and differentiation. For example stem cells are
believed to represent only 1% of the total population of
haematopoietic cells (Till and McCulloch, 1980).
14
In the embryo, pluripotent cells originate great distances from where 
they function in the adult. For example, haematopoiesis begins
extraembryonically in the blood islands in the yolk sac of the embryo
but by birth the major source of haematopoietic stem cells is the 
bone marrow (Hall, 1983). The stem cells must therefore migrate to 
the final mature destinations found in the adult. Stem cells from
different lineages migrate synchronously during early embryonic 
development indicative of common differentiation mechanisms operating 
at early developmental stages (Hall, 1983; Greaves, 1982). With 
migration the stem cells simultaneously undergo extensive and rapid 
proliferation. However, it has been shown that stem cell
differentiation will not occur unless the cell reaches the
appropriate microenvironment. For example, haematopoiesis is believed 
to be instructed by cells in the bone marrow stroma (Dexter and
Allen, 1983). Therefore it can be surmised that the microenvironment 
must provide support, either structurally or instructively, to 
initiate appropriate differentiation.
ii) Commitment to Differentiation
Mature cells appear to develop from a stem cell by way of a lineage 
of intermediate stages of differentiation. These lineages initiate 
at division of the stem cell producing progeny which either become 
committed to differentiate or remain in the stem cell pool and retain 
the potential to self-renew (Johnson and Metcalf, 1977). It is
believed that a single cellular event occurs when a stimulus
initiates the co-ordinated differentiation programme of a cell. This 
event is called commitment. The stimulus to initiate differentiation 
could be a factor(s) from the immediate cell microenvironment or the 
addition of a differentiation inducing agent in vitro (Dexter, 1984). 
Commitment is an irreversible stage, once a cell becomes committed it 
has only one option and that is to progress down the pathway leading 
to the next stage of differentiation (Levenson and Housman, 1981).
Several models have been proposed for the mechanism determining self 
renewal and commitment. These models have been formulated from 
studies of the kinetics of the commitment process to terminal 
differentiation during haematopoiesis. Two of the most widely
accepted models are the stochastic or probabilistic model and the 
instructive model.
15
a) The Stochastic Model
This model was first proposed by Till et al (1964) to explain data on 
proliferation of haematopoietic stem cells following spleen colony 
formation in mice (Till et al, 1964; Till and McCulloch, 1980). They 
observed that by transferring the cells from spleen colonies to a 
second irradiated recipient, the distribution of uncommitted stem 
cells in individual colonies was not uniform; some colonies had very 
few uncommitted cells whilst others contained a large number of 
uncommitted cells. They postulated that the stem cell decision to 
self renew or to become committed was a random or probabilistic 
event. A transition probability P was assigned to the chance that 
during any given generation, an uncommitted cell would become
committed. The probability of cell self renewal or commitment must 
however be sensitive to external signals if differentiation is 
determined in a stochastic manner. For example, differentiation of
haematopoietic colonies grown in semi-solid medium can be determined 
by external influences such as the addition of colony-stimulating
factors and it has been proposed that differentiation in vivo may be
influenced by interactions with bone marrow stromal cells (Dexter, 
1982; Metcalf and Burgess, 1982). This would then indicate that an
over lap exists between the stochastic and the instructive models for 
commitment to differentiation.
The stochastic model has also been favoured by Bennett (1983).
Studies of the differentiation of mouse melanoma cells have supported 
a modified stochastic model of commitment, the on-off stochastic 
model. It is postulated that stem cell choice between self-renewal 
and commitment may be probabilistic but the commitment process is
reversible at early times. However, later in the differentiation
process, a threshold is reached, when an increase in the 
concentration of regulatory molecules occurs. Cells at this stage 
become irreversibly committed to a specific terminal differentiation 
pathway. Others have also argued that progressive factors must also 
operate during commitment to differentiation down specific cell 
lineages, which allow the progression of multipotent progenitors to 
unipotent, terminally differentiated cells (Ogawa et al, 1983).
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b) The Instructive Model
This model was proposed by Trentin et al (1967), again formulated on 
data based on spleen colony formation. It is proposed that progenitor 
cells are intrinsically flexible and that commitment of stem cells to 
unipotent terminally differentiated cells is determined by a specific 
microenvironment and specific regulatory signals. This has been
supported by others studying the interactions between pluripotent
haematopoietic cells and bone marrow stromal cells (Dexter and Allen, 
1983) . However, contradictory evidence arises from the ability of 
haematopoiesis to occur in semi-solid media, in the absense of a 
structural, supportive microenvironment. In this system one single
colony can still give rise to multi-lineage differentiation (Ogawa
et al, 1983).
iii) Terminal Differentiation
Following the commitment event a specific pattern of differentiation
is initiated which results in a terminally differentiated cell, 
expressing a specific phenotype. However, progression down cell 
lineages is not totally restrictive. At specific stages the committed 
cell is faced with further commitment choices, at branch points where 
the differentiation pathway diverges into sublineages. Figure 1 
illustrates the highly divergent nature of the pathway leading to
mature haematopoietic cells. At each step of the differentiation
lineage there is a progressive narrowing of differentiation 
potential. Advance towards a terminally differentiated end-point is 
accompanied by co-ordinated repression and activation of specific 
gene patterns until the final stages of differentiation are reached. 
During this progression there must be stages at which crucial 
molecular and genetic changes occur before the cell progresses to a
terminally differentiated end-point. This must involve complex 
co-ordinated control mechanisms which are regulated by specific 
elements. With the onset of terminal differentiation the cell loses 
its proliferative capacity and eventually senesces and dies.
B) Haematopoiesis as an Example of a Differentiation System
Haematopoiesis, the differentiation system leading to the formation
17
Figure 1 Schematic representation of a model for haematopoietic cell 
differentiation.
Abbreviations:- CFU-S, spleen colony forming unit; Multi-CFU,
multipotential colony forming unit; CFU-M, megakaryocyte colony 
forming unit; BFU-E, erythroid burst forming unit; CFU-GH,
granulocyte macrophage colony forming unit.
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of mature blood cells, has been studied in depth because of the many
advantages this system possesses when compared to other tissues. One
main advantage is the availability of blood. It is also a liquid 
tissue composed of unicellular components which can be identified. 
Haematopoiesis occurs throughout adult life therefore stem cells and 
early progenitors are always present. Coupled to this the development 
of cell culture systems for the clonal growth of haematopoetic 
progenitor cells in semi-solid media has enabled differentiation to 
be critically analysed.
During embryogenesis, haematopoiesis occurs in the yolk sac. The 
cells then migrate to the foetal liver, and by birth the major source 
of stem cells has shifted from the liver to the bone marrow. It is 
here and in the lymphoid organs that haematopoietic stem cell 
differentiation occurs throughout adult life (Hall, 1983).
The haematopoietic system can be divided into two main compartments, 
lymphoid and myeloid. However, evidence suggests that a pluripotent
stem cell gives rise to both lineages (Till and McCulloch, 1980).
Following haematopoiesis in the bone marrow, spleen and lymphoid 
organs the differentiated cells produced, mature granulocytes, 
monocytes, erythrocytes, platelets and lymphocytes are released into 
the peripheral blood where each has a specific function.
i) Haematopoietic Stem Cells
The existence of a common haematopoietic stem cell was first proposed 
by Till and McCulloch (1961). They observed that bone marrow cells, 
injected into irradiated mice, migrated to the spleen and formed 
colonies which were able to self-renew and produce cells that
revealed terminal differentiation in the erythroid, granulocyte, 
monocyte and megakaryocyte lineages. Although haematopoietic
pluripotent stem cells only comprise 1% of all haematopoietic cells, 
they are capable of extensive proliferation and the production of 
committed progenitors capable of the repopulation of the entire
haematopoietic system of an irradiated animal, rescuing it from death 
(Till and McCulloch, 1980). They also showed that cells from a single 
spleen colony, when injected into a second irradiated mouse, were
also capable of rescuing the animal from death. The spleen colonies 
produced in the second animal contained all the cells necessary for
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reconstitution of the haematopoietic system and all had arisen from 
the original cell inoculum. This was demonstrated by chromosome marker 
studies and the examination of different isoenzymic forms of 
glucose-6-phosphate dehydrogenase (Till and McCulloch, 1980).
Treatment of some forms of leukaemia has put the ability of bone
marrow stem cells to repopulate the entire haematopoietic system to
practical use. The elimination of the "abnormal" bone marrow is 
accomplished by radiation treatment. This is followed by
transplantation of "normal" bone marrow from a donor. Out growth of
"normal" mature haematopoietic cells can then occur rescuing the 
patient from death. The entire haematopoietic cell system is 
established following bone marrow transplantation indicative of the 
haematopoietic stem cell's pluripotency (McCulloch, 1983).
ii) Haematopoietic Cell Lineages
With the development of semi-solid clonal cell culture techniques the 
study of in vitro haematopoiesis was expanded and elaborated. Initial 
studies of colonies revealed cells possessing bipotent 
differentiation. These were termed granulocyte-macrophage colony 
forming units (CFU-GM) and under appropriate conditions gave rise to 
blast cells expressing granulocyte or macrophage characteristics 
(Pluznick et al, 1965). Other, monopotent colony forming units were 
subsequently identified, for example erythroid colony forming units 
and megakaryocyte forming units (Stephenson et al, 1971 ; Metcalf and 
MacDonald, 1975). These cells were postulated to be at an almost 
terminal position in their respective haematopoietic lineages. More 
recently, it has been demonstrated that cells in haematopoietic cell 
colonies are capable of differentiation in more than 3 different 
lineages, for example GEMM-colonies, revealing differentiation in 
granulocytic, erythrocytic, monocytic and megakaryocytic lineages 
(Johnson and Metcalf, 1977). These cells are postulated to be early 
progenitor cells.
Hence, there exists a hierarchy of multipotent haematopoietic stem 
cells, the earliest of which have the highest self-renewal capacity. 
However all these cells are committed to differentiate down specific 
lineages. As cells move down through the different stages of 
haematopoietic differentiation a progressive loss of self-renewal
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potential concommitant with a narrowing in differentiation potential 
is observed, until a stage is reached when only one cell type is 
produced. Figure 1 represents a schematic diagram of the human 
haematopoietic lineages.
Such experimental observations, have led to the conclusion that the 
haematopoietic differentiation system can be divided into 3 main 
compartments (Ogawa et al, 1983).
a) The first, most primitive compartment consists of multipotent 
haematopoietic stem cells that possess self-renewal capabilities and 
the ability to generate primitive progenitors that are programmed to 
differentiate.
b) The second compartment consists of committed cells which 
proliferate and are responsible for maintaining the level of mature 
blood cells. These cells are responsive to environmental stimuli, as 
will be discussed later, and show progressive loss of differentiation 
potential.
c) The third compartment consists of terminally differentiated cells 
that do not proliferate.
iii) The Role of the Microenvironment in Haematopoiesis
From studies involving haematopoietic differentiation in long 
term bone marrow cultures it has been postulated that the stromal 
cells of bone marrow may play a role in haematopoiesis (Dexter and
Lajtha, 1976). In these cultures early and late progenitor cells have
been identified which is indicative of the capability of the system 
to support proliferation and differentiation. Bone marrow stromal 
cells provide mechanical and functional support, in the form of an 
adherent multilayer. Stroma consists of many cell types of which
adipocytes, fibroblasts and macrophages are examples (Dexter and 
Allen, 1983) . It has been observed that cell-cell specific
interactions appear to take place between developing haematopoietic 
cells and stromal cells in vivo and in vitro. In fact it is 
postulated that cells that undergo differentiation down specific 
lineages are found associated with a particular stromal cell type 
(Dexter and Allen, 1983). Synchrony in development of haematopoietic
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cells associated with a single stromal cell has also been reported, 
indicating that differentiation could be the result of locally 
administered differentiation stimuli to the surrounding 
haematopoietic cells. This stimulation could be in the form of 
various molecular compounds found to stimulate proliferation and
differentiation of haematopoietic stem cells, the colony-stimulating 
factors (Clark and Kamen, 1987).
The importance of the microenvironment in the successful 
differentiation of haematopoietic stem cells has been highlighted by 
the condition Steel anaemia, a congenital hypoplastic anaemia of 
mice. Steel (SI) mice can not be rescued by the inoculation of normal 
bone marrow, no spleen colonies are formed. However, by grafting of 
normal spleen into these animals they recover and develop normal
haematopoiesis (Dexter and Moore, 1977). This is indicative of the
abnormality being present in the microenvironment in which 
haematopoiesis takes place and not in the haematopoietic stem cells 
themselves. Further evidence to support this comes from long-term 
bone marrow culture assays. When stromal cells from SI mice are used 
to form the supportive, adherent multilayering no development occurs 
in the cultures and the cells die. Nevertheless if normal bone marrow 
cells are mixed with the bone marrow from SI mice the culture becomes 
viable and cell proliferation and differentiation is observed (Dexter 
and Allen, 1983). However the exact nature of the interactions 
between differentiating cells and the stroma still remains unclear.
Studies of haematopoietic cell colonies, grown from pluripotent 
progenitor cells, in semi-solid media, have suggested that the 
restriction in differentiation potentials of stem cells is 
intrinsically determined in a stochastic manner (Till, 1964; Ogawa 
et al, 1983). Others suggest that microenvironmental factors and / or 
interactions with stromal cells instruct the pathway of 
differentiation (Trentin et al, 1967; Dexter, 1982) (also see Chapter 
I, 1, A (ii)). The stochastic model has been favoured as a mechanism 
for determining commitment to differentiation. However evidence 
gathered from analyses of stromal associations and interactions with 
differentiating haematopoietic cells would tend to favour the 
instructive model. Most of the evidence supporting a stochastic model 
of commitment to differentiation has come from studies of pluripotent 
progenitor cells grown as colonies in semi-solid media. Therefore
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this raises the question of whether the environmental conditions and 
the availabilty of factors in these in vitro systems is comparable to 
that found in vivo (Brown et al, 1987). Alternatively, the influences 
exerted by stromal cells and the microenvironment encountered by 
differentiating cells in the bone marrow, may influence the 
probability of commitment to differentiate hence supporting the 
stochastic model.
iv) Regulatory Factors of Haematopoiesis
Analysis of events in haematopoietic clonal cell culture led to the 
recognition that haematopoietic cells are intrinsically incapable of 
unstimulated cell division. Growth of bone marrow progenitors 
required the addition of factors to sustain proliferation and 
differentiation. The sources of these factors were very diverse, for 
example, placenta, peripheral blood cells and tumour cell lines. The 
characteristics of many regulatory factors have been determined.
a) Haematopoietic growth factors
In the murine system 4 major growth factors have been identified. Two 
of these are lineage- specific, granulocyte-colony stimulating factor 
(G-CSF) and macrophage-colony stimulating factor (M-CSF). Colonies 
grown in the presence of the former consist largely of neutrophilic
granulocytes and their precursors, whereas colonies grown in the
presence of the latter mainly consist of macrophages (Stanley and 
Heard, 1977; Metcalf and Nicola, 1983). G-CSF and M-CSF are
postulated to support growth and proliferation of only relatively 
late progenitors, already committed to their respective lineages. In 
contrast, the remaining well characterised factors are effectors of
growth and differentiation in more than one haematopoietic lineage. 
Granulocyte-macrophage-CSF (GM-CSF) is found to stimulate colonies to 
give rise to granulocytes, macrophages and eosinophils, and
Interleukin-3 (IL-3), or multi-CSF exposed colonies contain many
different cell lineages (Metcalf, 1986). It is proposed that GM-CSF
and IL-3 interact with early progenitor cells that are pluripotent
and therefore capable of producing mature cells from many lineages. 
In the human system, a set of 4 analogous factors have also been 
characterised (Nicola et; al, 1985; Yang et al, 1986). This evidence 
supports the theory of the existence of a hierarchy of progenitor
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cells along the various haematopoietic cell lineages. Table 1 
summarises the cells that produce colony-stimulating factors and the 
differentiation end-products produced following colony exposure to 
these factors.
Other regulatory factors have also been identified, for example 
erythropoietin is a regulatory growth factor for terminal erythrocyte 
development and IL-2 and IL-4 regulate B and T lymphocyte growth and 
proliferation (Arai et al, 1986).
b) The Structure and Expression of Colony Stimulating Factors
The regulatory factors or CSFs are glycoproteins. They are produced 
by a number of different cell sources, as is described in Table 1. It 
is believed that the degree of glycosylation can vary greatly 
producing extensive heterogeneity in the sizes of these factors 
(Clark and Kamen, 1987). The function of the carbohydrate
modifications are unknown. Receptors for CSFs have been identified on 
responsive cells (Metcalf, 1984).
With the availability of DNA probes for CSFs expression of the CSF 
genes has been examined. Many different cell types have been shown to 
express CSFs but only when stimulated, for example, monocytes
stimulated by phorbol ester or endotoxin and activated T-cells (Wong 
et al, 1987). However no CSF gene expression has been detected in
normal, unstimulated primary cells. This suggests that factors such
as GM-CSF, IL-3 and G-CSF do not play a major role in constitutive
haematopoiesis but could act to enhance the production of mature
haematopoietic cells when the system is under stress, for example 
during infection. Nevertheless, it cannot be ruled out that extremely 
small amounts of these factors are produced locally by bone marrow 
stromal cells, but have not yet been detected (Clark and Kamen,
1987) .
The one exception is M-CSF. M-CSF gene expression is detectable in a 
variety of primary tissues and cells (Kawasaki et al, 1985; Wong
et al. 1987). However this may reflect one of the roles of this
molecule in vivo, a survival factor for monocytes and macrophages.
These cells leave the blood circulation as monocytes and migrate into
tissues where they develop into macrophages. It would therefore be
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Colony
Stimulating
Factor
Cellular
Source
Haemopoietic 
Lineages found 
in Colonies
G -C S F Monocytes 
Fibrob lasts
Neutrophils
G M -CSF
T-cells
Endothelial cells 
Fibroblasts
Neutrophils 
Monocytes /  Macrophages 
Eosinophils 
Megakaryocytes 
Erythrocytes
IL -3 T-cells
Neutrophils
Monocytes/Macrophages
Eosinophils
Basophils
Erythrocytes
Megakaryocytes
M -CSF
Monocytes 
Fibroblasts 
Endothelial cells
Monocytes /  Macrophages
Table 1 Table of the cellular sources of the human colony 
stimulating factors.
Abbreviations:- G-CSF, granulocyte colony stimulating factor; GM-CSF, 
granulocyte macrophage colony stimulating factor; IL-3, interleukin 
3; M-CSF, macrophage colony stimulating factor.
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important for a variety of cells to produce M-CSF for long-term
survival of macrophages (Wong et al, 1987).
v) Malignancy due to Abnormality of the Haematopoietic 
Differentiation System
The process of haematopoiesis can malfunction giving rise to a number 
of serious disorders from anaemia to leukaemia. Leukaemias can be 
lymphoid or myeloid, depending on the cell type the malignancy occurs 
in, and can be either acute or chronic. Leukaemias are therefore 
classified into 4 main categories, acute non-lymphoblastic leukaemia 
(ANLL), acute lymphoid leukaemia (ALL), chronic myeloid or
granulocytic leukaemia (CML or CGL) and chronic lymphoid leukaemia 
(CLL). Leukaemic patient characteristically have poorly 
differentiated haematopoietic cells in their peripheral blood 
replacing mature, fully functional cells.
It is widely believed that leukaemias arise as a result of
transformation event(s) in pluripotent cells. Transformation of 
different target cells leads to different types of leukaemia, even
within the same haematopoietic lineage. Characteristically, the 
progeny of these transformed cells accumulate at some point analogous 
to a recognisable stage in the normal pathway of haematopoiesis 
(Greaves, 1982). Much of the evidence for this theory comes from
studies of lineage-specific and differentiation stage-specific 
proteins as detected by monoclonal antibodies and cytochemical
markers (Fialkow, 1982). It is also widely held that different
leukaemias represent the clonal proliferation of a single pluripotent 
stem cell. Fialkow et al (1977) demonstrated this for ANLL by a study 
of female patients heterozygous for the X-linked isoenzyme 
glucose-6-phosphate dehydrogenase. Haematopoietic cell lineages from 
each patient expressed a single, common glucose-6-phosphate
dehydrogenase allele. This has also been shown through studies of the 
karyotypic abnormality, the Philadelphia chromosome (Ph') (t:22,9), 
found in CGL. This abnormality was found in basophils, erythroid
cells, platelet precursors and macrophages, supporting evidence that 
a pluripotent stem cell is the transformation target (Greaves, 1982; 
Zalcberg et al, 1896).
It has been postulated that the transformation of normal cells to
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malignancy involves changes in the regulation of gene expression. By 
examination of the requirement for GM-CSF for proliferation and 
differentiation of normal and malignant myeloid cells (CGL), it was
found that the malignant cells could be induced to differentiate by
GM-CSF but had lost the requirement for this factor for cell 
viability and proliferation (Sachs, 1980). In the presence of GM-CSF 
proliferation of normal cells would be followed by initiation of 
differentiation and termination of the differentiation programme. 
These 3 processes would be controlled co-ordinately in the normal
system. However it is postulated that uncoupling of the controls for 
proliferation and differentiation would result in a malignant
phenotype. These cells would have an advantage over normal cellular 
components because of their unrestrained proliferative capacity. This 
model therefore proposes that defective or incomplete regulation of
proliferation and differentiation is the origin of malignancy (Sachs, 
1980) .
In samples from leukaemic patients, haematopoietic cells are found 
"maturation arrested". These cells display cytochemical markers of 
immature cell types from different early stages of the normal
differentiation process. The stage of "maturation arrest" varies 
between the different classes of leukaemia, and is used as a
classification criteria. It is thought that "maturation arrest" 
occurs because of uncoupling of the proliferation and differentiation 
pathways. The variations between the stages of "maturation arrest" in 
different types of leukaemia is thought to be the result of the 
degree of uncoupling of proliferation and differentiation. If the 
co-ordinated control of these processes was virtually non-existent it 
would result in highly proliferative, poorly differentiated cells. 
Alternatively, if the uncoupling was only partial, more mature cell 
types would result but would still have proliferative capabilities 
(McCulloch et al, 1982). Phenotypic characterisation of lymphoid
malignancies has provided support for this model for malignant 
transformation. Several groups have observed that lymphoid tumours 
correspond phenotypically to various stages in lymphocyte maturation 
(Greaves et al, 1982; Reinherz et al, 1980).
Aberrant gene expression has also been proposed as a model for
transformation of haematopoietic stem cells. This might occur through 
introduction of genes from an exogenous source, by viral infection,
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or spontaneously, by mutation. The evidence for this type of model 
was derived from the discovery of tumour-specific antigens found on 
malignant cells but not on normal cells (Fioritoni et al, 1980). 
These were later discovered to be viral antigens and not 
tumour-specific markers. Lineage infidelity is also thought to 
support such a model. For example, K-562 cells, a cell line derived 
from the peripheral blood cells of a patient suffering from CML, were 
found to express markers for both erythroid and granulocytic cells. 
However, this could simply reflect the differentiation stage these 
cells arrested at due to the original transformation event, at an
early stage in haematopoiesis before the branch point which causes 
the divergence of the erythrocytic and myeloid lineages (Till and
McCulloch, 1980).
Many cell lines have been established from the haematopoietic cells 
of patients suffering from leukaemic disorders. These cells have a 
high proliferative capacity and invariably show some phenotypic 
characteristics of immature cells from normal haematopoietic 
lineages. For example, HL60 cells, established from a patient
suffering from acute promyelocytic leukaemia, are classified as 
promyelocytic, both morphologically and cytochemically (Collins
et al, 1977). Similarly, Friend erythroleukaemia cells are of murine 
erythroblastic origin (Friend et al, 1971). These cell lines possess 
the ability to differentiate to mature cell types similar to the 
normal cell, when treated with different agents. For example, HL60 
cells can be induced to terminally differentiate to granulocytes or 
monocytes depending on the inducing agent used (Breitman et al, 1980; 
McCarthy et al, 1983). Due to these properties these cell lines are 
frequently used as models for haematopoietic differentiation.
vi) Summary
The process of differentiation leads to variety and specialisation of 
cells in the multicellular organism. For example, haematopoiesis 
yields a variety of different cell types, erythrocytes, granulocytes, 
macrophages, monocytes, megakaryocytes, T and B lymphocytes which can 
all be derived from the same differentiating clone (Till and 
McCulloch, 1980). Each cell type is highly specialised to undertake a 
particular function in the multicellular organism. It can therefore 
be surmised that stem cells play a pivotal role in differentiation.
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Differentiation of haematopoietic cells has been studied in detail, 
not only as a result of technical convenience but also because of the 
importance in understanding the mechanisms which operate to create 
the different haematopoietic cell types; these cells maintain the 
immune system and gaseous exchange processes, amongst many other 
features which are crucial to survival. It is also hoped that 
determination of the control mechanisms which operate during 
haematopoiesis will aid in the elucidation of the origins of abnormal 
clones characteristic of leukaemia.
During the differentiation process multi-potent stem cells give rise 
to progenitors which either retain the parental cell's capacity to 
self-renew or become committed to differentiate down a particular 
pathway leading to terminal differentiation. Progress along the 
differentiation pathway results in changes in gene expression and a 
decrease in the differentiation potential of the cell. Co-ordinated
control mechanisms must operate to regulate patterns of gene 
expression which are specific to any one stage of differentiation.
The elucidation of these control mechanisms is therefore of vital 
importance to our understanding of normal and aberrant gene 
expression. To enable the study of these mechanisms model systems of 
differentiation, such as cell lines which are capable of induced 
differentiation and in vitro culture systems for the long term 
maintenance of bone marrow cells, have been and will be of vital 
importance.
2 CONTROL MECHANISMS OF CELLULAR DIFFERENTIATION
In the early 1960s it was established that differentiation is
implemented by controls operating on the cell genome. Gurdon 
demonstrated that nuclei transplanted, from cells of early stages of 
Xenopus laevis embryos, to enucleated oocytes, allowed those oocytes 
to develop into tadpoles with relatively high efficiency. Hence, it 
was postulated that the change in nuclear environment exposed the 
genes in the transplanted nucleus to different control pressures 
(Gurdon, 1962). These results also demonstrated that controls
operating to determine a particular differentiated phenotype are not 
permanent but under the appropriate conditions can be altered.
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Changes in gene expression during differentiation are reflected in 
the changes in the mRNA and protein content of the cell. This has 
frequently been reported during the induced differentiation of 
haematopoietic cell lines (Colbert et al, 1983; Reyland et al, 1986). 
These changes must follow co-ordinated relaxation and tightening of 
control mechanisms throughout the entire genome.
There are many stages on the pathway from gene to protein at which 
control mechanisms could operate to regulate the final functional 
protein complement of the cell and hence determine the cells ultimate 
differentiated phenotype. Figure 2 shows the flow of information from 
DNA to protein and indicates the stages at which potential control of 
gene expression could operate.
A) Structural Features of Chromatin Which may Affect Gene 
Transcription
i) Chromatin Structure
Chromatin, the term given to nuclear DNA and its complement of 
associated protein and RNA molecules, exists in two forms as 
demonstrated by electron microscopy studies: transcriptionally poised 
or active chromatin and transcriptionally repressed or inactive 
chromatin. Active chromatin, believed to occur at sites of frequent 
transcriptional activity, appears to have a more "open" structure 
than that of condensed inactive chromatin (Weisbrod, 1982).
Chromatin appears as a "beaded fibre" when examined by electron 
microscopy. Enzymic studies reveal that the chromatin exists in 
the form of repeated units of DNA 146-240 base pairs long, wrapped 
twice around a nucleosome, the unit which gives the chromatin fibre 
its beaded appearence. The nucleosome is derived from a histone core; 
histones are a family of basic proteins found exclusively associated 
with nuclear DNA. The nucleosome core is constructed from 2 X 4  inner 
histones, H2A, H2B, H3 and H4. A further histone HI is associated 
with linker regions of DNA between nucleosomes. Nucleosomes have been 
demonstrated in both active and inactive chromatin. However 
nucleosome formation in vitro has been shown to block initiation of 
transcription. Therefore mechanisms must operate to allow the cell to
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Nucleus
Cytoplasm
DNA
hnRNA
mRNA
V
Protein
Functional Protein
Figure 1 Schematic representation of the stages from the zene to the 
protein at which potential control of gene expression could 
operate.
1, Primary and secondary DNA structure; 2, transcription; 3,
hnRNA processing; A, transport/translation; 5, post-translational
changes.
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transcribe through a nucleosome template (Weintraub, 1985).
It is believed that folding of the chromatin fibre and cross-linking 
events allow the chromatin to be compacted sufficiently to enable its 
packaging in the nucleus. Non-histone proteins also aid in chromatin 
pakaging. These proteins form the scaffold on which the chromosome is 
constructed. The chromatin fibres are looped around this scaffold and 
attached to it, allowing further condensation (Weisbrod, 1982).
ii) DNase X Sensitivity
Evidence that chromatin from actively transcribed genes exhibits a 
structure differing from that of inactive genes developed from the 
use of endonucleases. Weintraub and Groudine (1976) demonstrated this 
with DNase X and microccocal nucleases by examination of their 
respective capabilities in digesting chick erythrocyte DNA. By 
determining fragment sizes from the globin gene they discovered that 
globin DNA was resistant to microccocal nuclease digestion, a feature 
of DNA packaged into nucleosomes, but sensitive to DNase I. This led 
to the suggestion that the globin gene was packaged info nucleosomes 
but its sensitivity to DNase I indicated that these nucleosomes were 
conformationally different from most nucleosomes in the chick 
erythrocyte (Weintraub and Groudine, 1976).
DNase I sensitivity appears to be a tissue specific phenomenon as is 
demonstrated by the sensitivity of the globin gene to endonuclease 
activity in erythrocytes but not in brain tissue. Conversely the 
ovalbumin gene is preferentially sensitive in oviduct and not in the 
erythrocyte (Garel and Axel, 1976). Stalder et al (1980) also 
demonstrated that DNase I sensitivity of embryonic and adult p-globin 
genes changed during development. In mature chick erythrocytes the 
embryonic p -globin gene is resist'>nt to DNase I digestion but the 
adult p-globin gene is sensitive. However, in embryonic cells both 
genes are digested by the endonuclease but only the embryonic gene is 
expressed. The fact that the adult form of p-globin is sensitive in 
embryonic cells is indicative of a pre-activation event prior to the 
stage at which gene expression is required,
DNase I sensitivity appears to be a general phenomenonof actively 
transcribed genes, but apparently only reflects transcription
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potential and not the process of transcription. This has been 
demonstrated in the chick ovalbumin gene in oviduct. The actively- 
transcribed ovalbumin gene is DNase I sensitive when transcription is 
induced by the action of steroid hormones. However removal of the 
hormone stimulus, which results in loss of ovalbumin gene expression, 
does not affect the DNase I sensitivity of the gene (Palmiter e_t al, 
1977). This is also demonstrated in the Friend erythroleukaemia cell 
system. These cells are capable of induced differentiation to mature 
erythrocytes when treated with a variety of agents (Friend et al, 
1971). The uninduced cells possess an inactive globin gene which is 
activated following differentiation. However DNase I sensitivity of 
the globin DNA does not differ between that observed in the uninduced 
cell and m  the fully differentiated erythrocyte (Miller et al,
1979).
iii) Proteins Associated with Active Chromatin
From endonuclease analyses of chromatin, a structural difference can 
be demonstrated between those genes capable of transcription and 
those that remain silent. By examination of the protein moieties 
released during DNase I digestion of DNA it has been proposed that 
modified histones, or the presence of non-histone proteins associated 
with the DNA, results in endonuclease sensitivity.
a) Non-histone Proteins
A family of non-histone proteins, the high mobility group (HMG) are 
found frequently associated with sites of active transcription. This 
was first demonstrated by fluorescent antibody detection of HMG 
proteins associated specifically with the transcriptionally active 
"puff" regions in salivary gland polytene chromosomes of Drosophila 
(Mayfield et al, 1978).
HMG proteins are highly conserved throughout evolution, and represent 
approximately 5% of nuclear proteins. They are slightly acidic and 
can be easily eluted from chromatin by low salt concentrations. HMGs 
14 and 17 can be eluted from chick erythrocyte DNA without any 
detectable change observed in the gross structure of individual 
nucleosomes. However the depleted chromatin is no longer DNase I 
sensitive. Reconstitution of the chromatin by readdition of HMGs 14
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and 17 results in the return of endonuclease sensitivity (Weisbrod 
and Weintraub, 1979; Weisbrod et al, 1980). This is indicative of 
these proteins playing an active role in the altered structure of 
active chromatin which could be implemented by protein interaction 
with the DNA.
From reconstitution studies between HMGs 14 and 17 from brain tissue 
and depleted chromatin from erythrocytes p globin gene DNase I 
sensitivity is recovered. This suggests that HMGs are ubiquitous DNA 
binding factors and not a specific mechanism for gene activation. In 
fact either HMG 14 or 17 from most cell types can restore DNase I 
sensitivity to most actively transcribed, HMG-depleted genes 
(Weisbrod et al, 1980). It is therefore unlikely that such a 
mechanism would operate to instruct tissue or development-specific
transcription. However, the presence of HMGs 14 and 17 at DNase I
sensitive sites indicates structural changes in these regions.
Many more non-histone proteins have also been discovered associated 
with regions of DNA which appear to be important in determining 
transcriptional activation. Some of these are discussed in Chapter I, 
2, B(iii).
b) Histone Proteins
Histone proteins are tightly associated with DNA. The conformation of 
DNA could therefore be fundamentally altered by modification or 
variation of the associated histone proteins. Variant forms of all 5 
histones have been identified electrophoretically, as have 
tissue-specific and species-specific subfractions (Insberg, 1978). 
Changes in histones have also been identified during chick and murine 
development and during Friend erythroleukaemia cell differentiation
(Newrock et al, 1976; Cohen et al, 1979; Grove and Zweilder, 1984).
These proteins may play an important part during development and 
differentiation but their role in these processes is still unclear.
iv) Postsynthetic Modifications of Histone Proteins
Postsynthetic modifications of histones, for example acetylation, 
methylation and phosphorylation have been described, and a 
correlation between acetylation of histones and transcriptionally
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active chromatin has been reported. For example, exposure of HeLa 
cells to sodium butyrate produces multiacetlyated forms of histones 3 
and 4. This correlates with an increase in detectable DNase I 
sensitive sites in the cellular DNA (Vidali et al, 1978; Sealy and
Chalkley, 1978). It has been postulated that histone acetylation
disrupts the overall positive charge of the protein therefore 
weakening its attraction to DNA. This would make the DNA more
accessable to RNA polymerases or nucleases. Although histone 
acetylation is a characteristic of active genes, its function, if 
any, in transcriptional activation is still uncertain (Weisbrod,
1982) .
v) DNA Modifications
2-7% of the total number of cytosine residues of genomic DNA are in
the form 5-methylcytosine. Methylation occurs enzymically, following
DNA synthesis, by methyl transfer from S-adenosyl methionine (SAM) to 
position 5 of cytosine. There appears to be an inverse relationship 
between methylation of cytosine and gene activation (Razin and Riggs,
1980). The study of this relationship has been aided by the use of
specific endonucleases, which recognise the sequence CCGG: Msp I cuts 
regardless of the methylation status of the internal cytosine residue 
of this sequence but Hpa II will only cut at unmethylated sites.
Treatment of cells with 5-azacytidine prevents DNA methylation after 
replication. This treatment is found to activate genes in otherwise 
non-expressed systems, for example the metallothionien-1 gene in 
mouse lymphoid cells. Activation of this gene was coincident with 
demethylation at specific Hpa II sites (Compere and Palmiter, 1981). 
Genetic inactivation of one X-chromosome occurs in female mammals to 
ensure that the XX female has an equivalent X complement to the XY 
male. It has been postulated that methylation acts as an inhibitor of 
gene activation of the X chromosome and a maintenance mechanism of 
that state (Monk, 1985).
Sites of undermethylated CpG are frequently demonstrated clustered in 
G+C rich "islands" which are several hundred base pairs long. These 
"islands" contain CpG at more than 10 fold its density in bulk DNA 
(Bird et al, 1985). They have been termed Hpa II Tiny Fragments 
(HTFs) because of their sensitivity to the Hpa II endonuclease. HTFs
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are commonly found associated with the 5' regions of genes in the 
vertebrate genome. To date most of the associated genes represent 
those in the "house-keeping" class. It has been proposed that lack of 
methylation at these sites facilitates transcription of the
associated gene but methylation is detrimental to transcription 
(Gardiner-Garden and Frommer, 1987). For example, the gene for
hamster adenine phosphoribosyl transferase, when methylated at the 5' 
regions where HTFs are situated, is silent. However methylation in 
the body of the gene does not affect transcription (Stein et al, 
1982; Keshet et al, 1985). This suggests that G+C rich "islands" are 
specifically situated and have a role to play in the regulation of 
gene activation.
The large majority of HTFs are present upstream from the
transcription start site of many genes. However in some
"house-keeping" genes, for example glucose-6-phosphate dehydrogenase, 
HTF clusters are found downstream from the coding region (Bird,
1986). The possibility that some of these 3' islands are actually 5' 
islands relative to as yet unidentified transcripts can not be 
excluded or indeed transcription from both DNA strands could account 
for the apparent presence of 3' G+C rich islands. It can therefore be 
speculated that the position of CpG islands is critical in 
"house-keeping" genes.
Others have reported that tissue-specific gene expression can be 
determined by the degree of methylation of the DNA. Busslinger et al 
(1983) demonstrated that the globin gene, when methylated at its 5' 
region, was not expressed in transformed non-erythroid cells.
However, when removing a tissue-specific gene from the appropriate 
cellular environment and placing it in a system in which it is not 
normally expressed, the sequence is deprived of tissue-specific 
transcription factors. This would inhibit transcription irrespective 
of the methylation status of the DNA. Therefore it remains unclear if 
methylation has a role in tissue-specific gene expression (Jackson 
and Felsenfeld, 1985).
It has been postulated that hypomethylation is a ubiquitous control 
mechanism for gene regulation. Evidence to support this has come from 
studies of the methylation status of CpG islands. To date a large 
proportion of G+C rich islands appear to be unmethylated, except for
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those in the inactive X-chromosome (Gardiner-Garden and Frommer, 
1987). It has also been calculated that approximately 30 000 HTFs 
exist in the mammalian genome which correlates with the predicted 
number of genes, 20 000 - 50 000 . This would allow a 1:1
relationship between every gene and an HTF (Bird, 1986). However this 
is unlikely as HTFs appear to occur as clusters and therefore are 
unlikely to be associated with every individual gene.
A model has been proposed for the role of HTFs in gene control. These
sites are postulated to be binding sites for ubiquitous transcription 
factors (Bird, 1986). A mechanism must function to maintain 
hypomethylation of HTFs. These regions are not intrinsically
unmethylated therefore it has been proposed that the maintenance 
mechanism would operate in the germ line. "House-keeping" genes must 
be transcriptionally active in germ line cells hence the binding of 
transcription factors could obstruct methylation. Once bound these 
factors would exclude methylases and therefore inhibite methylation. 
This would enable the progression of active transcription, possibly 
by causing conformational changes in the DNA, allowing access of RNA 
polymerases to the genes. Inactivation of the gene would occur with 
displacement of the factor and methylation of the exposed site (Bird,
1986). Many tissue-specific genes also have HTFs however it appears 
unlikely that an apparent ubiquitous mechanism for transcriptional 
activation would function in a tissue-specific manner. It has 
therefore been proposed that tissue-specific transcription may 
require both the binding of ubiquitous factors to HTFs and the 
binding of tissue-specific factors to other elements (Gardiner-Garden 
and Frommer, 1987). Indeed such tissue-specific factors have been 
described (Chapter I, 2, B (iii)). Alternatively, CpG islands may 
remain hypomethylated because they bind an "anti-methylase" protein 
that is not involved in transcription (Gardiner-Garden and Frommer,
1987) .
Uncertainty also exists about the involvement of methylation in 
events which initiate transcriptional inactivation. Little is known 
of the molecular events leading to de novo methylation of DNA, but 
the data implies that most cell types are capable of methylating 
accessible CpG dinucleotides. Interestingly, teratocarcinoma cell 
lines and embryonic cells are particularly active at methylation 
which may be a consequence of the requirement to inactivate gene
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expression during development and differentiation (Jaenisch and 
Jahner, 1984). However, evidence suggests that methylation may 
maintain the inactive state of DNA but is not the initiating event. 
For example, the integrated Moloney leukaemia provirus genes are 
inactive in embryonic cells prior to the detection of de novo 
methylation (Gautsch and Wilson, 1983). The evidence supporting the 
inactivation of the X-chromosome is also not conclusive. Comparison 
of accessibility of DNA sequences on the inactivated X-chromosome to 
the endonucleases Msp I and Hpa II show variation although all the 
genes are inactive. It therefore appears that methylation is not 
sufficient for transcriptional inactivation (Monk, 1985).
vi) Z- Form DNA
Transcriptional activation requires the decondensation of a 
chromosomal domain which contains the gene to be transcribed. It has 
been proposed that sequence specific topoisomerases may play an 
active part in uncoiling the DNA allowing relaxation of torsional 
stress and accessibility of RNA polymerases to the DNA (Cockerill and 
Ganard, 1986). Alternatively, decondensation / condensation may be 
associated with the formation of left-handed or Z-form DNA. In 
physiological salt concentrations Z-DNA is not stable and readily 
converts to the B-conformation. However, it can be stabilised by 
binding of specific basic proteins such as spermine or spermidine, or 
by the presence of 5-methylcytosine (Behe and Felsenfeld, 1981). It 
has been proposed that selective demethylation of Z-DNA, thereby 
destabilising it, would result in torsional stress. This stress would 
be overcome by positive supercoiling, resulting in unwinding of the 
double helix at a position removed from the initial event. This would 
yield nuclease-sensitive, single stranded regions capable of 
interaction with trans-acting transcriptional factors (Weisbrod
1982).
vii) Summary
Detection of DNase I sensitive sites, sites of methylation, regions 
containing modified DNA associated proteins and Z-form DNA all appear 
to coincide. However, it appears unlikely that these events are the 
initiating mechanisms involved in gene inactivation or activation. 
Nevertheless, they demonstrate that conformational changes do occur
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at the sites of active gene transcription and provide an insight into 
the possible maintenance mechanisms of these changes. It can also be 
postulated that these changes in DNA reflect the relaxation of the 
DNA helix at active transcription sites required to enable
trans-acting factors access to the DNA sequence hence stimulating 
transcription.
B) PRIMARY STRUCTURAL FEATURES OF DNA AFFECTING TRANSCRIPTION RATES
Transcriptionally active genes which encode protein are transcribed
by RNA polymerase II (Chambon, 1975). It is believed that recognition
of specific DNA sequences by the transcription machinery dictates
both the site of initiation of transcription and also the rate at 
which the gene is transcribed (Maniatis et al, 1987). Initiation of 
transcription is widely held to be the primary controlling step in 
regulation of gene expression.
The gene is transcribed in the 5' to 3' direction by RNA polymerase 
II as it moves along the DNA chain adding the correct nucleotides to 
the growing hnRNA molecule. The hnRNA separates from the DNA as it is 
assembled but does not become completely separated until the 
polymerase terminates transcription. Termination of transcription 
occurs downstream from the 3' end of the mRNA and is also believed to 
be determined by specific sequence motifs (Platt, 1986). This is 
followed by cleavage of the hnRNA molecule near the polyadenylation 
site and addition of adenosine residues to the 3' end of the 
transcript (Nevins, 1983). It remains unclear if the polyadenylation 
signal has a role in termination of transcription.
i) Cis-Acting DNA Elements
At least two DNA sequence elements are required for transcriptional 
regulation of gene expression in higher eukaryotes: promoters and 
enhancers. Promoters are located immediately upstream from the start 
site of transcription and are typically about 100 base pairs in 
length whereas enhancers can be found over 1 kb from the affected 
promoter (Dynan and Tjian, 1985; Serfling et al, 1985). The promoter 
is required for accurate and efficient initiation of transcription 
whereas enhancers increase the rate of transcription from promoters.
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These sites are thought to be protein binding sites as they are 
protected from DNase I attack in DNase footprinting experiments
(Dynan and Tjian, 1985; Parker and Topol, 1984).
a) Promoters
Promoter regions, required for initiation of transcription, appear to 
be organised according to a common plan. Many promoters have an 
element called a TATA box, with a consensus sequence 'TATAAA', 
located 25-30 base pairs upstream from the transcription start site. 
It is believed that this sequence determines the efficiency and 
precise location of the transcription start site (Breathnach and 
Chambon, 1981). However, it is unlikely that the TATA box determines
transcriptional control. This has been postulated following the
discovery that not all genes possess a TATA box but are still
transcribed (Breathnach and Chambon, 1981). Mutation in this region 
also does not significantly alter RNA transcription but may generate 
heterogeneity in the region of initiation of transcription (Benoist 
and Chambon, 1981).
Typical promoters also include upstream promoter elements (UPEs); 
these elements increase the rate of transcription and therefore could 
have an important role to play as a mechanism to stimulate specific 
gene transcription. UPEs normally occur 70-200 base pairs from the 
transcriptional start site and contain one or more elements (McKnight 
and Tjian, 1986). Some upstream promoter elements such as CCAAT and 
the GC box homologies have been found in many different promoters, 
whereas others, such as the heat shock response element appears to 
have a more specialised role (Pelham, 1982; Pelham, 1985).
From mutagenesis studies it has been suggested that the strength of a 
promoter is determined by the number and the types of UPEs associated 
with it (Maniatis et al, 1987). These cis-acting elements act 
regardless of orientation with respect to the TATA box. However 
insertion of nucleotides between the UPEs and the TATA box can 
decrease the level of transcription (McKnight, 1982). It has been 
demonstrated that insertion of odd multiples of half a DNA turn is 
more detrimental to transcription than insertion of even multiples. 
This observation has led to the suggestion that one or more proteins 
bound to the UPEs interact with protein bound to the TATA box to
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stimulate transcription. This interaction must require alignment of 
the proteins on the DNA helix as insertion of DNA between these 
elements demonstrates (Takahashi et al, 1986).
Studies of the effects of mutagenesis has also revealed that the 
sequence of the UPEs is functionally important. Mutagenesis studies 
of the p-globin promoter have revealed the precise location of the 
TATA box and two UPEs. Single base mutations within any of these 
three cis-acting elements resulted in a 5-10 fold decrease in 
transcription in HeLa cells. However, base substitutions elsewhere 
within the promoter region had no effect (Myers et al, 1986). These 
results indicate that protein recognition of specific DNA sequences 
must operate during initiation of transcription. By controlling the 
availability of the transcription factor(s) and / or the 
accessibility of the UPEs the cell could therefore control gene 
expression.
b) Enhancers
A second class of cis-acting DNA elements, the enhancers, have also 
been identified. These regions are found to dramatically potentiate 
transcription from RNA polymerase II promoters. They are functionally 
different from other cis-acting DNA elements in that they function to 
enhance transcription from distances greater than 1 kb away from the 
promoter region. Enhancers also functon in an orientation independent 
manner and in a position either upstream or downstream from the 
associated promoter (Rogers and Saunders, 1985).
It is believed that enhancer activity requires the interaction of 
cis-acting elements and trans-acting factors. Mutagenesis experiments 
on the SV40 enhancer have revealed that the enhancer consists of two 
functional domains, mutation in either domain led to decrease in 
transcription which indicated the requirement for both regions for 
enhancer activity. When one or other of the domains was tested it was 
found that, singly, they only possessed weak enhancing activity. 
However, duplication of one element resulted in high enhancing power. 
Therefore enhancing power appears to be dependent on the number of 
functional domains present in the enhancer sequence, in a manner 
analogous to that of UPEs (Herr and Gluzman, 1985; Herr and Clarke,
1986).
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In vitro foot printing experiments have demonstrated that enhancer 
and promoter elements are recognised by cellular protein factors 
(Dynan and Tjian, 1985; Parker and Topol, 1984). They also show 
remarkable similarity in function and structure. Therefore it has 
been postulated that enhancers and promoters are related (Maniatis 
et al, 1987). The only difference is the ability of enhancers to 
affect transcription at great distances and in an 
orientation-independent manner from the promoter. It has been 
surmised that these differences may simply be a consequence of the 
arrangement and the number of transcription factor recognition
elements in each case rather than differences in the mechanisms by 
which these elements operate. This conclusion is supported by 
experiments involving a heat-shock regulatory element. This element 
can not act at a distance to promote transcription but duplication of 
this sequence creates an element that functions in a similar manner 
to an enhancer. (Bienz and Pelham, 1986). Enhancing power can also be 
used as a mechanism for regulating gene expression. By regulation of
the availablity of transcription factors and / or the accessibility
of the enhancer regions gene expression could be controlled.
Several models have been proposed to explain how transcription 
factors, bound to enhancer elements, great distances upstream from a 
transcription start site, can influence the rate of transcription.
The most favoured model is that of DNA looping. It is proposed that 
proteins bound to the enhancer contact proteins bound to promoter 
regions by causing the intervening DNA to loop out. This results in 
the formation of a transcriptional complex the components of which 
ultimately determine the rate of transcription. The mechanism by 
which this is accomplished is still unclear (Ptashne, 1986).
ii) Regulated and Inducible Cis-Acting Regulatory Elements
It has been discovered that the activity of some enhancers and UPEs 
are tissue-specific or development-specific. For example, Gillies
et al (1983) described an immunoglobulin enhancer which was 
functional in murine B-lymphocytes but not in murine fibroblasts. 
Others have reported 5' flanking regions of the insulin and 
chymotrypsin genes which specifically control gene expression in 
pancreatic cells (Walker et al, 1983). Interestingly, a region 400 
nucleotides 3' to the polyadenylation signal of the ^-globin DNA
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sequence has also been demonstrated to determine erythrocyte cell 
specificity. This 3' enhancer sequence was also shown to be 
developmentally activated following induced erythrocytic
differentiation (Choi and Engel, 1986). The role of enhancer elements 
in the control of gene expression in differentiation is therefore of 
fundamental importance. To determine activation it is highly likely 
that tissue-specific and development-specific trans-acting factors 
are involved.
Cis-acting regulatory elements may also function to control 
co-ordinated gene expression in development. By possessing homologous 
UPEs adjacent to the genes required to act co-ordinately, gene 
expression would be activated simultaneously, when the appropriate 
factor bound to each of the elements. This has been demonstrated with 
inducible enhancer elements. For example, induction of gene 
expression by the action of steroid hormones is mediated by a number 
of high affinity binding sites which recognise the hormone bound 
receptor (Payvar et al, 1981). Regulation of the hormonally induced 
expression of egg white proteins is thought to be initiated by 
binding of trans-acting factors to the upstream regions of these 
genes. Sequence homologies have been observed within the 5' regions 
of ovalbumin, conalbumin and ovamucoid genes (Mulvihill et al,
1982).
A protein factor has also been demonstrated to bind to both SV40 and 
c-fos enhancer regions, PEA 1. However, although the same factor is 
involved, the binding site is not found in exactly the same context 
in each case but adjacent to different elements. The fact that 
enhancers from different sources interact with the same cellular 
protein may explain the analogous behaviour of these elements in 
certain physiological situations. For example, both SV40 and c-fos 
enhancers are weakly active in F9 embryonal carcinoma cells but 
strongly activated following TPA treatment (Piette and Yaniv, 1987). 
Indeed it has been demonstrated that a large number of TPA inducible 
genes share a conserved 9 base pair motif which confers TPA 
inducibility upon heterologous promoters. It is postulated that the 
TPA-responsive element is recognised by a common cellular protein. 
Interaction of this protein with genes containing the appropriate 
motif would result in co-ordinated gene expression (Angel et al,
1987).
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iii) Trans-Acting Factors
RNA polymerase II appears to lack any inherent ability to recognise 
promoters in an in vitro reaction. Recently, it has become clear that 
crude extracts from eukaryotic cells contain factors that impart
promoter specificity to RNA polymerase II. Some of these factors,
when purified, seem to be ubiquitous, required for the activity of
most promoters, whereas others function in a specific manner. These 
trans-acting factors could therefore be used as a mechanism for
control of gene expression. Many of the cis-acting DNA elements 
associated with promoter and enhancer regions, could interact with 
one or more of these soluble, cellular protein factors resulting in 
increased gene transcription (Dyan and Tjian, 1985),
Many trans-acting factors have been isolated. One such protein is 
Spl. This protein is obtained from cultured human cells and is 
required for SV40 transcription (Dyan and Tjian, 1983), Spl
recognises and binds specifically to a GC-rich decanucleotide region 
(GGGGGG) which is found in multiple copies upstream of the affected 
promoter. This region appears to represent a HTF discussed in Chapter 
I, 2, A(v), The consequence of Spl binding is an increase in 
transcription of 10-25 fold depending on the gene. However, Spl does 
not appear to be involved in tissue-specific gene expression as Spl 
binding sites are found associated with a wide range of genes and 
found in the nuclear extracts from a number of cell types (Short,
1987). Interestingly, the GC box motif, recognised by Spl, is found 
associated with many "house-keeping" genes which are constitutively 
expressed in all cells and would therefore require a ubiquitous 
mechanism for control of gene expression. However such sites are not 
unique to 'house-keeping' genes (Short, 1987).
The CCAAT sequence, also frequently found associated with a number of 
promoters from very diverse genes, appears to be recognised by 
trans-acting factors resembling Spl. From nuclear extract of HeLa 
cells a factor termed CTF has recently been isolated which recognises 
the CCAAT sequence. On binding to this region CTF increases 
transcription of the affected promoter up to 10 fold. This has led to 
the postulation that a number of trans-acting factors exist which 
share a common, as yet unknown, mode of action. This action however 
does not appear to be development or tissue-specific (Short, 1987).
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A factor which appears to facilitate the transcription of a specific 
group of genes is the Heat Shock Transcription Factor (HSTF). In most 
cell types, when exposed to abnormally high temperatures, several 
heat-shock mRNAs are induced. The induction of transcription of these 
genes is apparently mediated by a conserved heat-shock regulatory 
sequence found in the upstream region of the promoters for heat-shock 
genes (Pelham, 1985). The trans-acting HSTF interacts
specifically with those genes possessing the heat-shock regulatory 
sequence. It is therefore highly probable that a similar mode of 
control will operate to co-ordinate tissue-specific and 
development-specific gene expression (Dyan and Tjian, 1985). Indeed 
this is demonstrated by steroid hormone regulated genes and genes 
activated by TPA treatment. In the case of TPA induced gene 
expression the factor(s) Involved have still to be identified 
(Chapter I, 2, B(iii))
From the evidence presented it is apparent that promoter and enhancer 
interactions with trans-acting factors play a crucial role in 
determining gene expression. It is interesting to note that most 
genes possess multiple upstream promoter elements capable of binding 
a number of different factors. It has therefore been proposed that 
some factors will prove crucial for initiation of transcription 
whilst other factors will be involved in the "fine tuning" of the 
system (Short, 1987).
iv) Promoter Usage
Many genes have been described which possess more than one putative 
promoter region in the immediate upstream non-coding region of the 
gene. In many instances the reason why multiple promoters exist is 
unknown. For example, the gene encoding c-myc contains three promoter 
regions. Transcription can be detected from all three but the 
functions of the different transcripts are unknown (Battey et al. 
1983; Bentley and Groudine, 1986). However, other genes have been 
described which possess more than one promoter which function in a 
tissue-specific or development-specific manner. For example, the 
isozymic form aldolase A of fructose 1,6-diphosphate aldolase, is 
expressed as three different sizes of mRUA from the same gene. The 
three mRNA species are distributed in a tissue-specific manner; one 
species of mRNA is found in skeletal muscle, one in heart, spleen and
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brain and another in liver. On examination of the mRNAs and the 
aldolase A DNA sequence, It has been postulated that the aldolase A 
gene has multiple promoters to facilitate the tissue-specific 
generation of three mRNAs (Joh et al, 1986). A similar system has
been proposed to explain the tissue - specific distribution of murine 
-amylase. This gene possesses two promoters of different 
transcriptional strengths. The stronger promoter is exclusively 
active in liver whereas the weaker promoter is active in liver and 
parotid gland (Schibler v t_ al, 1983). Ghoice of promoter can 
therefore be utilised to control gene expression in a tissue-specific 
manner.
Activation of cryptic promoters has been postulated as a potential
mechanism leading to aberrant gene expression, which could result in 
neoplastic transformation. For example, activated cryptic promoters 
in the first intron of the c»myc gene have been described following
the t(8;14) translocation involved in Burkitt's lymphoma (Nishikura,
1987), This emphasises the Importance of control of transcription in 
normal development and differentiation,
v) Termination of Transcription
Little is known about transcriptional termination but evidence is now 
gathering to suggest that termination may function as a means of 
regulating gene expression. It has been postulated that termination 
sites function constitutively or can be regulated in a manner 
analogous to promoters (Platt, 1986), However, the study of the 
potential sequence motifs and the trans-acting factors which could 
operate to regulate termination is still in its infancy.
It was postulated that termination may be a control mechanism of gene 
expression following the discovery that not all RNA polymerase 11 
complexes that begin transcription, transcribe the entire sequence. 
Prematurely terminated transcripts have been described from both 
viral and cellular genes (Weisbrod et. ji, 1980; Weintraub, 1979), It 
is still unclear however where transcription terminates and how 
specific the termination signals are in eukaryotic cells, Most 
polyadenylated RUA transcripts terminate at distances far removed 
from the 3" terminus of the mature mRNA, up to 1 kb - 4 kb, with no 
apparent similarity in the region of termination. Hence the analysis
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of termination signals is complex (Platt, 1986)
From the analysis of 3' ends of many genes the consensus sequence 
AATAAA has been identified as the signal for polyadenylation.
Deletion of the polyadenylation signal results in apparent "read
through" of the gene in many instances, however no evidence has been
found to support its direct role in termination (Birnstiel et al,
1985). Endonuclease hypersensitive regions have been mapped to the 3' 
termini of many genes. This has led to the postulation that other
sequences and trans-acting factors must be involved in 
transcriptional termination (Fritton et al, 1983; Groudine et al.
1983).
Examination of the 3' termini of many yeast genes has revealed a 
sequence which on deletion reduces transcription from the affected 
gene. If mRNA is detected the transcripts appear larger than normal. 
Interestingly, there appears to be homology between the 3' sequence 
in yeast and a 3' sequence in the ADH3 gene of Drosophila (Falco 
et al, 1985; Henikaff et al, 1983). Others have described hair-pin 
loops at the 3' end of histone genes. Hair-pin loops have been 
postulated to act as simple termination signals in prokaryotes. It 
has been proposed that transcriptional complex pausing at hair-pin 
loops may facilitate termination (Platt, 1986). The hair-pin loops 
found in association with the histone genes are associated with a 
conserved sequence. However, deletion of these elements did not stop 
termination at the correct region. It has therefore been proposed 
that these elements exist to aid in the modification and maturation 
of non-polyadenylated RNA (Birchmeier et al. 1983; Birchmeier et al,
1984).
Premature termination of transcription has been observed in both 
viral and cellular systems. It is believed that this event may play a 
role in determining gene expression (Platt, 1986). Termination is 
thought to be brought about by changes in the secondary structure of 
DNA. For example, after the initiation of late transcription in SV40, 
RNA polymerase II terminates prematurely at a hair-pin loop in the 
VP1 gene, producing short aborted RNA (Hay et al, 1982), The VP1 gene 
is negatively regulated at the level of transcription by a protein 
(the agnoprotein) which causes this premature termination (Hay and
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Aloni, 1985). It is thought that by alteration of 5' end of the VP1 
gene transcriptional read-through or termination is determined. These 
changes are in turn determined by the presence or absence of the 
agnoprotein and have been associated with the formation of stem-loop 
structures. (Hay and Aloni, 1985). Interestingly, it appears that 
down regulation of c-myc gene expression following induction of HL60 
cells by DMSO may occur by an analogous mechanism to that described 
for VP1 (Eick and Bornkamm, 1986).
From the evidence available it would appear that termination does
play a role in the regulation of gene expression. However, it has 
been proposed that a number of cis-acting elements possibly act 
co-ordinately to determine the strength of the termination signal in 
a manner analogous to the 5' promoter and enhancer elements (Platt, 
1986). To implement termination trans-acting factors must also be 
involved. One such factor has been described in the prokaryotic 
system, the rho protein of E. coli. Rho functions as a terminator of 
transcription by specific sequence recognition of regions in the 
nascent RNA chain (Platt, 1986). Binding of the Rho factor to the RNA 
then facilitates the release of the transcript from the transcription 
machinery (Platt, 1986). It is tempting to speculate that factors
involved in the termination of eukaryotic gene expression may
function in a tissue-specific or a development-specific fashion. 
Evidence for development-specific termination has been described by 
Mather et al, (1984). They have reported that termination of
transcription between the ju and the o' immunoglobulin genes only 
occurs upon maturation of B-lymphocytes.
An example of gene expression determined by termination is 
demonstrated by adenovirus. The lytic cycle of adenovirus infection 
is divided into two functionally distinct phases, the early phase
preceding, and the late phase beginning at the onset of viral DNA 
replication. It had been assumed that the major late transcription 
unit of adenovirus was activated at the shift from early to late 
phase. However, a low level of transcription was detected from the 
late unit early in the infectious cycle. During early times of
infection the late promoter is active but transcription terminates 
within the L2 region of the late unit hence only LI is transcribed.
The shift from early to late phase appears to result in loss of a
termination signal, allowing transcriptional read-through and the
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expression of the other genes on the major late transcription unit 
(Akusjarvi and Persson, 1981).
vi) Gene Dosage
One potential mechanism for increasing gene expression is to increase 
the number of transcription units. Quantitative changes in gene copy 
number are found in many systems. For example, during amphibian 
development ribosomal RNA genes are amplified 1000 - 2000 fold (Brown 
and Dawid, 1968). The chorion genes in the ovaries of Drosophila are 
also amplified (Spradling and Mahowald, 1980). Specific gene
amplification has also been detected when bacteria or mammalian 
somatic cells are cultured under selective conditions (Anderson and 
Roth, 1977; Schimke, 1984).
However, amplification as a mechanism for increasing gene expression 
does not appear to be a common event in eukaryotes. Even in cell 
types almost totally dedicated to the production of one protein only 
one gene copy exists; for example, erythroid cells are almost solely 
concerned with the production of globins but only possess one copy of 
each of the globin genes (Harrison et al, 1977). The amplification of 
certain genes has been implicated in processes leading to neoplastic 
transformation. For example, amplification of the c-myc gene has been 
observed in the promyelocytic cell line HL60, derived from a patient 
suffering from acute promyelocytic leukaemia (Dalla-Favera et al,
1982). Similarly, L-myc sequences have also been reported to be 
amplified only in small cell lung carcinoma cells (Little et al,
1983) and amplification of N-myc sequences have been reported in 
neuroblastomas, retinoblastomas and small cell lung carcinomas 
(Schwab et: al, 1983). It has been speculated that amplification of 
myc sequences results in over production of myc products which could 
play a role in the events leading to transformation. Indeed a 
correlation between the degree of c-myc amplification and the 
relative abundance of c-myc transcripts in HL60 cells has been 
reported (Graham et al, 1985). However, it is unknown if 
amplification is causally related to cancer.
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C) Post-Transcriptional Control
RNA processing is the term given to the sequence of events that 
convert a primary RNA transcript to a mature mRNA. These events begin 
immediately after RNA polymerase II initiation of transcription, 
possibly before the polymerase moves past the initiation site. The 
first known event in RNA processing is the addition of
7-methyl-guanosine triphosphate and methylation of the 5' end of the 
nascent RNA chain, the cap structure (Salditt-Georgieff et al, 1980). 
Few, if any, RNA polymerase II products escape this 5' modification; 
this has been demonstrated not only in vivo but also on prematurely 
terminated RNA chains and RNA transcripts synthesised in vitro by 
cell extract supplemented RNA polymerase II activity 
(Salditt-Georgieff et al, 1981). Therefore capping appears to be a 
ubiquitous event in mRNA processing.
As the RNA chain grows it is thought to become organised into a 
ribonucleoprotein (RNP) complex by association with basic proteins. 
This may protect the nascent RNA chain from degradation by endogenous 
cellular nucleases and maintain the RNA chain in a conformation 
optimum for further processing steps (Padgett et al, 1986).
Transcription then proceeds beyond the 3' end of the mature mRNA 
before termination. A processing event follows, at the 3' end of the 
RNA chain, resulting in cleavage at the polyadenylation site followed 
by polyadenylation of the RNA (Nevins, 1983).
RNA, at this stage, is termed heterogeneous (hn) RNA. It has long
been recognised that not every part of every hnRNA molecule
contributes to cytoplasmic mRNA. This was demonstrated by kinetic 
labelling studies in cultured cells which showed labelling of hnRNA 
to be as great as 20 fold that of cytoplasmic RNA (Jelinek et al, 
1973; Lengyel and Penman, 1975). In addition complexity studies, 
based on nucleic acid reassociation kinetics, established that hnRNA 
has a complexity approximately ten fold greater than cytoplasmic 
polyadenylated RNA (Getz et al, 1975). This led to the discovery of 
intron sequences in eukaryotic genes, regions which are specifically 
excised out of the hnRNA with subsequent splicing of adjacent exons 
to produce a mature mRNA. This process occurs in the cell nucleus
before transportation of the transcript to the cytoplasm but 
following polyadenylation (Padgett et al, 1986).
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Obviously control of gene expression in differentiation could be 
implemented at any point in the succession of steps leading to 
the production of a mature mRNA transcript. The evidence to support 
such controls will be discussed.
i) The Cap Structure
The cap structure is a ubiquitous feature of all RNA polymerase II 
transcripts and therefore this modification would appear unlikely to 
play a significant role in the control of gene expression. However, 
it has been proposed that the cap structure has a role in pre-mRNA 
splicing. This has been demonstrated using in vitro RNA processing 
systems. It has been reported that capped pre-mRNAs are spliced more 
efficiently and that they produce less aberrantly spliced molecules 
than uncapped pre-mRNAs. Furthermore, cap analogues reduce the 
efficiency of splicing in HeLa cell extracts (Konarska et al, 1984). 
Others have reported that the formation of pre-mRNA splicing 
complexes, a complex structure consisting of a number of nuclear 
proteins and RNA elements required for efficient splicing, is 
inhibited by cap analogues and is not correctly formed when uncapped 
pre-mRNAs are used in jin vitro assays of splicing. This has led to 
the proposal that the splicing complex interacts with the cap 
structure in some way, which is crucial to the assembly of the active 
splicing complex (Patzelt et al, 1987). However, it is still unclear 
if the cap structure has a role in regulation of splicing.
ii) Polyadenylation
Polyadenylation occurs after transcription is completed but prior to 
splicing events. The signal for polyadenylation is believed to be the 
consensus sequence AATAAA, found down stream from the coding region 
of most RNA polymerase II transcription units. Transcription 
continues past the polyadenylation signal before terminating. This is 
followed by cleavage at the polyadenylation site and the addition of 
poly(A) to the 3' end of the hnRNA (Nevin, 1983). Many genes have 
been reported which apparently possess multiple polyadenylation 
consensus sequences, for example the dihydrofolate reductase (DHFR) 
genes and the gene encoding the cap recognition protein (CRP), 
involved in initiation of the translation process, possess three. It
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has therefore been proposed that selection of the appropriate 
polyadenylation site may act as a control mechanism in the regulation 
of gene expression (Rychlick et al, 1987; Kaufman and Sharp, 1983).
Polyadenylation has also been implicated in determining the stability 
of mRNAs. Stabilisation could act as a potential mechanism of gene 
control: increase in transcript stability would effectively increase
the translation potential of the affected mRNA; instability would 
obviously have the opposite effect, leading to reduced translation 
potential or lack of availability altogether due to rapid 
degradation. Initial experiments demonstrating the effects of 
polyadenylation on transcript stability utilised in vivo translation 
systems; injection of non-polyadenylated or polyadenylated 
transcripts into HeLa cells or Xenopus eggs was carried out followed 
by comparison of the half-lifes of the transcripts. From this work it 
was concluded that polyadenylation was a prerequisite for ensuring 
stability. Non-polyadenylated transcripts were not detectable at 
short times after injection and were not translated whereas
polyadenylated RNA translation products were observed (Huez et al,
1981). Interestingly, a hair-pin loop structure found at the 3' 
terminal region of histone mRNAs, which are not polyadenylated, has 
also been shown to confer stability to non-polyadenylated p-globin 
mRNA when it is exchanged with the globin polyadenylated tail. This 
highlights the importance of 3' RNA sequences in determining 
transcript stability (Whitelaw et al, 1986). Transcript stability is 
discussed in Chapter I, 2, C (v) .
iii) Splicing Events
Splicing is a crucial event in determining the correct coding 
sequence of mature mRNA and therefore the correct cellular protein 
complement. Regions of RNA sequence, introns, that do not contain 
coding sequence required for the particular mRNA being processed, are 
removed from hnRNA with the concomita nt splicing of two adjacent 
exons, to form a mature mRNA transcript. This transcript can then be 
transported from the nucleus for translation in the cytoplasm 
(Breathnach and Chambon, 1981). Control of the splicing event in RNA 
processing can therefore be used as a mechanism of regulation of gene 
expression. The splicing event is initiated by a splicing complex or 
splicesome which consists of many components including proteins and
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small ribonucleoproteins (SnRNPs) (Grabowski et al, 1985). Splicing
results in the production of the spliced exons relating to the mature
mRNA and the excised intron RNA which is termed lariat RNA; this is 
rapidly degraded on release from the splicing complex (Padgett et al, 
1986) .
Specificity of splicing is determined by recognition of consensus
sequences surrounding the intron / exon boundaries. However, some 
splicing consensus sequences are selected over others. This has led 
to the postulation that other sequences and trans-acting factors must 
also be involved in determining the splicing event. Tight control 
must also operate to eliminate trans-splicing events, that is 
splicing between two exons from heterologous genes (Padgett et al,
1986). Many genes contain intron sequences of varying size and 
number. It is therefore feasible that by manipulation of the splicing 
event and by use of alternative splicing patterns one gene could 
effectively code for a number of different but related proteins.
Examples of this have been described; various mRNAs are transcribed 
from the major late transcription unit of adenovirus late in 
infection. These transcripts are produced from one region of DNA by 
the interaction of alternative splicing events and selection of 
different termination sites (Akusjarvi and Persson 1981). Alternative 
splicing has also been reported in the production of two la antigen 
associated invariant chain proteins encoded by a gene located in the 
HLA-D region of the major histocompatibility complex (MHC) in man 
(Strubin et al, 1986). Other examples of alternative splicing have 
been reported for the immunoglobulin genes and the mouse major 
urinary protein genes (Alt et: al, 1980; Clark et al, 1984).
Splicing has also been implicated as one of the requirements for the 
efficient transport of mRNA to the cytoplasm. However, RNAs which do 
not possess introns are efficiently transported from the nucleus to 
the cytoplasm without any splicing event which contradicts this 
proposal (Padgett et al, 1986). Nevertheless others have demonstrated 
a requirement for splicing prior to transport. When a cDNA copy of 
the 16S transcription unit of SV40, replaces itself in a replicating 
SV40 vector, the inserted cDNA did not produce cytoplasmic mRNA 
products. Only after reinsertion of an intron into the 16S 
transcription unit was the production of cytoplasmic mRNA restored 
(Gruss et al, 1979) . Therefore there are contradictory views on the
53
necessity of splicing for transport to the cytoplasm. However, it 
seems that these two processes may be linked in some way to determine
that only mature mRNA is transported from the nucleus.
It therefore appears that splicing can act as a mechanism for the 
regulation of gene expression. Alternative splicing patterns enable a 
number of products to be produced from the one gene. Control of
splicing could therefore determine which product is produced. This 
could be determined by tissue-specific or development-specific
factors which could alter the specificity of the splicing reaction. 
However, the existence of factors which specifically regulate 
transcription has still to be established. The rate at which the
splicing reaction occurs could also act as a mechanism to regulate
the production of mature mRNA. It has already been established that 
the half-life of introns within precursor RNAs can vary from a few
seconds to 10-20 minutes (Padgett et al, 1986). However the factors
which determine the rate of removal of introns o^e not known. A model 
has been proposed by Pikielny and Roshbach (1985) which indicates how 
the rate of splicing can affect the levels of mRNA in the cytoplasm. 
It is proposed that if the rate of the splicing reaction is faster 
than the turnover of hnRNA the level of mRNA will be maximal, almost 
all the hnRNA is processed into mRNA. However, if the rate of the 
splicing reaction is less than that of the turnover of the precursor
most of the hnRNA will be degraded before it can be spliced. 
Therefore, by altering the rate of splicing regulation of gene 
expression could be accomplished. However there have been no reports 
to support this type of regulation of gene expression.
iv) Nucleo-cytoplasmic Transport
Before a mRNA can be translated into protein and therefore contribute 
to the cell phenotype the transcript has to be transported from the 
nucleus to the the cytoplasm and hence to the translation machinery. 
The mechanisms involved in this process are unknown and examples of 
control at the level of nucleo-cytoplasmic transport are difficult to 
determine as other factors, such as increased nuclear stability or 
decreased cytoplasmic stability could generate data consistent with 
transport regulation. However, an example of regulation of gene 
expression at the stage of transcript transportation has been 
described for the transcripts from the <i,i-2u -S^0 )^U^ ^n §ene •
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°C2u"slobulin is a glucocorticoid regulated liver gene. However, 
following adrenalectomy of rats, it was found that in the absence of
glucocorticoid stimulation oc 2u "Slobulin RNA was depleted in
polysomal RNA but increased in nuclear RNA of liver cells. It was 
proposed that loss of glucocorticoid stimulation led to the
inhibition of the nucleo-cytoplasmic transport of °<2U -globulin RNA. 
Injection of Dexamethasone (a synthetic glucocorticoid hormone)
resulted in the reduction of nuclear oc 2u-globulin RNA and a
concomitant increase in polysomal transcripts supporting the proposal 
of control of expression operating at the stage of nucleo-cytoplasmic 
transport (Fulton et al, 1985).
Evidence that specific transport mechanisms must exist have come from 
many sources. Injected histone mRNAs are matured and transported from 
Xenopus nuclei within 30 minutes. This can not simply be due to 
unrestricted diffusion as unprocessed histone transcripts would also 
appear in the cytoplasm (Georgiev et al, 1984). Others have studied 
the regulation of transport of mRNAs from isolated nuclei (Schumm and 
Webb, 1983). They reported hormonal regulation of gene expression at 
the level of nucleo-cytoplasmic transport as it appeared that only 
specific mRNAs were transported from the nucleus in response to a 
hormonal stimulus. However, these experiments are prone to artifacts 
therefore specificity of the response of the isolated nuclei is 
difficult to assess. Chan (1976) has also reported an example of 
possible control of gene expression at the level of 
nucleo-cytoplasmic transport. Globin mRNA was found to be synthesised 
and retained in the nucleus of embryonic erythroid cells during the 
first 24 hours of culture. Within the next 24 hours there was an 
almost complete transfer of globin mRNA from the nucleus to the 
cytoplasm. These results indicate that sequence-specific regulation 
of transport from the nucleus to the cytoplasm exists. However the 
mechanisms which function to determine transport are not known.
v) mRNA Stability
It has been demonstrated that different mRNAs have different rates of 
decay or half-lives. Many transcripts are short lived while others 
have half-lives of many hours, p-globin mRNA is relatively stable 
with a half-life greater than 17 hours (Volloch and Housman, 1981). 
In contrast, c-fos transcripts have a half-life of 15 minutes or less
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(Greenberg and Ziff, 1984). Clearly, some factor(s) must operate to 
determine transcript stability. By changing their stability mRNAs 
would be available for long periods of time increasing their 
translation potential, or conversely, could be made so unstable as to 
effectively eliminate any possibility of translation. Modulation of 
transcript stability could therefore regulate gene expression.
Many have reported increased transcription as a mechanism of 
increasing the relative abundance of specific mRNAs. For example, 
steroid hormones are thought to initiate the transcription of genes 
in a highly specific manner; oestrogen selectively activates the 
vitellogenin gene in liver (Brock and Shapiro, 1983a) and the peptide 
hormone prolactin specifically activates casein gene expression in
mammary gland tissue (Guyette et al, 1979). However, it has 
subsequently been demonstrated that the effects of hormone-activated
transcription are amplified by a specific stabilisation of the
affected mRNAs. The half-life of the casein message was increased 
seventeen fold in the presence of prolactin; vitellogenin mRNA 
half-life increased over thirty fold in the presence of oestrogen 
(Guyette et al, 1979; Brock and Shapiro, 1983b).
Others have reported the change from stable to unstable transcripts 
as a means of regulating gene expression. For example, the 
dihydrofolate reductase (DHFR) genes are active during exponential 
phase of growth in methotrexate-resistant mouse cell lines but the 
transcripts from these genes are undetectable in resting cells. Leys 
et aJL (1984) have demonstrated that DHFR mRNA is more stable in 
growing than resting cells and have postulated that most DHFR 
transcripts are processed into mRNA in growing cells but in resting 
cells the transcripts are rapidly degraded in the nucleus.
Relatively little is known about the mechanisms controlling mRNA
stability. However, evidence is now gathering that indicates that 
specific sequence recognition could be involved. For example, 
truncated c-myc genes, found in certain B lymphoid tumour cells, 
transcribe a more stable mRNA than the full length c-myc gene. 
Truncation results in the loss of the c-myc gene first 5' exon which 
indicates that interaction between this sequence and as yet unknown 
factors could determine c-myc transcript instability (Rabbits et al,
1985). Shaw and Kamen (1986), recently demonstrated that an A and T
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rich sequence in the 3' untranslated region of many short lived
transcripts confers instability. The sequence was initially 
identified within the 3' untranslated region of the lymphokine
granulocyte-macrophage colony stimulating factor (GM-CSF) transcript, 
but has subsequently been identified in many more transcripts
including c-fos and c-myc. Shaw and Kamen (1986) demonstrated the 
effects of this sequence on transcript stability by inserting the 3' 
untranslated sequence of GM-CSF into the 3' untranslated region of 
the p-globin gene. In transfection studies the inserted sequence 
conferred instability on the £-globin transcripts resulting in 
B-globin mRNA with a half-life of less than thirty minutes compared 
to the normal seventeen hours (Shaw and Kamen, 1986).
Shaw and Kamen (1986) also demonstrated that cycloheximide treatment, 
a protein synthesis inhibitor, increased the half-life of the mRNA 
transcribed from the JS-globin construct. This has also been 
demonstrated for other short lived mRNA species, for example c-fos 
and c-myc (Greenberg et al, 1986). This has led to the proposal that 
the conserved sequence at the 3' untranslated region of short lived 
transcripts may be a recognition site for a labile RNA binding 
protein involved in the specific degradation of transiently expressed 
mRNAs (Rahmsdorf et al, 1987). In the light of these discoveries it 
seems highly probable that other cis-acting elements and trans-acting 
factors will be involved in the determination of transcript
stability.
It has been postulated that polyadenylation of mRNA has a role in 
determining stability of mature transcripts (see Chapter I, 2, C
(ii)). Stability of both polyadenylated and deadenylated transcripts 
has been determined by the efficiency of translation of these RNAs 
when injected into Xenopus oocytes. Conflicting results have been
reported; deadenylated mRNAs have been observed to be more labile 
than adenylated species but conversely some data indicate that 
deadenylated transcripts are as stable as adenylated mRNA in this 
system (Heuy et al, 1974; Sehgal et al, 1978). Recently it has been 
reported that c-myc transcripts which lack long poly(A) tails exist
in HL60 cells and that these transcripts are more stable than c-myc
mRNA which possess a long poly(A) tail. This contradicts the proposal 
that polyadenylation of RNA is required for stability (Swartwout 
££ al, 1987). Therefore, it remains unclear if polyadenylation is
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important in determining RNA stability and hence plays a role in the 
regulation of gene expression.
vi) Control of Translation
Once transported from the nucleus to the cytoplasm the mRNA 
transcripts are translated by the translation machinery to protein. 
Translation requires the interaction of the ribosomal complex with 
specific sequences at the 5' end of the transcript. Once this is 
accomplished the ribosomal complexes move along the RNA chain
facilitating the synthesis of protein as directed by the coding 
region of the mRNA. Gene expression could therefore be determined by 
the efficiency of translation. This could be implemented by 
regulation of the interaction between mRNA and the translation 
machinery.
Examples of differential translation of mature cytoplasmic mRNAs have 
been described in embryonic development. Rosenthal et al (1980) 
demonstrated that striking changes occurred in the pattern of protein 
synthesis shortly after the fertilisation of clam eggs. The synthesis 
of specific oocyte proteins was reduced whereas the synthesis of many 
proteins found during early embryogenesis of the clam were increased. 
However, the mRNAs for both sets of proteins were present at all 
times but differentially expressed. These results suggest that 
selection of mRNAs for translation can act as a mechanism for the 
regulation of gene expression. Others have reported an apparent 
increase in translation efficiency as a mechanism operating to 
increase the concentration of translation products. Following 
fertilisation, sea-urchin oocytes become at least 50 fold more active 
in protein synthesis, from the same number of mRNAs as is detected at 
pre-fertilisation times (Brandhorst, (1976). Variation in protein 
synthesis has also been detected in non-embryonic cells. For example, 
following heat-shock of mammalian cells, decrease in total protein 
synthesis occurs despite the presence of a normal mRNA complement 
(Kelley and Schlessinger, 1978).
To control gene expression at the level of translation mechanisms 
could operate at the initiation step of mRNA recognition by the 
translation machinery. Indeed interaction between the 5' cap 
structure and cap-binding protein appears to be an important step in
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the initiation of translation (Shatkin, 1985). The cap binding 
protein is thought to interact with the translation complex to 
facilitate the start of translation (Lax et al, 1985). Therefore, by 
controlling this interaction the mRNA would effectively be removed 
from the translation pool.
RNA / RNA interactions have also been proposed as a mechanism for 
regulation of gene expression at the translation stage. It is 
postulated that anti-sense RNA, produced from naturally occurring 
regulatory genes, can directly control gene expression by specific 
sequence interaction.
Anti-sense RNA was initially discovered in prokaryotestAere it has 
been implicated in the regulation of diverse processes in bacteria 
such as plasmid replication and bacterial and phage gene expression 
(Rosen et al, 1981; Mizuno et al, 1984). For example, in E.coli the 
micF anti-sense RNA represses the synthesis of the outer membrane 
porin OmpF. The region encoding the micF RNA was found to contain a 
stretch of approximately 85 base pairs which was homologous to DNA 
encoding the 5' end of the OmpF mRNA, including the ribosomal binding 
site and the OmpF initiation codon. From SI mapping studies, it was 
found that the homologous DNA was transcribed in the opposite 
direction from the Omp F gene. It has been proposed that the 
complementary micF RNA inhibits OmpF expression by forming a hybrid 
with the OmpF transcript hence inhibiting translation of the OmpF 
mRNA (Mizuno et al, 1984).
It has been postulated that a similar mechanism could operate in 
eukaryotic cells. Potential regions of anti-sense transcription have 
been demonstrated in vitro. using nuclear run-on assays. For example, 
regions of anti-sense transcription have been reported in the regions 
upstream of the human c-myc exon 1 gene. However, no anti-sense 
transcripts could be detected by Northern blot analysis (Nepvue and 
Marcu, 1986). Therefore the potential for anti-sense transcription 
must exist in eukaryote cells. However, to date, no naturally 
occurring anti-sense genes have been discovered. This implies that 
the regions of anti-sense transcription detected by nuclear run-on 
may be artifactual. It is unlikely that all the controlling factors 
found in the cell will be present in in vitro systems for analysis of 
transcription therefore this could allow transcription events to
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occur in these analyses which would normally be restricted in the 
cell.
In vitro assays have also revealed that artificially synthesised
anti-sense RNA can be used to regulate the expression of a selected 
gene in eukaryotes. For example, experiments have been carried out 
involving co-transfection of plasmids containing the sense and 
anti-sense forms of a specific gene. This resulted in a significantly 
lower level of expression of the assayed cDNA than was detected when 
the cDNA was transfected in the sense orientation only. This has now 
been observed for a number of genes including actin, the thymidine 
kinase gene and others (Izant and Weintraub, 1984; Izant and 
Weintraub, 1985). This demonstrates the wide-spread sensitivity to
anti-sense inhibition in the eukaryotic genome. However, to
successfully regulate gene expression by this method antisense
transcripts have to be co-transfected at concentrations 50-100 fold 
greater than the sense transcripts. It can therefore be surmised that 
regulation of gene expression by anti-sense transcription is not 
efficient. Alternatively, anti-sense transcripts may be rapidly 
degraded hence the need for such a high ratio of anti-sense to sense 
RNA in transfection analyses.
Repression is thought to be accomplished by the formation of
anti-sense RNA : mRNA hybrid complexes. In the prokaryotic system the 
most effective anti-sense RNAs are complementary to the 5' end of the 
target mRNA which generally includes the translation initiation site. 
However, in eukaryotes, anti-sense RNA complementary to 5' non-coding 
regions and 3' coding regions have been equally associated with
efficient inhibition of expression. This may be due to the need for 
several parameters operating co-ordinately in the eukaryotic genome 
to facilitate the inhibitory effect (Green et al, 1986).
D) Post-Translational Control
Following translation, a protein may require a number of
modifications to become fully functional. This may entail the 
addition of prosthetic groups, glycosylation, methylation or 
phosphorylation. Proteolysis of the primary translation product may 
also be required. Therefore, by controlling the availability of the
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effectors of these processes a cell can effectively regulate protein 
activity.
For example, it has been postulated that proteolytic cleavage occurs 
in the posterior pituitary, where cells can produce either 
adrenocorticotropin or £-lipotropin from the same primary translation 
product (Roberts and Herbert, 1977). Changes in protein glycosylation 
have been observed during differentiation. The human colon cell line 
HT-29 differentiates to mature enterocytes when cultured in 
glucose-free medium. This is accompanied by expression of microvillar 
hydrolases and other enterocytic proteins. In the case of 
sucrase-isomaltase, the enzyme activity is absent in undifferentiated 
cells but present following induced differentiation. The mRNA 
encoding sucrase-isomaltase is present and the protein is synthesised 
in undifferentiated cells. However the enzyme is rapidly degraded and 
appears to have a glycosylation pattern which is altered from that of 
differentiated cells. Therefore it has been proposed that the enzyme 
would normally be processed, transported and integrated into the 
plasma membrane of differentiated enterocytic cells but aberrant 
glycosylation impairs this process (Trugnan et al, 1987).
The addition of prosthetic groups has also been recognised as 
occupying a prominent position in the pathways that govern the 
phenotypes of vertebrate cells. Phosphorylation of specific amino 
acid residues has been demonstrated as crucial to the function of 
many proteins (Hunter and Cooper, 1985). Therefore by controlling the 
addition of prosthetic groups the cell can regulate gene expression. 
It is interesting to note that some oncogenes have been identified 
which possess the ability to modify proteins and hence activate them. 
For example, the retroviral oncogene v-src and its cellular 
progenitor c-src are protein-tyrosine kinases (Collett and Erikson, 
1978; Collett et al, 1978). It is believed that one of the functions 
of tyrosine kinases is to act as transmembrane receptors for 
polypeptide hormones, such as insulin and epidermal growth factor. 
Interaction with the hormone initiates a chain of events from cell 
division to specific differentiation hence these proteins play a 
crucial role in gene expression and regulation (Staros et al, 1985; 
Taylor, 1987).
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E) Summary
i) Regulatory Mechanisms for Individual Genes
Many potential mechanisms for the regulation of gene expression have 
been identified. The primary control step would appear to be at the 
initiation of transcription but it is becoming increasingly clear
that regulation at both transcriptional and post-transcriptional 
levels contribute to differential gene expression. Studies have
revealed that a single gene can possess many potential control 
elements, indicating that control of gene expression is a complex 
process probably involving the function of a number of different 
regulatory mechanisms. For example, the c-myc gene contains many 
elements upstream from the coding region which could be used as
mechanisms for controlling gene expression; these include both
cryptic and active promoter sites and regions which have been
implicated in anti-sense transcription and transcriptional pausing 
(Battey et al, 1983; Bentley and Groudine, 1986; Nishikura, 1987; 
Nepveu and Marcu, 1986 and Eick and Bornkamm, 1986). At the 3' end of 
the c-myc gene two polyadenylation sites have been identified and 
also in this region there exists a sequence motif that is believed to 
be involved in determining transcript stability (Shaw and Kamen,
1986). However, it is unclear if all these elements are functional in 
determining the expression of c-myc.
It has been proposed that the interaction of transcriptional and 
post-transcriptional control mechanisms for the regulation of gene
expression operate in the form of a cascade to mediate rapid response 
to changing conditions and act as fine tuning devices (Short, 1987). 
Interaction of different control mechanisms would also amplify the 
effects of stimulation on gene transcription. This would result in 
increasing the abundance of the final protein product by many factors 
more than would be achieved by stimulation of transcription alone 
(Tobin, 1979). For example, steroid hormones have been demonstrated 
to increase the rate of transcription of hormone-responsive genes by 
5-10 fold. However, this increase was not sufficient to account for 
the enormous accumulation of specific mRNA from these genes. It has 
been demonstrated that this increase is accomplished by interaction 
of mechanisms for regulation of transcription and also for regulation 
of mRNA stability (Guyette et al,1979; Brock and Shapiro, 1983b).
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Hence, by employing two different mechanisms for regulation of gene
expression the stimulatory effect of the hormone is amplified.
ii) Co-ordination of Control
In addition to the interaction of individual control mechanisms 
operating on single genes, there are wider ranging control mechanisms 
determining the repressed or active state of sets of genes which are 
co-ordinately expressed or repressed during differentiation or are 
required in a co-ordinated manner, for example in an enzyme cascade. 
For these processes to occur some form of primary control must exist 
which allows sets of genes to be switched on and off in a controlled 
manner. From cell hybrid studies between unrelated cell types which 
under go "phenotypic switching" under different culturing conditions, 
it has been proposed that "master" regulatory factors must play a
role in establishing cell phenotype (Harrison, 1984). However, such 
factors have yet to be identified.
For sets of genes, present in the genome in tandem, such as the 
histone genes of sea-urchins, control could conceivably be
implemented at one end of the gene array and be sufficient to control 
all the related genes (Hentschel and Birnsteil, 1981). However, it
would be more difficult to co-ordinately control genes separated by
large distances or even on different chromosomes. Many different
proposals have been made to explain how co-ordinated control of gene 
expression could be implemented. For example, actively transcribing
genes have been shown to be associated with the nuclear matrix with
looping out of intervening non-transcribed regions (Ciejek et al, 
1983). This would allow genes, which are spatially far apart, to be 
brought very close to one another and concentrate the action of
regulatory molecules in specific regions hence facilitating 
co-ordinate gene expression.
Other models have proposed the interaction of trans-acting factors
with cis-acting sites as a mechanism for co-ordinated control. An
initial model, proposed by Davidson and Britten (1979) stated that
repetitive sequence transcripts could act in trans to regulate the 
expression of a set of genes containing homology with the repetitive 
sequence transcripts. These homologous regions may represent 
cis-acting regulatory elements for the differentially regulated
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genes. Co-ordination of gene control in this model ultimately depends 
on regulation of transcription of the repetitive elements. Murphy 
et al (1983) have supported this model. They discovered sets of genes 
which are activated in all SV40 transformed cell lines and are 
regulated during embryonic development. All these genes share a 
repetitive element and it is proposed that this element may act as a 
co-ordinate regulatory sequence.
Analysis of the 5' flanking regions of co-ordinately expressed genes 
have revealed regions of homology and synchronous appearance of 
nuclease sensitive sites during gene activation. This has been 
proposed to indicate common control mechanisms operating for each of 
the co-ordinately expressed genes. For example, Affara et al (1985) 
demonstrated that genes which are co-ordinately expressed in 
erythropoiesis are controlled by trans-acting factors which modify 
the chromatin structure around these genes. Fowlkes et al (1984) have 
also demonstrated that the three genes encoding the fibrinogen 
proteins, although separated by large intervening DNA sequences, have 
conserved homology in their 5' flanking regions.
A model has also been proposed which states that formation of stable 
transcription complexes may repress or activate eukaryotic genes. 
Brown (1984) proposes that transcription complexes are composed of
more than one molecule. Formation of these complexes may be involved
in commitment to a particular differentiation pathway but binding of 
trans-acting factors would actually modulate the effect of the stable 
complex on gene transcription during differentiation. If a set of 
co-ordinately expressed genes all require the same molecules to 
construct the transcription complex this would provide a suitable 
mechanism for co-ordination of gene expression. Evidence to support 
this model has come from the discovery of tissue-specific and 
development-specific promoter and enhancer elements which may compete 
for trans-acting factors (see Chapter I, 2, B). Therefore activation 
or repression of such trans-acting factors would result in the 
co-ordinated control of all those genes containing the cis-acting
element responsive to the trans-acting factor.
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3 THE HL6Q PROMYELOCYTIC CELL LINE
The human promyelocytic cell line HL60 was established from the 
peripheral blood leukocytes from a patient with acute promyelocytic 
leukaemia (Collins et al, 1977). HL60 cells maintain continuous 
growth in suspension culture, with a doubling time of 24 hours when 
the cells are in exponential phase of growth. The cells have been 
shown to be tumo .rigenic when inoculated into athymic nude mice 
(Collins et al, 1978). The majority of HL60 cells are promyelocytic 
in morphology and histochemistry, but 4-15% can display morphological 
characteristics of more mature myeloid cells, such as myelocytes, 
metamyelocytes and polymorphonuclear leukocytes (Collins et al,
1977). Promyelocytes are thought to be an early cell found on the 
cell lineage leading to mature granulocytic differentiation. Figure 3 
shows a schematic representation of the myeloid differentiation 
lineages and gives the proposed position of the HL60 cell line on the 
differentiation pathway.
A) The HL60 Genome
HL60 cells are aneuploid; abnormalities have been described in the 
genetic complement of these cells. Amplification of DNA sequences 
homologous to c-myc, the oncogene of the transforming avian 
retrovirus MC29, have been found in the cell line and have also been 
demonstrated in the primary leukaemic cells from which the cell line 
was established. The abundance of c-myc RNA, in HL60 cells was also 
higher than in cells which did not contain amplified c-myc DNA 
sequences (Collins and Groudine, 1982; Dalla Favera et al, 1982a).
However, they did not compare the abundance of c-myc transcripts in 
HL60 cells and normal promyelocytes therefore it is unclear if the 
abundance of c-myc RNA in HL60 cells is abnormal for haematopoietic 
cells at the promyelocytic stage.
The cellular homologs of the oncogenes of transforming retroviruses 
are highly conserved in evolution and all but one or two are found 
expressed in normal cells. This has led to the suggestion that these 
sequences have an important role to play during development and 
differentiation (Duesberg, 1983). Therefore increased or aberrant 
expression of these sequences might lead to the uncoupling of the 
co-ordinated control of proliferation and differentiation leading to
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Figure 3 Schematic representation of the myeloid cell lineages.
I
The proposed position of HL60 cells on this differentiation pathway 
is indicated. The effects of commonly used chemical agents on the 
differentiation of HL60 cells is also shown.
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neoplastic transformation. Consequently, c-myc amplification may have 
been involved in the process of leukaemogenesis which gave rise to 
HL60 cells (Dalla-Favera et al, 1982a). Myc sequences have been 
frequently postulated to play a role in many different types of 
cancer, the details of this role being ,as yet undiscovered. For 
example, in Burkitt's lymphoma translocation occurs between 
chromosome 8 , on which the c-myc gene is found, and chromosomes 2 , 14
and 22, carrying the immunoglobulin genes. A similar event has also
been described in murine plasmacytomas (Erikson et al, 1983). 
Amplified c-myc sequences have also been reported in COLO320, a human 
colon cancer cell line, and in human lung cancer cell lines (Alitalo
et al, 1983; Little et al, 1983).
Interestingly, the transforming sequence in HL60 DNA, detected by the 
3T3 transformation assay, was shown not to be c-myc but N-ras (Murray 
et al, 1983). It may be significant that ras, the cellular homolog of 
the oncogene of the Harvey and Kristen sarcoma virus, and myc 
oncogenes have been shown to cooperate and be essential for the 
transformation of primary rat fibroblasts (Land et al, 1983).
Many different sublines of the HL60 cell line exist. Histochemical, 
karyotypic and immunological analyses have confirmed that they are 
all HL60. However, it has been demonstrated that c-myc homologous DNA 
sequence amplification, in many of these sublines, varies from 4-32 
fold. This was also reflected in the abundance of c-myc transcripts 
detected in these cells. Due to this variation between sublines, it 
has been postulated that while high levels of the c-myc gene, and its 
transcripts, may have had a role in the initial establishment of HL60 
cells, these are not required for the maintenance of the HL60 
phenotype (Graham et al, 1985).
p53 is a tumour antigen found at elevated levels in tumour cells of 
many different tissues and species. However, it has been determined 
that HL60 cells do not express p53 mRNA due to major deletion in the 
p53 DNA sequence of these cells. p53 has also been demonstrated to 
transform primary rat fibroblasts following co-transfection of the 
p53 gene and the ras oncogene, in an analogous manner to myc and ras 
(Parada et al, 1984). It has therefore been speculated that 
deficiency of p53 synthesis in HL60 cells was overcome by using an 
alternative element which apparently can function in a similar
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fashion to the product of p53, this could have been c-myc (Wolf and 
Rotter, 1985).
B) Induction of Differentiation
HL60 cells are capable of induced differentiation when treated with a 
number of different agents. A number of other established, 
haematopoietic cell lines also possess this capacity; for example, 
U937 cells, a human monoblastic cell line can be induced to
differentiate to monocytes by various agents and the Friend murine 
erythroleukaemia cell line can differentiate to mature erythrocytes 
under the appropriate stimulatory conditions (Olsson and Breitman,
1982; Rifkind et al, 1984). However, HL60 cells are of particular
interest because there is evidence that they are bipotent (Fontana 
et al, 1981). These cells can differentiate to granulocytes or 
macrophages depending on the inducing agent used. It has been 
proposed that uncoupling of the controls which regulate the processes 
of proliferation and differentiation result in neoplastic
transformation (Sachs, 1980). It can be speculated that uncoupling of 
these processes played a part in the leukaemogenic event from which 
HL60 cells are derived. Therefore HL60 cells may be "maturation 
arrested" at a stage similar to that which occurs in the course of
normal haematopoietic differentiation. Chemical agents which induce 
HL60 cells to differentiate may enable the cells to overcome the 
block in differentiation with the restoration of the differentiation 
programme.
The most commonly used granulocytic inducing agents are retinoic acid 
(RA) or dimethyl sulphoxide (DMSO). HL60 cells, when cultured for 5 
days in the presence of RA or 5-7 days in the presence of DMSO,
differentiate to mature myeloid cells with many of the
characteristics attributed to mature granulocytes (Collins et al, 
1978; Breitman et al, 1980). The HL60 cell line can also be induced 
to differentiate to monocyte / macrophages on exposure to many
agents, the most commonly used being phorbol ester or 
1,25-dihydroxyvitamin D^. Following the period of induction, 3 days 
for phorbol ester or 5 days for 1,25-dihydroxyvitamin D3 treatment, 
the terminally differentiated cells possess many of the 
characteristics attributed to mature macrophages (Rovera et al, 1979;
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McCarthy et al, 1982).
The bipotent differentiation ability of HL60 cells is unlikely to be 
due to two cell types present in an HL60 culture. It has been 
demonstrated that cultures derived from a single cell clone still 
retain the potential to differentiate to either granulocytes or 
macrophages depending on the inducing agent used (Fibach et al, 
1982). It has also been demonstrated that the presence of inducing 
agent throughout the whole period required for terminal 
differentiation characteristics to appear is not necessary; up to 12 
hours exposure of HL60 cells to phorbol ester or 48 hours exposure to 
DMSO is all that is required for the irreversible commitment of the 
majority of cells to a particular course of differentiation. Removal 
of the inducer before these times resulted in reversal of the 
inducer-mediated changes in the cell. However these cells were still 
bipotent. Hence, cells in which differentiation was initiated by 
exposure to DMSO were able to develop into macrophages by replacing 
DMSO with phorbol ester and cells initially exposed to phorbol ester 
were capable of differentiation to granulocytes with removal of the 
phorbol ester and addition of DMSO (Fibach et al, 1982). From these 
results it has been suggested that HL60 cells are derived from an 
early cell in haematopoiesis common to both myeloid and macrophage 
cells.
C) Changes Observed During Induction of Differentiation of HL60 Cells
i) Morphological Changes
Uninduced HL60 cells possess large round nuclei, each containing 2-4 
nucleoli. The cell cytoplasm is basophilic with prominent azurophilic 
granules and the nuclear / cytoplasmic ratio is high (Collins et_ al^ ,
1978). The addition of an agent, which promotes granulocytic 
differentiation, to the growth medium of an HL60 cell culture, 
induces striking morphological changes in the majority of cells. 
These morphological changes have been described by Collins et al 
(1977) and are characteristic of terminally differentiated myeloid 
cells. RA or DMSO induced HL60 cells are smaller in size and have a 
decreased nuclear / cytoplasmic ratio. The cell nucleus is convoluted 
and lobed with reduced or complete disappearance of nucleoli and the
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cytoplasm is diffuse with less prominent cytoplasmic granules. These 
morphological characteristics are representative of normal
metamyelocytes and banded and segmented neutrophils, the terminally 
differentiated cells of the granulocytic lineage of differentiation. 
The progress of induction can be followed by analysis of the changes 
in cell morphology. It has been demonstrated that 24 hours of 
induction is required before the first morphological changes are 
found but by 4 days of treatment with either RA or DMSO cells 
displaying terminally differentiated cell morphology are present in 
the culture (Breitman et al, 1980).
Following treatment with agents which induce HL60 cells to 
differentiate to monocyte / macrophages, the cells settle out of 
suspension and clump together on the surface of the tissue culture 
flask and attach to the plastic. The adherent HL60 cells have a 
spindle-shaped morphology. Ruffling of the cell cytoplasm is evident 
and the cells possess blunt pseudopods which are characteristic 
features of macrophages (Fibach et al, 1982).
ii) Changes in Cell Growth During HL60 Differentiation
During the induced differentiation of HL60 cells to granulocytes or 
to monocyte / macrophages, Breitman et al (1980) demonstrated that 
terminally differentiated cells accumulated in G0/G1 phase of the 
cell cycle. The loss of cell cycling potential is reflected in the 
reduced ability of induced HL60 cells to form colonies in semi-solid 
medium (Daniel et al, 1987). Terminal differentiation of normal cells 
leads to senescence and death therefore HL60 cells appear to reflect 
a normal response to a differentiation stimulus by arresting in G0/G1 
phase of the cell cycle with the resultant loss of the potential to 
self-renew.
iii) Functional Changes During HL60 Differentiation
Functional changes can also be detected in differentiating HL60 cells 
which reflect the functions of normal granulocytes and macrophages. 
For example, nitroblue tetrazolium (NBT), a water soluble dye, is 
reduced to insoluble, intracellular blue-black formazan by mature 
myeloid cells. The reduction process requires the production of 
superoxide. All terminally differentiated HL60 cells possess this
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ability (Breitman et al, 1980). HL60 cells induced to differentiate 
to granulocytes also phagocytose Candida albicans and opsonised 
particles (Collins et al, 1978). Increased chemotactic response to 
formylated peptides has been reported and expression of myeloid 
surface antigens detected (Tsiftsoglou and Robinson, 1985). All these 
are characteristic functions of mature granulocytes.
Similarly, HL60 cells induced to differentiate to monocyte /
macrophages also show mature cell characteristics. Following HL60
induction by phorbol ester and other monocyte inducing agents an 
induction of oc -napthyl acetate esterase, a histochemical marker of 
mature macrophages, is detected (Daniel et al, 1987). These cells 
also display phagocytic properties, increase in lysozyme protein 
production and expression of monocytic surface antigens which
indicate that they are monocytic cells (Munroe et al, 1984; Polansky 
et al, 1985).
iv) Changes In Gene Expression Following HL60 Differentiation
It has been demonstrated that differentiation-associated increase 
and decrease in the relative abundance of specific mRNAs occurs 
during induced terminal differentiation of HL60 cells. This was
indicated from results of experiments comparing the translation 
products detected following in vitro translation of polysomal 
poly(A)+ RNA extracted from uninduced and induced HL60 cells. No
gross change in the amount of poly(A)+ RNA was detected following
induction but different sets of proteins were translated (Colbert 
et al, 1983; Reyland et al, 1986). This is indicative of change in 
patterns of gene expression occuring during the induced 
differentiation of HL60 cells. The differentiation process is 
believed to be implemented by changes in the pattern of gene
expression therefore HL60 induced differentiation apparently reflects 
the normal process.
The regulation of specific gene expression has also been reported 
following HL60 induction. Most notable is the loss of detectable 
c-myc transcripts in terminally induced HL60 cells (Reitsma et al, 
1983; Westin et al, 1982). However more has been determined about the 
expression of other genes during HL60 induced differentiation with 
increased availability of DNA hybridisation probes. Analysis of
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individual gene expression is useful in determining control
mechanisms but in the context of HL60 it is hoped that eventually 
whole sets of genes will be identified whose abundances change in a 
co-ordinated manner during differentiation. Identification of these 
genes will aid in the lucidation of the mechanisms operating to 
determine co-ordination of gene expression.
D) HL60 as a Model of Differentiation
I have used the HL60 cell line as a means of isolating mRNAs whose
abundance varies during differentiation. From analysis of these
sequences during the course of HL60 differentiation I wanted to 
determine the potential control mechanisms operating, on the genes 
they represented . I also used HL60 cells to determine the order of 
events which occur as a cell becomes committed to a terminal 
differentiation pathway. In the future it is hoped that the sequences 
I have isolated and those isolated by other people will aid in the 
discovery of the control mechanisms for co-ordinated gene expression.
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1) MATERIALS
All chemicals used were generally Analar Grade, British Drug Houses. 
Some of the more specialised chemicals, including TPA, RA, sodium 
lauryl sarcosine, MOPS, antibiotics, ethidium bromide, 
2-mercaptoethanol and all the reagents required for hybridisation 
solutions, except where stated, were purchased from Sigma. Yeast 
extract, bacto-tryptone and agar for bacterial culture, were 
purchased from Difco Laboratories. Ultra-pure CsCl, sucrose, urea and 
agarose were obtained from Bethesda Research Laboratories, Gibco 
Limited. All tissue culture media were obtained from Gibco Limited or 
Flow Laboratories. All radioisotopes were supplied by Amersham 
International.
All glassware, for handling RNA or DNA, was sterilised by treatment 
with Baysilon-Olemulsion-H and baked at 80°C overnight. All 
plasticware, tubing and glassware was further sterilised by soaking 
overnight in 0.05% diethyl pyrocarbonate in water then drying in an 
oven at 80°C. Exogenous nucleases were removed from all buffers used 
during the preparation of nucleic acids, by addition of diethyl 
pyrocarbonate at 0.05% and then destruction of the chemical by
n
autoclaving at 15 lbs/in for approximately 15 min. Disposable 
plastic pipette tips and tubing were sterilised by autoclaving. Other 
solutions were either sterilised by autoclaving or by passing through 
a Millex 0.45 yum filter (Millipore (UK) Limited).
Normal leukocytes were kindly supplied by the West of Scotland Blood 
Transfusion Service, Law Hospital. Normal mucosa samples were 
supplied by Dr. P. Elvin, Beatson Institute. Normal human kidney 
samples were provided by K. Duncan, Western Infirmary, Glasgow and 
normal human liver samples were supplied by G. Moffat, also of the 
Western Infirmary, Glasgow.
The vector/host system used, pUC8 / JM83, was described by Viera and 
Messing (1982).
The cloned probes used were as follows:-
a) pMC41-3RC, containing DNA representing the third exon and 3' 
flanking region of the human c-myc gene in the Pst I site of pBR322;
76
originally supplied by Dr. R.C. Gallo (Dalla Favera et al, 1982 b).
b) B2-microglobulin, containing DNA representing 77% coding region 
plus 3' flanking sequence of the human B2-microglobulin gene in the 
Pst I site of pBR322; supplied by Dr. S. Suggs. (Suggs et al, 1981).
c) pHR28-l, a 7.2kb genomic DNA fragment from the 28S RNA gene, in 
the Eco RI site of pAT, a gift from A. Sproul.
d) Chick lysozyme cDNA; a full length cDNA cloned into the Pst I site 
of pBR322; (Land et al, 1981); supplied by Dr. G. Schutz, Heidelberg.
DNA size markers used were A c  857 digested with Hind III or Hind III 
and Eco RI , and -0'X174 (replicative form) digested with Hae III 
(Bethesda Research Laboratories, Gibco Limited). RNA size markers 
were derived from bacteriophage T7, yeast 2 ju, and bacteriophage d'DNA 
and were purchased as an RNA Ladder from Bethesda Research
Laboratories.
2) METHODS
A) Cell Culture
The original HL60 cells used during experimental work in this project 
were obtained from Dr. R. C. Gallo. However, following mycoplasm 
contamination the original HL60 subline had to be abandoned. It was 
replaced with cells received from Dr. G. Brown (Birmingham). These
cells were from an early passage of HL60 cells which had originally 
been obtained from Dr. R. C. Gallo. These HL60 cells were therefore 
derived from the same source as our initial HL60 subline. HL60 cells 
were cultured in RPMI-1640 (Flow) plus 0.2% sodium bicarbonate,
2 mM sodium pyruvate, 10% foetal calf serum and 4 mM glutamine. Cells 
were passaged every 3 days at 2 x 105 cells/ml in Nunclon tissue
culture grade flasks and kept at 37°C in 5% C02 , 95% 02 . The
average doubling time for HL60 was 24 h.
77
U937 cells were cultured in RPMI-1640 (Flow) as described for HL60.
B) MycoplasmaTesting
Cells were tested periodically for the absence of mycoplasma. The 
cells to be tested were pelleted by centrifugation at 1500 rev/min 
for 5 min in an MSE bench centrifuge. The cell free supernatant was 
then placed in a sterile tissue culture grade petri dish (Nunclon), 
2 ml of fresh medium were added and 2 x 10^ NRK49 fibroblasts were 
seeded into the dish. These cells are known to be mycoplasma free. 
The dish was incubated at 37°C in a humidified incubator at 5% C02 ,
95% 02 for 3 days. At the end of the incubation period the cells
were fixed by addition of an equal volume of fixative (1 volume of 
glacial acetic acid : 3 volumes of methanol) for 5 min. The fixative 
was then removed and the cells air dried. Hoechst 33258 stain was 
prepared from a 1 mg/ml stock by diluting 1:20 000 in phosphate
buffered saline. This solution was poured onto the fixed cells and
incubated at room temperature for 10 min. The stain was removed and 
the cells were washed two times in water. The cells were viewed by 
fluorescent microscopy using a water immersion lens. Hoechst 33258 is 
a fluorescent stain for DNA. If the cells were mycoplasma free only 
the cell nucleus fluoresced, however if the original cells had been 
mycoplasma infected fluorescence was also detected in the cytoplasm 
of the NRK49 cells.
C) Induction of Differentiation
i) Phorbol Ester
Stock TPA solution, prepared from Sigma 12-O-tetradecanoyl 13-phorbol 
acetate, was dissolved in acetone at a concentration of
1.6 x 10"4 M and stored at -20°C. HL60 were induced at a 
concentration of 5 x 105 cells/ml at a final concentration of
1.6 x 10"7 M TPA. The induction lasted over a 3 day period with 
only one addition of the inducing agent.
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ii) Dimethyl Sulphoxide
HL60 were induced at a concentration of 2 x 105 cells/ml with Merck 
dimethyl sulphoxide giving a final inducer concentration of 1.5% 
(v/v) DMSO. Induction was over a 5 day period with only one addition 
of the inducing agent.
iii) Retinoic Acid
Retinoic acid (Sigma) was kept in solution, in ethanol, at a
_ o
concentration of 10 M. Stock solution was kept for up to 2 weeks
only and stored in a light-tight container at -20°C. HL60 cells were
5induced at 2 x 10 cells/ml giving a final RA concentration of 
- 610" M. RA was added every 24 h throughout the 5 day induction 
period. The induced cultures were incubated at 37°C as normal but in 
the dark to limit degradation of the inducing agent throughout the 
period of treatment.
All cells used in the inductions were taken from exponentially 
growing cultures. The cells were passaged 24 h before addition of 
inducing agent to reduce any potential serum stimulation from the 
fresh medium.
D) Staining Procedures
i) May-Grunwald and Giemsa Staining
Cells were spun on to clean glass slides using a Shannon 
cytocentrifuge at 50 rev/min for 5 min and air dried. The cells were 
then fixed in 70% (v/v) methanol. May-Grunwald stain was prepared by 
diluting 2 volumes of stain in 3 volumes Sorensens Buffer pH 6.85 
(0.066 M disodium hydrogen orthophosphate, 0.066 M potassium 
dihydrogen orthophosphate) and filtering through Whatman Filter 
paper. Giemsa stain was also diluted in Sorensens Buffer, 1 volume 
stain : 9 volumes buffer and filtered. The slides were stained for
5 min in May-Grunwald stain, followed by 10 min in Giemsa stain. They 
were then washed twice in double distilled water, air dried and 
mounted in DPX mountant, and examined by light microscopy.
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ii) Non-specific Esterase - a Monocyte Specific Stain
Cells were spun on to clean glass slides using a Shannon 
cytocentrifuge at 50 rev/min for 5 min and air dried. The slides were
then incubated at 37°C for 2 h with 0.05 M x-napthyl acetate, 0.1 M
hexazonium pararosanilin-HCl in 0.2 M disodium hydrogen 
orthophosphate solution at pH 7.4. 1% (w/v) methyl green pH 4.0 was 
used to counterstain prior to washing in double distilled water and 
dehydration through 50%, 70%, 90% and 100% (v/v) ethanol. The slides 
were air-dried, mounted in DPX mountant and examined by light 
microscopy.
iii) Nitroblue Tetrazolium - a Myeloid Cell Specific Stain
£
1 X 10 cells were harvested by centrifugation in an MSE bench 
centrifuge at 1500 rev/min for 5 min at room temperature. The
supernatant was discarded and the cell pellet was resuspended in 
10 mM tetra decanoyl phorbol acetate (Sigma) containing 0.2% (w/v) 
nitroblue tetrazolium (NBT) (Sigma). The cell suspension was
incubated at 37°C for 25 min. Following incubation 0.5 ml of the cell 
suspension was removed and the cells centrifuged on to a clean glass 
slide using a Shannon cytocentrifuge. The slide was then air dried 
before staining for 5 min in May-Grunwald stain followed by 10 min in 
Giemsa stain. The stains were prepared as described in Chapter II, 2, 
D (i). After removing excess stain by washing in double distilled 
water the slide was air dried and mounted in DPX mountant before 
viewing by light microscopy.
E) Lysozyme Protein Assay
i) Secreted Lysozyme Protein
The medium from HL60 cell cultures was decanted and spun at
1500 rev/min for 5 min in an MSE bench centrifuge to remove cells. 
This cell-free medium was then taken in 1 ml samples, and added to
0.2 mg/ml micrococcus lysodeikticus in 5 ml of 0.1 M PBS pH 6.3. The
optical density was measured at 450 nm. Following a 30 min incubation 
at 37°C the optical density was again determined and expressed as 
°D450nm* Dilutions of human lysozyme (Sigma) were made in fresh
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culture medium and assayed as above to serve as controls and to 
determine the quantity of lysozyme present in the cell culture medium 
by comparison.
ii) Intracellular Lysozyme Protein
To measure intracellular lysozyme protein in HL60 cells, 1 x 106 
cells were collected by centrifugation at 1500 rev/min for 5 min in 
an MSE bench centrifuge. The supernatant was discarded and the cells 
were resuspended in 3 ml 0.1% (v/v) triton X-100. The cells were
incubated in this solution for 5 min at room temperature to ensure 
efficient cell lysis. The lysate was then taken in 1 ml aliquots and 
added to 0.2 mg/ml micrococcus lysodeikticus in 5 ml of 0.1 M PBS 
pH 6.3. The optical density was measured at 450 nm. Following a 
30 min incubation at 37°C the optical density was again determined 
and expressed as ^^450nm' Dilutions of human lysozyme (Sigma) were
made in RPMI 1640 medium (Flow) and assayed as above to serve as
controls and to determine the quantity of lysozyme present in the
cell lysate by comparison.
F) Fluorescence Activated Cell Sorting
Samples containing 1 x 10 cells were removed from cultures of HL60 
cells. These samples were then centrifuged at 1500 rev/min for 5 min 
in an MSE bench centrifuge, the medium decanted, and the cells washed 
2 times in ice cold PBS before resuspension in 70% (v/v) methanol 
with continual vortexing. Cells could be kept in this fixed state at 
4°C indefinitely. Before analysis, the cells were removed from the 
methanol and resuspended in 1ml 15 mM M g C ^ , (0.002%) (w/v)
Chromomycin A3 stain (Sigma). To allow efficient staining the cells 
were kept on ice, in the dark, for up to 2 h prior to FACS analysis. 
Samples were examined using a Fluorescence Activated Cell Sorter 
(FACS II) as described by Young et al (1981). Chromomycin A3 is a 
fluorescent stain for DNA. The FACS II detects fluorescence emitted 
from bound stain following exposure to a laser ray. The cells are 
then sorted according to the intensity of fluorescence detected which 
is directly proportional to the DNA content of the cell.
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G) Measurement of Cell Cloning Potential
HL60 cells were induced as described previously in Chapter II, 2, C. 
Following induction, cells were removed at specific intervals, 
counted on a Coulter counter and washed in ice cold PBS. They were 
then diluted in Flow RPMI 1640 medium to give a final concentration 
of 5-10 cells/ml. 200 ,ul volumes of this dilution were plated out 
into 96 well, flat bottomed Nunclon tissue culture grade plates.
These were incubated at 37°C in 5% C02 / 95% 02 in a humidified 
cell incubator. To analyse the cloning ability of the cells each 
plate was examined every 24 hours. The number of cells/well were 
counted and recorded for each plate over a 7 day period.
H) Isolation of RNA
i) Cell Harvesting
8 91 x 10 1 x 10 cells were harvested from exponentially growing
cultures by centrifugation in an MSE bench centrifuge at 1500 rev/min 
for 5 min, if the volume was less than 100 ml. For larger volumes 
cells were spun in a GS-3 rotor at 2000 rev/min for 10 min in a 
Sorvall RC-5B centrifuge at 0°C. The medium was decanted and the cell 
pellet washed twice in ice-cold PBS.
ii) Cell Fractionation
92 x 10 cells were harvested as described in Chapter II, 2, H (i) ,
the cell pellet was resuspended in hypotonic buffer I (0.14 M NaCl,
1.5 mM MgCl2 , 100 mM tris-HCl pH 7.4) at a concentration of 
5 X 107 cells/ml. NP40 was added to a final concentration of 0.5% 
(v/v) to lyse the cells. The cells were allowed to lyse on ice for 
15 min then homogenised gently by hand (10 strokes) with a teflon 
ball pestle in a tight fitting, pre-chilled glass Potter homogeniser, 
on ice. Cell lysis was checked by phase contrast microscopy. Nuclei 
were pelleted from the lysate by centrifugation in an M.S.E. 4L 
centrifuge (8 x 50 ml rotor) at 2000 rev/min for 15 min at 4°C. The 
post-nuclear supernatant was retained for preparation of polysomes.
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iii) Preparation of Nuclei and Nuclear RNA
Following cell fractionation the pelleted nuclei were resuspended in 
ice-cold 5% citric acid at a concentration of 1 x 108 cells/ml. 
Nuclei were further purified by homogenisation in this solution, on 
ice, as before. The homogenate was centrifuged at 4°C for 5 min at
1000 rev/min in the 8 x 50 ml rotor of an M.S.E. 4L centrifuge. The
supernatant was removed and the loose pellet was resuspended in 
ice-cold 0.25 M sucrose in 1.5% (w/v) citric acid. The suspension was
then homogenised with 5 strokes of the homogeniser, as described
above. The homogenate was transferred to a 50 ml centrifuge tube 
(20 ml/tube), underlayered with 20 ml of ice-cold 0.88 M sucrose in
I.5% citric acid and centrifuged at 4°C for 5 min at 2000 rev/min in
the 8 x 50 ml rotor of an M.S.E. 4L centrifuge. The supernatant was
removed by aspiration to just below the level of the interphase then 
the remaining solution was decanted. The tube was drained and the 
sides wiped with sterile gauze. The pellet was resuspended,
homogenised and centrifuged through sucrose at least twice more to 
remove any remaining cytoplasmic debris. Purity of the preparation 
was checked by phase contrast microscopy. The nuclei were washed free 
of citric acid by resuspending the pellet in 0.25 mM KC1, 3 mM 
MgCl2 , 50 mM tris-HCl pH 7.4 and centrifuging at 4°C for 5 min at 
1000 rev/min in the 8 x 50 ml rotor of an MSE 4L centrifuge. The 
supernatant was discarded and the sides of the tube were wiped with 
sterile gauze. Total nuclear RNA was prepared by lysing the purified
nuclear pellet in 5 M guanidinium thiocyanate, 50 mM tris-HCl pH 7.0,
50 mM EDTA, 5% (v/v) 2- mercaptoethanol at 1-2 x 10^ nuclei/ml.
Preparation of RNA from the nuclear lysate was carried out exactly as 
described for the preparation of total RNA from whole cells (Chapter
II, 2, H (v)).
iv) Preparation of Polysomes and Total Polysomal RNA
Polysomal RNA was prepared essentially as described by Young (1976) 
and Affara and Young (1976). Following lysis, homogeninisation and 
isolation of nuclei as described in Chapter II, 2, H (ii), the 
post-nuclear supernatant was retained for preparation of polysomes.
2 M sucrose in Buffer I (0.14 M NaCl, 1.5 mM MgC^, 100 mM tris-HCl 
pH 7.4) was added to the post-nuclear supernatant to a final
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concentration of 0.25 M. To remove mitochondria, the post-nuclear 
supernatant was centrifuged at 8000 rev/min for 10 min at 4°C in the
HB-4 rotor of a Sorvall RC-5B centrifuge. The supernatant was
collected and triton-X-100 was added to a final concentration of 1%, 
to release membrane bound polysomes; 15 ml of this solution was
transferred to 25 ml polycarbonate MSE ultracentrifuge tubes and 
underlayered with 5 ml 2 M sucrose in Buffer I. Polysomes were
purified and pelleted by centrifugation through the sucrose pad at 
55 000 rev/min for 3.5 h at 4°C in an 8 x 25 ml titanium fixed angle
rotor in an MSE SS65 ultracentrifuge. Following centrifugation the 
supernatant was removed by aspiration down to the interphase of the 
two sucrose solutions then the remaining solution was decanted and 
the tubes were drained well. After wiping the sides of the tubes with 
sterile gauze, the pellets were resuspended gently in 1 ml of NETS 
buffer (100 mM NaCl, 10 mM tris-HCL ph 7.4, 10 mM EDTA, 0.5% SDS). An 
equal volume of 8 M urea and two volumes of 4 M LiCl were added and 
the polysomal RNA was precipitated by incubation at 4°C overnight. 
The polysomal RNA was recovered by centrifugation of the solution at 
10 000 rev/min for 15 min at 4°C in the HB-4 rotor of the Sorvall
RC-5B centrifuge. The pellet was resuspended in 5 ml NETS buffer and 
proteins were removed by shaking the solution with an equal volume of 
a 1:1 mixture of phenol and chloroform saturated with NETS buffer. 
The phenol and aqueous layers were separated by centrifugation of the 
mixture at room temperature at 5000 rev/min for 5 min in the Sorvall 
HB-4 rotor. The aqueous layer was removed and extracted with an equal 
volume of chloroform to remove residual phenol. The aqueous layer was 
retained and sodium acetate was added to a final concentration of 
0.3 M. RNA was precipitated from solution by addition of 2.5 volumes 
of ethanol and overnight incubation at -20°C. This step was repeated 
once more and each time precipitated RNA was collected by 
centrifugation at 10 000 rev/min for 10 min at -15°C in the HB-4
rotor of a Sorvall RC-5B centrifuge. Pelleted RNA was washed by 
resuspension in 70% (v/v) aqueous ethanol, then 95% ethanol,
collected each time by centrifugation as before. The RNA pellet was 
then dried and resuspended in DEP treated double distilled water to a 
final concentration of 1 jig/pl.
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v) Preparation of Whole Cell RNA
The method used was adapted from that of Chirgwin et al (1979).
Following cell harvesting, cells were lysed by addition of 5 M 
guanidinium isothiocyanate (Bethesda Research Laboratories), 0.05 M
tris pH 8.0, 0.5 M EDTA, 0.7 M 2-mercaptoethanol, at pH 7.0. to give
O
a final cell concentration of 1-2 x 10° cells/ml. The preparation 
could be stored frozen at this stage before the isolation of total 
whole cell RNA. The solution was then sonicated, in a Bronson
sonicator at 20 Hz, by 3 x 30 second pulses, to shear the DNA. The
preparation was kept on ice at all times. Lauryl-sarcosine was then
added to a final concentration of 2% and the solution heated for 
2 min at 68°C to dissolve the sarcosine. This was then loaded on to a
2.5 ml CsCl cushion (5.7 M CsCl, 50 mM EDTA pH 7.0, at a refractive 
index of 1.3995) in a B60 14 ml polypropylene tube and spun for 36 h 
at 15°C, 35 000 rev/min in a B60 Damon IEC ultracentrifuge. Following 
centrifugation the guanidinium isothiocyanate was unloaded leaving 
the RNA clearly visible as a gelatinous, clear pellet. The tubes were 
inverted and allowed to drain well. The RNA pellet was then 
resuspended in DEP treated double distilled water and precipitated 
from solution at -20°C, by the addition of 3 M sodium acetate to 
0.3 M and 2.5 volumes of ethanol. RNA was retrieved by centrifugation 
at 10 000 rev/min for 10 min at -15°C in a Sorval HB-4 swing out
rotor. The pellet was resuspended in DEP treated double distilled 
water to which was added an equal volume of 4 M LiCl and 8 M Urea. 
The RNA was precipitated from this solution by incubation overnight 
at 4°C. This precipitation step removed any residual DNA from the RNA 
as DNA does not precipitate under these conditions. The RNA was again 
collected as before by centrifugation at 10 000 rev/min in a Sorval 
HB-4 swing out rotor. Finally the RNA was precipitated once more by 
addition of sodium acetate to 0.3 M and 2.5 volumes of 95% ethanol, 
collected by centrifugation and washed in 70% (v/v) ethanol and then 
95% ethanol. The pellet was then dried briefly and resuspended at 
1 in DEP treated double distilled water.
vi) Preparation of Poly(A)+ and Poly(A)' RNA Fractions
This method was modified from that of Aviv and Leder (1972). A 1.5 ml 
column of oligo(dT) cellulose (0.3 g) was prepared as described by 
the suppliers (Bethesda Research Laboratories). The column was then
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well rinsed in approximately 20 bed volumes of lx Binding Buffer 
(0.5 M NaCl, 10 mM tris-HCl pH 7.5, 1 mM EDTA). Total whole cell RNA 
was dissolved in DEP treated double distilled water to give a maximum 
concentration of 200 ^g/ml and then heated at 68°C for 2 min to 
denature any secondary structure. The solution was then chilled 
rapidly on ice. An equal volume of 2x Binding Buffer was added to the 
solution to give a final RNA concentration of 100 jug/ml. This was 
slowly passed through the oligo(dT) cellulose column. When the RNA 
solution had passed through, the column was washed with lx Binding 
Buffer (approx. 20 bed volumes) until the OD260nm was less than 
0.1. The elutate was collected,on ice, as it contained unbound 
poly(A) RNA. The bound poly(A)+ RNA was eluted with sterile
water. The RNA was collected in 1 ml fractions and kept on ice. The 
fractions were then measured by OD260nm and those containing the 
poly(A)+ RNA pooled. These pooled fractions were again denatured at 
68°C for 2 min. 2x Binding buffer was added to adjust salt conditions 
to that of lx Binding buffer. The solution was then reapplied to the 
column and eluted with lx Binding buffer. The poly(A)+ RNA, bound 
to the column, was again eluted with sterile water and 1 ml fractions 
collected. The second application of RNA to the oligo(dT) cellulose 
column increases the fractionation of poly(A)+ RNA from poly(A)" 
RNA. The RNA was then precipitated from solution overnight by 
addition of 3 M sodium acetate to 0.3 M and 2.5 volumes ethanol at 
-20°C. The poly(A)+ RNA was collected by centrifugation at 10 000 
rev/min at -15°C in a Sorvall RC-5B using an HB-4 rotor, washed in 
70% (v/v) ethanol and then 95% ethanol. The pellet was then dried and
resuspended in DEP treated double distilled water at a concentration 
°f 1 jig/jil.
The poly(A)" RNA fractions were retained from the column and the 
RNA precipitated by addition of 3 M sodium acetate to 0.3 M and two 
volumes of ethanol. The RNA was precipitated at -20°C overnight and 
the RNA then collected by centrifugation at 10 000 rev/min at -15°C 
in a Sorvall RC-5B centrifuge using an HB-4 rotor. The RNA was then 
washed in 70% (v/v) ethanol followed by 95% ethanol (being collected 
each time by centrifugation as before), dried and resuspended in DEP 
treated double distilled water to a final concentration of 1 jxg/y.1.
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I) Analysis of RNA
i) Quantitative RNA Dot Blot Analysis
A stock solution of RNA in DEP treated water (20 pi) was prepared 
(500 pg/ml for total whole cell RNA); 10 pi of RNA solution was 
transferred to a tube containing 10 pi of DEP treated double 
distilled water to, give a 1:2 dilution. 10 pi from this tube was then 
transferred to a third tube containing 10 pi of DEP treated double 
distilled water and so on until 12 doubling dilutions had been 
prepared. These samples were then heated at 65°C for 15 min to 
denature any secondary RNA structure and chilled on ice. The tubes 
were then spun briefly in an Eppendorf microfuge to collect 
condensation from the sides of the tube. 4 ,ul of RNA were spotted on
f
to nitrocellulose membrane (Sartopius 0.10 pm) in duplicate. The 
nitrocellulose was prepared by soaking in water, then in 20x SSC (3 M 
NaCl, 0.3 M sodium citrate pH 7.0) for 30 min and air drying. After
dotting the membrane was allowed to air dry and was then baked at
80°C for 2 h to immobilise the RNA.
ii) RNA Fractionation on Denaturing Agarose Gels
This method was taken from Boedtker (1971). 10-30 pg of total whole 
cell RNA or 1-5 pg poly(A)+ RNA were freeze-dried then resuspended 
in 9 pi formamide denaturation buffer (50% formamide, 2.2 M 
formaldehyde, lx MOPS buffer (40 mM sodium MOPS, 10 mM sodium
acetate, 1 mM EDTA pH 7.0)). The samples were then denatured by 
heating for 15 min at 68°C and chilled immediately. Prior to loading 
on the gel 1 pi of loading buffer (50% glycerol, 0.1% bromophenol 
blue, 10 mM sodium phosphate pH 7.0) were added. The RNA was
electrophoresed through 50 ml horizontal, denaturing, 1% agarose gels 
containing 2.2 M formaldehyde. Gels were buffered in MOPS buffer 
(40 mM sodium MOPS, 10 mM sodium acetate, 1 mM EDTA pH 7.0) and 
subjected to electrophoresis at 90 volts for 1 h with buffer 
recirculation.
iii) Northern Blot Analysis of RNA
The electrophoresed RNA was transferred directly on to nitrocellulose 
membrane (Sartorius 0.10 pm) by blotting in 20x SSC (3 M NaCl, 0.3 M
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sodium citrate pH 7.0) as described by Thomas (1980). The blotting 
apparatus was set up as described by Southern (1975). The 
nitrocellulose was first soaked in DEP treated double distilled water 
then in 20x SSC for 30 min prior to blotting overnight. At the 
completion of transfer the nitrocellulose was air dried and then 
baked at 80°C for 2 h to immobilise the RNA.
J) Preparation of Genomic DNA
Genomic DNA was prepared using a modification of the method of 
Gross-Bellard et al (1973). 1 x 10^ cells were harvested as
described in Chapter II, 2, H (i). The cells were then lysed by 
resuspension in 10 mM EDTA, 10 mM tris- HC1 pH 8, 10 mM NaCl 
containing 4% sarcosine (w/v) and proteinase K (20 units/mg) 
(Boehringer Corporation Limited) at a final concentration of 
100 /ag/ml. This mix was incubated overnight at 37°C. An equal volume 
of phenol and chloroform with 0.5 M tris-HCl pH 8.0, 10 mM NaCl, 
10 mM EDTA, 0.5% SDS, was added and mixed gently for 10-30 min. This 
was followed by centrifugation in an MSE 4L centrifuge at room 
temperature and at 1000 rev/min for 10 min. The aqueous phase was 
then removed and sodium acetate added to a final concentration of 
0.3 M. Following the addition of 2.5 volumes of ethanol the DNA was 
spooled out from the solution using a sterile glass rod. This was 
washed twice in 70% (v/v) ethanol, twice in 95% ethanol and then once 
in chloroform. The DNA was washed, while still wound onto the glass 
rod, by immersion in each wash for 1 min, followed by expulsion of as 
much fluid from the DNA as possible before moving on to the next 
wash. Finally the DNA was air dried and the rod placed in 10 ml of 
0.lx SSC overnight to allow the DNA to resuspend. Following 
resuspension, the solution was RNase treated for 3 h by addition of 
boiled RNase A (50 yug/ml) and RNase T (1 /ag/ml). 0.4 M EDTA was added 
to a final concentration of 10 mM, sarcosine to 4% and proteinase K 
(20 units/mg) to a final concentration of 50 ;ug/ml. This solution was 
incubated for 3 h at 37°C. At the end of incubation the DNA solution 
was again phenol / chloroform extracted as before and the DNA from 
the aqueous phase spooled out of solution containing 0.3 M sodium 
acetate and 2.5 volumes ethanol. The DNA was washed and dried as 
described above and then dissolved in TE buffer (10 mM tris pH 8.0,
1 mM EDTA) to give a final concentration of 500 pg/ml.
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K) Preparation of Plasmid DNA
i) Large Scale Preparation
This method was a modification of that described by Birnboim and Doly 
(1979). From 10 ml overnight cultures of the bacteria containing the 
plasmid to be prepared 1 ml was inoculated into 500 ml of L-broth (1% 
(w/v) bacto-tryptone, 1% (w/v) NaCl, 0.5% (w/v) yeast extract). 
50 jug/ml ampicillin was added if the plasmid contained the 
appropriate antibiotic resistent gene. The culture was incubated 
overnight at 37°C in a shaking incubator. Following incubation the 
cells were pelleted by centrifugation at 7000 rev/min for 5 min at 
4°C in a GS-3 rotor of a Sorvall RC-5B centrifuge. The supernatant 
was decanted and the pellet drained. The cells were then lysed by 
resuspension of the pellet in 18 ml of cold lysis buffer (50 mM 
glucose, 25 mM tris-HCl pH 6.8, 10 mM EDTA, 2 mg/ml lysozyme). The 
resuspended pellet was left on ice for 30 min. To this was added 
40 ml of a solution containing 0.2 M NaOH, 1% SDS and the mixture 
further incubated on ice for 5 min. This solution denatures the 
bacterial chromosomal DNA. Finally 20 ml of ice cold 5 M potassium 
acetate pH 4.8 was added to neutralise the lysate. Addition of this 
causes the bacterial chromosomal DNA to aggregate and become 
insoluble. After 1 h incubation on ice this insoluble material was 
pelleted by centrifugation at 8000 rev/min, at 4°C in a GS-3 rotor of 
a RC-5B Sorvall centrifuge. The supernatant was then removed and 
filtered through gauze to prevent any contamination by aggregated 
bacterial DNA. The plasmid DNA was precipitated by addition of 
0.6 volumes of ice cold isopropanol and incubated at room temperature
for 15 min. DNA was pelleted by centrifugation at 8000 rev/min for
10 min at 4°C as before. The supernatant was removed and the pellet 
drained then resuspended in 5 ml 50 mM tris-HCl pH 8.0, 10 mM EDTA , 
0.5 ml ethidium bromide (10 mg/ml) plus CsCl (Bethesda Research
Laboratories) to give a final refractive index of 1.3890. The 
solution was then transferred to 10 ml polycarbonate tubes for an MSE 
10 x 10 ml titanium, fixed angled rotor. The tubes were filled to 
three quarters with the plasmid DNA solution, the remainder of the 
volume was filled with paraffin oil. The tubes were centrifuged at 
4-0 000 rev/min for 40-60 h at room temperature. Following
centrifugation two bands were usually observed on U.V. exposure. The 
uPper band was comprised of residual bacterial chromosomal DNA, the
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lower band contained the plasmid DNA. This band was removed by 
pipetting using a pasteur pipette. To remove the ethidium bromide 
from solution the mixture containing the plasmid DNA was extracted 5 
times with an equal volume of isopropanol saturated with CsCl. The 
plasmid solution was then dialysed for 1 day against several changes 
of TE buffer (10 mM tris-HCl pH 8.0, 1 mM EDTA) to remove the CsCl. 
Following dialysis the plasmid DNA was precipitated from solution by 
incubation at -20°C overnight following the addition of 3 M sodium 
acetate to a final concentration of 0.3 M and 2.5 volumes of ethanol. 
The plasmid DNA was then pelleted by centrifugation at -15°C, at 
10 000 rev/min in an HB-4 rotor on a Sorvall RC-5B centrifuge. The
DNA was washed once in 70% (v/v) ethanol and once in 95% ethanol then 
repelleted by centrifugation.
ii) Further Purification of Plasmid DNA
To further purify the plasmid DNA from contaminating bacterial 
chromosomal DNA, the DNA was resuspended in 1 M NaCl, 10 mM tris-HCl 
pH 7.5, 1 mM EDTA at a concentration of 2 mg/ml and sedimented rate
zonally by centrifugation through a sucrose gradient. 100 jul samples 
of DNA were layered on top of 14 mis 5% - 20% neutral sucrose 
gradients in the same buffer. These samples were then centrifuged in 
a 6 x 14 ml rotor of a B60 Damon IEC ultracentrifuge for 4 h at 
40 000 rev/min at 20°C. Following centrifugation the gradients were
unloaded by upward displacement by fluorochemical FC43 (3M Chemical 
Company Limited) and 1 ml fractions collected. The was read
for these fractions and those containing plasmid DNA were pooled. The 
plasmid DNA was precipitated by addition of 3 M sodium acetate to a 
final concentration of 0.3 M and 2.5 volumes of ethanol followed by 
overnight incubation at -20°C. The plasmid DNA was then pelleted by 
centrifugation at -15°C, at 10 000 rev/min in an HB-4 rotor on a
Sorvall RC-5B centrifuge. The DNA was washed once in 70% (v/v) 
ethanol and once in 95% ethanol then collected by centrifugation as 
before. The DNA pellet was dried and resuspended in lx TE buffer at 
°-5 Fg/H1-
iii) Small Scale Preparation
For quick analysis of plasmid DNA small scale preparations were used. 
To 2 ml of L-broth, containing the appropriate antibiotic if
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required, a single bacterial colony was inoculated and incubated 
overnight at 37°C with shaking. Cells were then pelleted from 1.5 ml 
of culture medium in screw capped Sarstedt tubes by centrifugation at 
10 000 rev/min, at room temperature, in an Eppendorf microfuge. The
supernatant was discarded and the cell pellet resuspended in 100 pi 
of lysis buffer which contained 0.9% (w/v) glucose, 25 mM tris-HCl pH
8.0, 10 mM EDTA pH 7.5, and 25 ul of a fresh solution of lysozyme
(10 mg/ml) in the same solution. This mixture was incubated on ice
for 15 min. To this was added 200 pi of 0.2 M NaOH, 1% SDS and the
mixture incubated on ice for 5 min. 150 pi of ice cold 5 M potassium
acetate pH 4.8 was then added and the mixture again incubated on ice
for 5 min. This precipitates the bacterial DNA and protein. To remove
this the tubes were centrifuged for 1 min in an Eppendorf microfuge 
and the supernatant containing the plasmid DNA then transferred to a 
fresh tube. Boiled RNase A (50 pg/ml) was then added to a final 
concentration of 10 ug/ml and incubated at 37°C for 30 min to remove 
contaminating RNA. The plasmid DNA was then precipitated by addition 
of 3 M sodium acetate to 0.3 M and 2 volumes of ethanol and incubated 
at -20°C for 15 minutes. The DNA was collected by centrifugation in 
an Eppendorf microfuge for 5 min, the pellet dried and then 
resuspended in 50 jul TE buffer which gave approximately 1 pg/pl DNA.
L) Restriction Endonuclease Digestion
The digestions were carried out as recommended by the manufacturers. 
For plasmid DNA restriction enzyme digestions were routinely carried 
out with the appropriate restriction enzyme added to a final
concentration of 5 units/pg of DNA. The mix was then incubated for 
1 h at 37°C in the appropriate buffer. Restriction digestion of 
genomic DNA was carried out using the appropriate restriction enzyme 
added to a final concentration of 10 units/pg of DNA. Incubation of 
the mix was 6 h at 37°C; genomic DNA was at a concentration of 
pg/ml. At the completion of the incubation period the enzymic 
reaction was stopped by addition of EDTA pH 8.0 to 20 mM. To 
determine the concentration of genomic DNA present accurately, after 
digestion, the digested samples were dialysed against O.lx TE buffer 
(10 mM tris-HCl pH 8.0, 1 mM EDTA ) and then the OD260nm of each
sample read on a Cecil spectrophotometer.
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M) Analysis of DNA
i) DNA Fractionation by Gel Electrophoresis
Digested genomic DNA samples were fractionated by horizontal 
electrophoresis on a 1% agarose gel. The gel was made up by boiling 
the appropriate weight of agarose with 200 ml of lx TBE 
electrophoresis buffer (0.089 M tris-base , 0.089 M boric acid, 
0.002 M EDTA pH 8.3). This was cast in a 14 cm by 20 cm mould. 
Separation of plasmid DNA fragments of greater than 1 Kb was also 
accomplished by the method described above. However DNA fragments of 
less than 1 Kb were fractionated on 1.5% agarose TBE buffered gels. 
20-30 ^g of genomic DNA in 30 jal TE buffer , or 0.5-2.0 x^g plasmid
DNA were routinely electrophoresed. Prior to loading of the DNA
samples a sixth volume of sample loading buffer was added to each 
tube (30% sucrose, 10 mM tris-HCl pH 8.0, 1 mM EDTA, 5% SDS, 0.1% 
bromophenol blue). Electrophoresis was carried out overnight at 
30 volts. Markers were run simultaneously, these were normally 
y\ phage digested with Eco RI / Hind III for sizing of large DNA 
fragments, or O' X174 DNA (replicative form) digested with Hae III for
sizing of small fragments. Following electrophoresis the gel was
stained for 15 min in ethidium bromide at a final concentration of 
0.5 ^ig/ml, in water. The DNA was visualised by U.V. fluorescence on a 
Chromato-Vue transilluminator, then photographed through a red No 9 
Kodak Wratten gelatin filter.
ii) DNA Fractionation Under Denaturing Conditions
0.5-1.0 ;ug of restriction digested plasmid DNA was fractionated by 
electrophoresis on a 1.4% agarose gel under denaturing conditions 
(55 mM NaOH). Fractionation under these conditions eliminates 
artifactual results caused by DNA secondary structure. 1.4 g of 
agarose was added to 100 ml of 50 mM NaCl and 1 mM EDTA then boiled 
until the agarose dissolved. Following this the gel was poured and 
allowed to set. Sufficient lx alkaline electrophoresis buffer (lOx 
alkaline electrophoresis buffer is 300 mM NaOH, 10 mM EDTA) was added 
to cover the gel and allowed to soak for 30 min. Addition of NaOH to 
hot agarose solutions can cause hydrolysis of the polymer; hence gels 
ate prepared in neutral unbuffered solution and then equilibriated in
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alkaline electrophoresis buffer. Prior to loading of the samples the 
DNA was dissolved in alkaline loading buffer which is 50 mM NaOH, 
1 mM EDTA, 2.5% (w/v) Ficoll and 0.025% (w/v) bromocresul green. The 
samples were then loaded and electrophoresed at 80 volts for 1 h. The 
gel was then removed from the gel apparatus and stained in ethidium 
bromide (0.5 ,ug/ml in water). The gel was then washed in water and 
the DNA visualised by UV fluorescence on a Chromato-Vue
transilluminator, then photographed through a red No 9 Kodak Wratten 
gelatin filter.
iii) Isolation of cDNA Fragments from Recombinant Plasmid DNA
Plasmid DNA was restriction digested as described in Chapter II, 2, 
L. The reaction mix was electrophoresed on a 1.5% low melting point 
agarose gel (Bethesda Research Laboratories) at 70 volts for 30 min 
at 4°C in TBE buffer. The gel was then stained in ethidium bromide at 
0.5 /ig/ml in water for 10 min. The DNA fragments could then be
visualised by UV fluorescence on a "Chromato Vue" transilluminator.
The cDNA fragment was cut from the gel and then heated at 70°C for 
10 min to melt the agarose. To this was added 100 pil of phenol 
saturated with TE (10 mM tris-HCl pH 8.0, 10 mM EDTA). The tube was 
vortexed vigorously then centrifuged at 10 000 rev/min in an
Eppendorf microfuge for 5 min. The aqueous phase was removed and this 
was further phenol extracted until no precipitate was visible between 
the aqueous and phenol phases. These steps removed the agarose from 
the DNA. The DNA from the aqueous phase was then precipitated by
addition of 3 M sodium acetate to 0.3 M and 2.5 volumes of ethanol 
and overnight incubation at -20°C. The DNA was collected by 
centrifugation at 10 000 rev/min for 10 min in an Eppendorf microfuge 
then resuspended in TE buffer at a concentration of 10 ng/yil.
iv) Southern Blot Analysis of DNA
Following fractionation of endonuclease restriction digested DNA as
described in Chapter II, 2, M (i), DNA was transferred to
nitrocellulose membrane as described by Southern (1975). Prior to 
blotting the marker lanes were removed and the gel subjected to a 
number of washes. The gel was washed twice, for 15 rain, in 0.25 M HC1
to depurinate the DNA. The gel was then washed twice for 20 min in
1-5 M NaCl, 0.5 M NaOH to shear and denature the DNA. Finally the gel
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was neutralised by washing 3 times for 30 min in 3 M NaCl, 0.5 M tris 
pH 7.4. Each wash was carried out with gentle shaking. The DNA was 
then transferred from the gel to nitrocellulose membrane by blotting 
in 20x SSC (3 M NaCl, 0.3 M sodium citrate). The nitrocellulose 
membrane was first wetted in DEP treated double distilled water then 
soaked in 20x SSC for 30 min before assembly of the blotting 
apparatus. Blotting transfer was carried out overnight. The 
nitrocellulose membrane was then air dried and baked for 2 h at 80°C 
to immobilise the DNA.
v) Preparation of Plasmid DNA Dot Blots
Plasmid DNA was restriction digested with the endonuclease Eco RI, as 
described in Chapter II, 2, L. This linearised the supercoiled DNA. 
The DNA was then denatured by heating at 90°C for 10 min. 5 ul of 
this mixture was dotted in duplicate on to a nitrocellulose filter 
(Sartorius, 0.10 /pm) which had been soaked in double distilled water 
then 20x SSC for 30 min. The filter was air dried prior to use. The 
prepared filters were then air dried and baked at 80°C for 2 h to 
immobilise the DNA.
N) Preparation of Hybridisation Probes
i) Nick Translation of cDNA
DNA labelling was carried out using the Amersham nick translation kit 
and following the protocol described in Amersham (1980) which is a 
modification of the procedure described by Rigby et al (1977). 1 i^g 
of DNA was used in a 50 jul reaction mix which contained 50 pCi 
32PdCTP (410 Ci/mmole), 2.5 mM dATP, 2.5 mM dTTP, 2.5 mM dGTP, 
100 mM tris-HCl pH 7.8, 10 m M M g C ^ ,  1% (v/v) 2-mercaptoethanol,
100pg DNase I and 5 units DNA polymerase I. Incubation of the 
reaction was for 1.5 h at 14°C. The reaction was then terminated by 
addition of EDTA to 20 mM. Labelled cDNA was separated from 
unincorporated nucleotides by gel filtration through Biogel A-1.5M 
agarose (BioRAD) columns. Columns were prepared by plugging a 
siliconised pasteur pipette with a small plug of sterile glass wool. 
The column was then filled with A-1.5M Biogel (100-200 mesh) (BioRad) 
and allowed to settle. Presaturation of the column was carried out by
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elution with 10 jil of solution containing 500 jug/ml sonicated salmon 
sperm DNA. This was eluted with 0. lx SSC solution before the nick 
translation mix was loaded on to the column. The eluted cDNA peak 
fraction was collected from the column and used as a hybridisation 
probe. Prior to use the cDNA was boiled for 10 min to denature any 
secondary structure, then cooled rapidly on ice.
ii) Reverse Transcription of Total Poly(A)+ RNA
Total poly(A) RNA was isolated as described in Chapter II, 2, H (vi). 
Reverse transcription was carried out as described by Getz et al 
(1975). Using 25 units/^g RNA, Avian myeloblastosis virus reverse 
transcriptase (Bethesda Research Laboratories, 5 units/jul ), was 
added to a reaction mix containing 100 mM tris-HCL pH 8.2, 10 mM
magnesium acetate, 5 mM dithiothreitol, 50 mM NaCl, 10-20
poly(A)+ RNA, oligo(dT)-^y (Boehringer Corporation Limited) to a 
final concentration 10 times that of the final RNA concentration, 
100 /-tg/ml actinomycin D (Boehringer Corporation Limited), dATP, dGTP, 
dTTP (Boehringer Corporation Limited) at 2 mM, 50 juCi 32PdCTP 
(410 Ci/mmole). The reaction mix was incubated for 90 min at 37°C 
then terminated by addition of EDTA to 20 mM. Labelled cDNA was 
isolated from unincorporated nucleotides by gel filtration as
described in Chapter II, 2, N (i). Prior to use the cDNA was boiled
for 10 min to denature any secondary structure, then cooled rapidly 
on ice.
iii) Preparation of cDNA Hybridisation Probes by Random Priming
DNA labelling was carried out using the Boehringer Mannheim random 
priming kit and following the protocol described by the supplier. 
This in turn is based on the random priming technique of Feinberg and 
Vogelstein (1984). 25 ng of denatured DNA was added to a reaction mix 
containing 0.5 mM dATP, 0.5 mM dTTP, 0.5 mM dGTP, 50 ^ iCi 32P dCTP 
(3000 Ci/mmole), and 2 ul of the kit reaction mix which contains 1 M 
tris pH 7.4, C.T. hexanucleotide (150 OD/ml) 2 M Hepes, 1 M MgC^, 
0.004% (v/v) 2-mercaptoethanol. 1 unit of Klenow enzyme (1 unit/jLL)
(Boehringer Manneim) was added and the total volume of the reaction 
mix made up to 20 jil with double distilled water. The mixture was 
incubated for 30 min at 37°C, following this the reaction was 
stopped by addition of EDTA to 20 mM. The labelled cDNA was separated
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from the unincorporated nucleotides as described previously (Chapter 
IT, 2. N (i)). Prior to use the labelled cDNA was boiled for 10 min 
to denature any secondary structure, then rapidly cooled on ice.
0) Hybridisation Procedure
The method used to prehybridise and hybridise nitrocellulose 
membranes produced from the previously described procedures was taken 
from Jeffreys and Flavell (1977). Prehybridisation was carried out at 
42°C in sealed polythene bags. Prehybridisation buffer contained 50% 
formamide (Fluka), 5x Denharts solution (lx Denharts solution is 
0.02% (w/v) ficoll, 0.02% (w/v) polyvinylpyrrolidone, 0.02% (w/v)
bovine serum albumin), 50 mM sodium phosphate pH 6.8, 0.1% SDS, 
100 /ig/ml sonicated salmon sperm DNA, 10 ^ ug/ml poly(A) and 10 jug/ml 
poly(C). Approximately 1.5 ml of prehybridisation buffer was added 
per 5 cm of filter. Incubation was carried out overnight in a 
shaking water bath. Following prehybridisation the buffer was removed 
from the bag and replaced with hybridisation buffer (approximately 
1 ml per 5 cm filter). The hybridisation buffer contained 
radioactively labelled probe at a concentration of 
1-2 x 10 cpm/ml. The buffer contained 50% formamide (Fluka), 
5x SSC, lx Denharts solution, 20 mM sodium phosphate pH 6.8, 0.1% 
SDS, 10% dextran sulphate, 100 p.g/ml sonicated salmon sperm DNA, 
10 p.g/ml poly(A) and 10 yig/ml poly(C). The polythene bags were then 
resealed, ensuring all air bubbles were expelled, and incubated 
overnight at 42°C in a shaking water bath. Washing of hybridised 
filters was carried out with buffers preheated to 65°C. Prior to 
washing the hybridisation solution was removed from the polythene 
bags, the filters were then put into approximately 250 ml of 3x SSC, 
0.1% SDS and washed at room temperature. Five washes in this solution 
for 5 min each, ensured that all unbound radioactive probe was 
removed. Filters were then washed two times, for 30 min each wash, in 
0.5x SSC, 0.1% SDS at 65°C in a shaking water bath. Finally filters 
were washed twice in a solution of O.lx SSC, 0.1% SDS, 1 h for each 
wash, in a shaking water bath at 65°C. At the completion of washing 
filters were placed in polythene bags and autoradiographed with Kodak 
" XAR " or " XRP " X-ray film using Cronex " lightning plus " 
intensifying screens in Harmer X-ray cassettes. After exposure at
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-70 C the films were developed in a Kodak M7A automatic X-ray 
processor.
P) Stripping of Hybridised Nitrocellulose Filters
Removal of hybridised radioactively labelled probe from
nitrocellulose filters was accomplished by incubation of the filters 
at 55°C for 30 min in a solution containing 70% formamide (Fluka), 
0.1 mM EDTA pH 8.0, 10 mM tris-HCl pH 7.4, 0.2% SDS. Approximately 
50 ml of strip buffer was added per filter. Following incubation the 
strip buffer was then removed and replaced with a further 50 ml of 
fresh buffer and the filters incubated for a further 30 min at 55°C. 
The second wash ensured the efficient removal of all bound probe. 
Following incubation the filters were autoradiographed to check the 
completeness of probe removal. The filters could then be
prehybridised and hybridised again, as described in Chapter II, 2, 
0 .
Q) Screening of a cDNA Library by Colony Hybridisation
i) Preparation of Nylon Membranes
This method was adapted from that of Grunstein and Hogness (1975). 
Biodyne A nylon membranes (Pall) were sterilised by autoclaving. The 
filters were then placed on to agar plates (0.1% (w/v) bacto
tryptone, 0.1% (w/v) NaCl, 0.05% (w/v) yeast extract, 1.5% (w/v) 
agar) containing ampicillin (5 yig/ml). Using a transfer plate
(Dynatech) recombinants were transferred from a 96 well microtitre
plate (Titertek) on to the nylon filter. The agar plates, with the
filters, were then incubated overnight at 37 C. Following incubation 
the bacterial colonies should have grown to approximately 1 cm 
diameter on the filter. Trays were lined with Whatman filter paper 
soaked in lysis buffer (0.5 M NaOH, 0.2% (w/v) triton-X-100). The
nylon membranes were removed from the agar plates and placed on the
trays allowing the buffer to soak into them. Following 5 min of lysis 
the membranes were then transferred to another tray to denature the 
plasmid DNA. This tray was soaked in denaturation buffer (2.5 M NaCl,
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0.5 M NaOH). Membranes were soaked in this buffer for 10 min then 
transferred into neutralisation buffer (3 M sodium acetate pH 5.5). 
Neutralisation was for 10 min. The membranes were air dried and then 
baked at 80°C to immobilise the DNA.
ii) Hybridisation of Nylon Membranes
Biodyne nylon membranes were prehybridised in buffer containing
5x Denharts buffer, 5x SSPE, 0.2% (w/v) SDS, 500 ug/ml denatured
salmon sperm DNA (20x SSPE contains 3.6 M NaCl, 0.2 M sodium
phosphate pH 7.5). Approximately 1.5 ml of prehybridisation buffer
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was used per 5 cm of membrane. The filters were then incubated at
65°C overnight in a sealed plastic box in a shaking water bath. Prior
to hybridisation the filters were removed from the prehybridisation 
buffer and placed into polythene bags. Each bag contained 1.5 ml 
hybridisation buffer per 5 cm of membrane. Hybridisation buffer 
was made exactly as described for prehybridisation buffer but in 
addition contained 0.5 x 10^ cpm 22P dCTP (440 Ci/mmole)
labelled, reverse transcribed cDNA. Hybridisation was carried out in 
a shaking water bath at 65°C overnight. After this time the membranes 
were washed briefly in wash buffer (5 mM sodium phosphate pH 7.0,
1 mM EDTA, 0.2% (w/v) SDS) to remove unbound cDNA probe. The filters 
were then washed twice at room temperature in wash buffer, 30 min for 
each wash, with vigorous shaking. Autoradiography was carried out in 
Harmer X-ray cassettes using Cornex "lightning plus" intensifying 
screens using Kodak "XAR" or "XRP" X-ray film. After exposure at 
-70°C the autoradiographs were developed in a Kodak M7A automatic 
X-ray processor.
iii) Removal of Hybridised Probe from Nylon Membranes
Membranes were placed in 250-300 ml of strip buffer (10 mM sodium 
phosphate pH 6.5, 50% formamide) and incubated for 1 h at 65°C with
shaking. Following this, to ensure total removal of probe, the 
filters were washed in wash buffer (2x SSC, 0.1% SDS) for 15 min at 
room temperature, with vigorous shaking. The membranes were then 
ready for further prehybridisation and hybridisation.
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R) In Situ Hybridisation
i) Fixation of Cells
Glass slides were washed in concentrated nitric acid for 2 h then
well rinsed in double distilled water. They were then stored in 70%
(v/v) ethanol until required. Prior to use the slides were 
air dried. Approximately 2 x 105 cells were spun onto the glass 
slides using a Shannon cytocentrifuge at 450 rev/min for 5 min. The
slides were air dried and fixed immediately. Fixation entailed 
incubation of slides in 70% (v/v) methanol, at room temperature, for 
10 min. The slides were then transferred through 3 changes of ice
cold 10% (w/v) trichloroacetic acid before being dehydrated through
50%, 70%, 90% and 100% ethanol. They were then air dried and stored
at -20°C with silica gel.
ii) Preparation of Radioactively Labelled cDNA
1 ^ug of plasmid DNA was nick translated, as described in Chapter II, 
2, N (i). However the labelled nucleotide used was "^S dCTP 
(600 Ci/mmole). The hybridisation probe was stored at -20°C for up to
2 weeks before use. The labelled cDNA was then separated from 
unincorporated nucleotides by passing through a Biogel A-1.5 (BioRad) 
column (Chapter II, 2, N (i)) .The radioactively labelled cDNA was 
eluted by O.lx SSC. The DNA was dialysed against 0.lx TE buffer at 
4°C then freeze dried. Radioactively labelled cDNA was resuspended in 
hybridisation buffer (Chapter II, 2, R (iii)) to give 
2 x 10^ cpmy^uil.
iii) Procedure for Hybridisation
Before hybridisation the slides were rehydrated through 100%, 90%, 
70% and 50% ethanol then rinsed in PBS. They were then treated with 
proteinase K (1 jug/ml in 2x SSC) for 10 min at 37°C then rinsed 
briefly in PBS containing 1% (w/v) glycine. Following a further wash 
in PBS the slides were prehybridised for 2 h at 42°C in coplin jars. 
The prehybridisation buffer contained 4x SSC, 10 mM tris pH 7.5, 
lx Denharts buffer, 1 mM EDTA, 50% formamide (Fluka), 50 mM sodium 
phosphate pH 7.5, 0.05% (w/v) yeast tRNA and 100 ug/ml denatured
salmon sperm DNA. Following prehybridisation the buffer was poured
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from the slides and the excess buffer carefully wiped from the glass 
surface. 5 p.1 of hybridisation buffer (prehybridisation buffer plus
10% (w/v) dextran sulphate, 0.1 mg/ml poly(A), 0.1 mg/ml poly(C), 
2 mM vanadyl ribonucleoside complexes) containing 1 x 106 cpm 
labelled cDNA was spotted over the cells. Coverslips were then placed 
over the buffer and sealed around the edge with cowgum. The slides 
were placed in a moist chamber and incubated at 80°C for 10 min and 
then transferred to a shaking water bath. Hybridisation was carried 
out at 42°C, overnight. Following hybridisation the cowgum was 
carefully peeled off and the coverslips removed in a beaker of 
2x SSC. Slides were washed twice in lx SSC for 30 min and rinsed in 
PBS. They were then dehydrated through 50%, 70%, 90%, and 100%
ethanol and air dried .
iv) Autoradiography
Slides were coated in Ilford K2 Nuclear Research emulsion, in the 
dark. This comes in gel form. To prepare the emulsion an equal volume 
of gel was added to double distilled water containing 2% (v/v) 
glycerol. This mixture was heated for 3 min at 50°C until an emulsion 
was formed. The slides were dipped into the emulsion then left to dry 
at a 45° angle for 1 h at room temperature. This ensured that excess 
emulsion drained from the glass surface. The slides were then stored, 
with silica gel, in a light tight box at 4°C. Following exposure the 
slides were developed in D19 Ilford developer for 5 min then rinsed 
in water. They were then fixed in Hypam fixer for 3 min then washed 
for 1 h under running water and air dried. To visualise the cells the 
slides were stained using May-Grunwald and Giemsa stains as described 
in Chapter II, 2, D (i). The slides were mounted in DPX mountant 
before viewing by light microscopy.
S) Sequencing Procedure
i) Recloning of cDNA into M13
cDNAs were prepared by Eco RI + Bam HI digestion of pUC8 recombinants 
then isolated by gel fractionation of the restriction digested 
plasmid DNAs as described in Chapter II, 2, L . M13
bacteriophage DNA was similarly digested and purified. To reduce
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self-ligation the vector DNA was then phosphatased by incubation of 
2 yug Ml3 DNA in 2x CIP dilution buffer (10 mM tris-HCl pH 9.2, 1 mM 
magnesium acetate, 1 mM ZnSO^, 100 yig/ml bovine serum albumin, 50%
(v/v) glycerol) and 1 jil calf intestinal phosphatase (1 unit/^ul)
(Bethesda Research Laboratories) at 45°C for 30 min. A further 1 jal 
of calf intestinal phosphatase was then added and the reaction 
re-incubated for a further 30 min at 45 °C to ensure the efficiency of 
the phosphatase reaction. The reaction was stopped by extracting the 
phosphatased vector DNA by addition of an equal volume of phenol. The 
mixture was then vortexed and centrifuged for 5 min at 10 000 rev/min 
in an Eppendorf microfuge. The aqueous phase was removed, containing 
the DNA. The DNA was then diluted to 1 ng/jal with TE buffer. To
ligate the vector and cDNAs 100 ng of vector DNA and 20 ng of cDNA
were incubated in 10 mM ATP, 50 mM dithiothreitol, lx ligase buffer
(lOx ligase buffer is 0.66 M tris-HCl pH 7.5, 50 mM MgCl2 , 50 mM
dithiothreitol) plus 1 unit T4 DNA ligase (1 unit/jul) (Bethesda
Research Laboratories). Ligation reactions were carried out overnight 
at room temperature.
ii) Transformation of E.coli JM83 Cells with M13 Recombinants
1 ml of an overnight JM83 E.coli cell culture was inoculated on to
100 mis of 2x TY medium ( 0.16% (w/v) bacto-tryphone. 0.1% (w/v) 
yeast extract, 0.05% (w/v) NaCl ) and the culture incubated at 37°C
for 2 h or until the OD^q q^  was 0.3. The cells were then pelleted
by centrifugation in an MSE 4L centrifuge at 2000 rev/min for 5 min 
at 0°C. The pellet was resuspended in 10 ml of ice cold 10 mM 
magnesium sulphate and incubated on ice for 30 min. Following
incubation the cells were repelleted by centrifugation in an MSE 4L 
centrifuge at 2000 rev/min as before. The supernatant was discarded 
and the cells resuspended in 5ml of ice cold 50 mM CaCl2 • These 
competent cells were then stored on ice for up to 2 h before use. To
transform the JM83 cells with M13 phage DNA 0.3 ml of the competent
cell mix was added to 0.5 volume of ligation mix (Chapter II, 2, S
(i)). The cells were then heat shocked by incubation for 3 min at 
42°C then returned to ice. Heat shock facilitates the uptake of
exogenous DNA. To each tube of heat shocked cells 
isopropyl-B-D-thio-galactopyranos ide (IPTG) (Sigma) was added to 
7 mM, 5-bromo-4-chloro-3-indolyl-B-D-galactoside (X-Gal) (Sigma) in 
dimethyl formamide to 0.13% and 3 ml of molten H top agar (42°C)
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(H top agar is 1% (w/v) bacto-tryptone, 0.8% (w/v) NaCl, 0.8% (w/v) 
agar) was added. This mixture was then poured out on to freshly 
prepared, prewarmed (37°C ) H-plates (1% (w/v) bacto tryptone, 0.8%
(w/v) NaCl, 1.2% (w/v) agar). The agar was allowed to set then the 
plates were inverted and incubated overnight at 37°C.
iii) Preparation of Single Stranded Template
This method was taken from Amersham (1984). 100 ml of 2x TY medium 
(0.016% (w/v) bacto tryptone, 0.01% (w/v) yeast extract, 0.005% (w/v)
NaCl) was inoculated with 1 ml of an overnight E.coli (JM83) culture.
1.5 ml samples of this were aliquoted into sterile bijou tubes 
(Sterilin). From the H-plates set up previously (Chapter II, 2, S
(ii)) single, colourless plaques were removed using sterile, wooden 
cocktail sticks and inoculated into the bijou tubes. The tubes were 
then incubated, with shaking, for 5 h at 37°C. At the completion of 
the incubation period the medium was transferred into Sarstedt
microcentrifuge tubes and centrifuged for 5 min at 10 000 rev/min in 
an Eppendorf microfuge, to collect the cells. The supernatant, 
containing the viral particles, was transferred to fresh tubes and
0.12 volumes of PEG/NaCl (20% polyethelene glycol 6000, 2.5 M NaCl) 
added. The tubes were vortexed briefly then left to stand for 15 min 
at room temperature. To collect the viral DNA the tubes were 
centrifuged at 10 000 rev/min for 5 min in an Eppendorf microfuge and 
the supernatant discarded. To remove contaminating protein, the viral 
DNA pellet was resuspended in TE buffer and 0.5 volume of phenol 
saturated with TE buffer was added. The tubes were vortexed for 
30 sec then centrifuged for 3 min. The aqueous phase, containing the 
DNA, was removed and transferred to fresh tubes. To precipitate the 
single stranded viral DNA, 3 M sodium acetate was added to 0.3 M and
2.5 volume of ethanol. The tubes were incubated overnight at -20°C.
The viral DNA was collected by centrifugation in an Eppendorf
microfuge and then washed once in 1 ml of cold (-20°C) ethanol. The 
pellet was drained and dried before resuspension in 30 jil of TE 
buffer.
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iv) Sanger " Dideoxy Chain Termination " Sequencing Method
a) Sequencing Reaction
This method is exactly as described by Amersham (1984). The method
was previously described by Sanger (1981) and more recently Biggins
et al (1983). The Amersham M13 sequencing kit was used exactly as
described by the manufacturers (Amersham International). Briefly, 
annealing of the M13 primer to the single stranded viral template was 
carried out in a reaction mix containing 0.5 volume of single 
stranded template, 0.1 volume M13 primer, 0.15 volume lx Klenow 
reaction buffer (lOx Klenow reaction buffer is 0.5M tris-HCl pH 7.2, 
0.1 M MgSO^, 1 mM dithiothreitol, 500 ug/ml bovine serum albumin). 
These components were well mixed then incubated for 2 h at 60°C. To 
the annealed template / primer hybrid 15 uCi of ^ S  dATP 
(600 Ci/mmole) and 1 unit of Klenow fragment (1 unit/jul) were added.
2.5 jal of this mix were added to tubes marked A,C,G,T (4 tubes / 
clone). To each of the 4 tubes was added the appropriate dideoxy mix 
(the mixes contained 0.5 mM of each appropriate deoxynucleotide plus 
the appropriate molarity of dideoxynucleotide). The reaction was
incubated for 15 min at room temperature following which 0.5 volume 
of chase mix was added. The chase mix is 0.5 mM dATP, 0.5 mM dCTP,
0.5 mM dTTP and 0.5 mM dGTP. The tubes were again incubated for a 
further 15 min at room temperature. At the completion of incubation 
an equal volume of formamide dye mix (20% formamide, 0.002% (w/v) 
xylene cyanol FF, 0.002% (w/v) bromophenol blue, 500 mM sodium EDTA) 
was added to each tube to stop the reaction. The tubes were then 
incubated for 3 min at 90°C, to denature the DNA, before loading on 
to a polyacrylamide gel.
b) Gel Electrophoresis
To prepare the gel 1.1 M urea, 15% (w/v) acrylamide, and lOx TBE 
buffer diluted to 0.5 was dissolved in water. 60 ml of this solution 
was required. To this was added 0.001% (w/v) TEMED, (NNN'N'-
tetramethylethylenediamine) and freshly prepared 0.001% (w/v)
ammonium persulphate solution. This solution was carefully poured 
between two glass plates (40 x 20 x 0.04 cm) which had previously 
been siliconised using 2% dimethyl-dichlorosilane in
1,1,1-trichloroethane (BDH-Replicote). The plates were taped together
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with spacers in place prior to pouring of the gel. The gel was poured 
by slowly letting the solution flow between the glass plates ensuring 
that no air bubbles were trapped. The gel was left to set for 1 h at 
room temperature. Samples were loaded on to the gel and then 
electrophoresis was carried out at 45 mA, 1.5 kV for 2 h. The gel was 
buffered in lx TBE buffer. Following electrophoresis the gel 
apparatus was dismantled and the glass plates separated. The gel, 
still resting on one glass plate, was immersed in Fix buffer (10%
(v/v) methanol, 10 % (v/v) glacial acetic acid) for 15 min then
drained. It was then transferred on to Whatman filter paper, covered 
in saran wrap, and dried on a Shandon Gel drier for 1 h. The saran 
wrap was removed and the dried gel autoradiographed using Kodak "XAR" 
X-ray film in Harmer X-ray cassettes with Cronex "lightning plus"
intensifying screens. After exposure the films were developed in a 
Kodak M7A automatic X-ray processor.
T) End Labelling of Restriction Digested Plasmid DNA
This method is exactly as described by Maniatis et al (1982). 10 jug 
of restriction digested, linearised plasmid DNA was added to 
lx Klenow reaction buffer (lOx buffer is 0.5 M tris-HCl pH 7.2, 0.1 M 
MgSO^, 1 mM dithiothreitol, 500 jug/ml bovine serum albumin), 2 nM 
dATP, 2 nM dGTP, and 2 nM dTTP, 2 pM 32P dCTP (440 Ci/mmole) and 
1 unit of Klenow fragment (1 unit/}il) (Bethesda Research 
Laboratories). This mixture was incubated at room temperature for 
30 min. The reaction was terminated by addition of EDTA to 20 mM. To 
remove unincorporated nucleotides the labelled DNA was precipitated 
by adding 3 M sodium acetate to 0.3 M and 2.5 volume of ethanol and 
incubation at -20°C for 20 min. Labelled plasmid DNA was collected by 
centrifugation in an Eppendorf microfuge for 10 min at 10 000 
rev/min. To determine the sizecfthe labelled fragments the DNA was 
electrophoresed on a 5% polyacrylamide gel buffered in lx TBE buffer. 
The polyacrylamide gel was prepared exactly as described in Chapter 
II> 2, S (iv). markers digested with Eco RI and Hind III restriction 
enzymes were used as standards. Following electrophoresis the gel was 
removed and stained in ethidium bromide (0.5 jug/ml in water). The 
marker bands were visualised by UV fluorescence on a Chromato Vue 
transilluminator. Prior to autoradiography the gel was covered in 
saran wrap then exposed to "XRP" X-ray film at -70°C. X-ray films
were developed in a Kodak M7A automatic X-ray processor.
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1 INDUCED DIFFERENTIATION OF THE HL60 CELL LINE
A) The HL60 Cell Line
The HL60 cell line was initially isolated from the peripheral blood 
leukocytes of a patient suffering from acute promyelocytic leukaemia 
by Collins et al (1977). HL60 cells are grown in suspension culture 
and in exponential phase of growth have a doubling time of 24 h. 
These cells possess the potential to differentiate down the 
granulocytic differentiation pathway by treatment with DMSO or RA, 
but can also terminally differentiate to monocyte / macrophage cells 
by treatment with TPA (Collins et al, 1978; Rovera et al, 1979;
Breitman et al, 1980).
B) Changes Observed During the Course of HL60 Differentiation
i) Morphological Changes
Uninduced HL60 cells have a characteristic promyelocytic morphology. 
Figure 4 shows uninduced HL60 cells stained with May-Grunwald and 
Giemsa stains. A typical uninduced HL60 cell population contains
large, blast-like cells with large, round nuclei and a high 
nuclear-cytoplasmic ratio. The cytoplasm is basophilic with a
granular appearance. The nuclei have clearly visible nucleoli, 
normally 2-4 per nucleus.
The course of granulocytic differentation can be followed by changes 
in HL60 morphology. At day 3 of both DMSO and RA induction HL60 cells 
resemble myelocytes (Figure 5, (a) and (c)). The cell cytoplasm is
less basophilic, in comparison to uninduced cells, and the cell 
nucleus has the characteristic kidney-shape of the myelocyte. By days 
4 and 5, the cells exhibit the morphological characteristics 
attributed to mature granulocytes; the cells become smaller and the 
nuclear-cytoplasmic ratio decreases, the nucleus acquires a lobed
configuration, the nucleoli disappear and the cytoplasm becomes more 
diffuse. Figure 5, (b) and (d) shows HL60 cells following a 5 day
DMSO and RA induction. These cells are classified morphologicaly as 
banded and segmented neutrophils.
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Figure 4 Uninduced HL60 cells.
A 250 i^l sample of uninduced HL60 cells was cytocentrifuged on to a 
clean, glass slide. The cells were fixed in methanol and then stained 
with May-Grunwald and Giemsa stains.
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Figure— 5— (A_)_ 3 day and 5 day DMSO induced HL60 cells.
250 ul samples of HL60 cells (2 x 10^ cells) induced for 3 days and
5 days with DMSO (1.5% (v/v)) were cytocentrifuged on to clean, glass 
slides. The cells were then fixed in methanol and stained with
May-Grunwald and Giemsa stains. (a), HL60 cells induced for 3 days
with DMSO; (b), HL60 cells induced for 5 days with DMSO.
(B) 3 day and 5 day RA induced HT.60 cells_^
250 wl samples of HL60 cells (2 x 105 cells) induced
5 days with RA (1 x 10 M) were cytocentrifuge on ^cained with
slides. The cells were then fixed in methanol and stain.,d «i
May-Grunwald and Giemsa stains. (c) , HL60 cells induced for y 
with RA; (d), HL60 cells induced for 5 days with RA.
HL60 cells induced to differentiate to monocyte/macrophage cells by 
TPA become adherent after only 8-16 h of treatment. The cells clump 
together on the tissue culture flask surface, adhere, then spread out 
with a spindle-shaped morphology. TPA induced HL60 cells stained with 
May-Grunwald and Giemsa stains can be seen in Figure 6.
ii) Appearance of Histochemical Markers of Differentiation
a) Myeloid cell marker
During HL60 induction, the appearance of histochemical markers of 
differentation occur concomitant with changes in cell morphology. 
Mature cells from the myeloid lineage possess the ability to produce 
superoxide, hence are capable of reducing nitroblue tetrazolium (NBT) 
to formazan. When HL60 cells, induced by DMSO or RA, are incubated at
37°C for 25 min with 0.2% (w/v) NBT and 10 mM tetradecanoyl phorbol
acetate, reduction of NBT can be assessed by the appearance of 
blue/black granular deposits in the cell cytoplasm. Figure 7 shows 
NBT positive RA induced cells and uninduced HL60 cells which did not 
stain and therefore do not produce superoxide. To determine when HL60 
cells develop the ability to reduce NBT, and hence become terminally 
differentiated, cells were sampled at time points throughout the 
course of a DMSO and RA induction and subjected to the treatment 
described above. The appearance of NBT positively staining cells
during DMSO induction was a late event occurring between 48-72 h of 
treatment and reaching a maximum at 96-120 h when almost 90% of the 
cells were capable of reducing NBT. However, only 54% of a RA induced 
HL60 cell culture were NBT positive at day 5 of treatment. These 
results are summarised in Figures 16 and 17.
b) Monocyte cell marker
Non-specific esterase (NSE) is a routine histochemical marker for
monocytes. Following the incubation of cells with -napthy1 acetate, 
NSE positive cells can be detected by the presence of black/brown 
granular deposits throughout the cell cytoplasm. This is due to the 
hydrolysis of ^ c-nap thy 1 acetate. TPA induced HL60 cells were positive 
for NSE activity, which was detected as early as 8-16 h following TPA 
treatment. Figure 8 (a) shows 3 day TPA induced HL60 cells with brown 
cytoplasmic staining signifying the presence of NSE. The percentage
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Figure 6 HL60 cells induced to differentiate for 3 days with TPA.
2 x 10^ cells were cultured on clean, glass slides for 3 days in 
the presence of TPA (1.6 x 10"7 M) . The medium was then removed, 
the cells fixed in methanol and then stained with May-Grunwald and 
Giemsa stains.
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Figure 7 NBT positively stained 5 day RA induced HL60 cells and NBT 
negatively stained HL60 cells.
250 ^1 samples (2 x 105 cells) of uninduced HL60 cells and 5 day RA
induced HL60 cells were removed from an assay to determine the cells 
ability to reduce NBT to formazan, a marker for mature myeloid cells. 
Reduct ion leads to the appearance of blue/black cytoplasmic granules. 
The cells were cytocentrifuged on to clean, glass slides, fixed in 
methanol and then stained with May-Grunwald and Giemsa stains, (a), 
uninduced HL60 cells; (b), 5 day RA induced HL60 cells.
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of cells which stained positively for NSE activity increased rapidly 
during induction until almost 100% were capable of hydrolysing 
cx-napthyl acetate by 24 h of TPA treatment. Uninduced HL60 cells, 
however, showed no black granulation and had to be counter-stained 
with methyl green to visualise the cells by light microscopy (Figure 
8 (b)). These results are summarised in Figure 15. RA and DMSO
induced HL60 cells also stained negatively when assayed for NSE.
iii) Examination of the Cell Cycling Potential of HL60 Cells During 
Induced Differentiation
With the onset of commitment to terminal differentation, cells lose 
their potential to self-renew and cease to proliferate. To 
investigate the changes occurring in cell cycling potential of HL60 
cells undergoing induction, and to determine if and when, during the 
induction time course, the cells ceased to proliferate, cells were 
sampled at time points throughout the course of DMSO, RA and TPA 
treatment, and analysed by Fluorescence Activated Cell Sorting
(FACS). The cell profiles generated are shown in Figure 9.
To standardise the profiles, and to eliminate any discrepancies which 
could have arisen from drift of peaks during analysis on the FACS II, 
an aliquot of chick red blood cells was added to each sample prior to 
analysis. No variation occurs in the DNA content of these cells, 
which enables them to be used as a control.
Routinely, in samples taken from an exponentially growing uninduced
HL60 cell culture, the FACS analysis profile showed cells scattered
throughout the cell cycle, in Gl, G 2 , M and S phases. However, TPA
treatment rapidly reduced the ability of HL60 cells to divide; 
following only 24 h of induction, approximately 95% of the cells were 
observed to cease proliferation and arrest at G0/G1. If the doubling 
time of HL60 cells is 24 h this would only allow cells to traverse 
the cell cycle once. In the course of DMSO induction the cells 
divided 2-3 times during the treatment period. Only after 72 h 
exposure to the inducing agent were the cells also observed to arrest 
at G0/G1 (Figure 9 (a) and (b)).
RA induced HL60 cells were unusual in their cell cycle behaviour when
compared to the induced cells described previously. At completion of
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Figure 8 3 day TPA induced HL60 cells and uninduced HL60 cells
stained to detect the presence of NSE.
250 jj. 1 samples (2 x 10^ cells) of uninduced HL60 cells and 3 day
TPA induced HL60 cells were cytocentrifuged on to clean, glass slides
and assayed for the presence of NSE by determining the cells ability
to hydrolyse o--napthy1 acetate. (a), 3 day TPA induced HL60 cells 
which stained brown indicating the presence of NSE; (b), uninduced 
HL60 cells which did not contain NSE and therefore had to be
counterstained with methyl green.
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the 5 day RA induction period, a proportion of the cells were still
present in G2, S and M phases of the cell cycle. The fact that these
cells were still cycling indicated that not all the cells had
undergone terminal differentiation (Figure 9 (c)).
iv) Changes in Potential to Self-Renew During HL60 Differentiation
FACS analyses give results generated from a population of cells. As 
was shown, prior to addition of inducing agent to an HL60 culture, 
the cells are not synchronous but are dispersed throughout the cell 
cycle. Hence, it is unlikely that these cells will respond to an 
induction stimulus simultaneously. Therefore, to examine individual 
cell response to treatment by inducing agents, cell clonogenicity was 
assayed.
To assess cell clonogenicity throughout the course of TPA, DMSO and 
RA treatment, cells were sampled at different time points throughout 
the course of induction, washed, and then plated out into microtitre
dishes at 1-2 cells per well. These cells were cultured for up to 
7 days in the absense of inducer; the cells were counted every 24 h.
It was found that approximately 15% of an uninduced cell population 
was incapable of self-renewal before induction. However, this was 
increased rapidly by pretreatment of HL60 cells with TPA for only 
8-24 h when almost 85% of the cell culture had lost the potential to
divide. Clonogenicity was also lost by cells treated with DMSO. This
occurred gradually throughout the course of induction but with the 
majority of cells arresting between 24-96 h of DMSO treatment. By
96 h of induction only 10% of the HL60 cells still retained the
potential to divide.
When similar analyses were carried out on RA induced HL60 cells, it 
was found that a proportion of the cells never lost the potential to 
self-renew, this percentage was as much as 40-50% of the RA treated 
cell culture, and is in agreement with the results obtained from FACS 
analysis and examination of histochemical markers of differentiation. 
The results from the clonogenicity studies are summarised in Figures 
15, 16 and 17.
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Figure 9 Examination of the cell cycle during HL60 differentiatioru.
1 x 106 cells were sampled at times throughout the course of TPA, 
DMSO and RA induction of HL60 cells. The cells were fixed in methanol 
and then stained with a fluorescent stain for DNA. These cells were 
sorted by fluorescence activated cell sorting according to cell DNA 
content which was directly proportional to the degree of fluorescent 
DNA stain bound to each cell. Chick red blood cells were used as 
standards as these cells have a constant amount of DNA. The profiles 
displayed are for (a), TPA induced HL60 cells; (b), DMSO induced HL60 
cells; (c), RA induced HL60 cells.
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From these analyses, the length of Induction time required to allow 
maximum commitment to differentiation could be deduced. 8-24 h 
exposure to TPA or 48-96 h of DMSO treatment was required to produce 
almost 90% commitment in an induced HL60 cell culture. However, 
because RA does not induce a large proportion of HL60 cells to 
differentiate within the 5 day induction time course, it is unclear 
what length of exposure to the induction stimulus is required to 
produce the maximum number of committed cells.
v) Changes in Expression of Specific Genes as Markers of HL60 • 
Differentiation
Changes in morphology, enzymic changes and cell cycle changes, which 
occur during the course of HL60 differentiation, must all have an 
initiating event, the induction stimulus. This, in turn, must 
eventually operate on the cell nucleus, resulting in changes in gene 
expression. Thus, the expression of two genes, c-myc and lysozyme, 
where chosen for study during induction of HL60 differentiation.
a) c-Myc
In total cellular RNA of uninduced HL60 cells, c-myc RNA is 
detectable, by Northern blotting analysis, as a doublet of 2.4 kb and 
2.2 kb, when hybridised to ^P-labelled pMC41-3RC cDNA, which
contains the exon 3 sequence of the human c-myc gene. However, 
terminally differentiated HL60 cells, from both granulocytic and 
monocytic inductions, do not express c-myc RNA (Westin et al, 1982, 
Reitsma et al, 1983). Loss of detectable c-myc transcripts was used 
as a marker of terminal differentiation, however, the time at which 
c-myc expression ceased during HL60 induction was not known.
To investigate the relative abundance of c-myc RNA in HL60 cells
during differentiation, total RNA was isolated at time points
throughout the course of TPA, RA and DMSO inductions. These RNAs were
used to produce Northern blots, which were then hybridised with
32
P-labelled pMC41-3RC cDNA. During the course of monocytic
differentiation, c-myc RNA could not be detected following 2-4 h of 
TPA treatment (Figure 10). The transcripts remained undetectable 
throughout the rest of the induction period. DMSO induced HL60 cells
also lost c-myc RNA very rapidly, within 1 h of treatment (Figure 11)
119
A9.5
7.5
4.4
2.4
1.4
0.3
9-5 > 
7 5 > 
4-4 >
2-4 ► 
1-4 >
0-3 ►
a b c d 'e f g h
a b e d  e f g h i
Figure 10 Northern bloc analysis of c-mvc transcripts during TPA 
induced differentiation of HL60 cells,
10 n g samples of total cellular RNA from time points throughout the 
3 day course of TPA induction of HL60 cells were fractionated by 
electrophoresis on a denaturing, agarose gel. The RNA was then
blotted from the gel on to nitrocellulose membrane. The
nitrocellulose membrane was hybridised with P-labelled probes
for (A), human c-myc (pMC41-3RC); (B), B2 -microglobulin, each at a
concentration of 2 /. 10 cpm/ml. a, 0 h; b, 1 h; c, 2 h; d, 4 h;
e . 8 h; f, L6 h; g, 24 h; h, 48 h; i, 72 h of TPA treatment.
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Figure 11 Northern blot: analysis of c-myc transcripts during DMSO 
induced differentiation of HL60 cells.
1-0 i^g samples of total cellular RNA from time points throughout the
5 day course of DMSO induction of HL60 cells were fractionated by
electrophoresis on a denaturing agarose gel. The PJJA was then blotted
from the gel on to nitrocellulose membrane. The nitrocellulose
membrane was hybridised with P-labelled probes for (A), human 
c-inyc (pMC41-3RC); (B) , B2 -microglobulin, each at <1 concentration
°f 2 x 10 cpm/ml. a, Oh; b, Ih; c, 2 h; d, 4 h; e, 8 h; f, 16 h; 
g. 24 h; h, 72 h; i, 120 h of DMSO treatment.
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Figure 12 Northern blot analysis of c-mvc transcripts during RA 
induced differentiation of HL60 cells.
10 jug samples of total cellular RNA from time points throughout the 
5 day course of RA inducion of HL60 cells were fractionated by 
electrophoresis on a denaturing agarose gel. RNA was then blotted 
from the gel on to nitrocellulose membrane. The nitrocellulose 
membrane was hybridised with P-labelled probes for (A), human 
c-myc (pMC41-3RC); (B), B2-microglobulin at a concentration of
2 x 10 cpm/ml. a, 0 h; b, 1 h; c, 2 h; d, 4 h; e, 8 h; f, 16 h, 
g, 24 h; h, 72 h; i, 120 h of RA treatment.
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However, HL60 cells, induced by RA, did not lose c-myc RNA at early 
times during induction. It was only after 3 days exposure to RA that 
these cells showed a drop in the level of c-myc RNA. c-Myc 
transcripts eventually disappeared at the completion of the 5 day 
induction period (Figure 12). It is an interesting observation that 
two agents (DMSO and RA) which both induce granulocytic 
differentiation in HL60 cells, exhibit such different patterns of 
c-myc expression. Similar analyses were repeated using total RNA 
isolated from HL60 cells from a number of different RA, TPA and DMSO 
inductions, and from cells from different HL60 clones. In each 
instance it was found that the results were similar to those 
described above.
The Northern blots were stripped and rehybridised to radioactively 
labelled B2-microglobulin cDNA. This hybridises to a 1.1 kb 
transcript which is present at a con s.ant level during the course 
of HL60 differentiation (Figures 10, 11, 12). From these results it 
is apparent that the concentrations of RNA used throughout these 
analyses were comparable.
b) Lysozyme
bl) Lysozyme protein secretion
The production of lysozyme protein is associated with terminally 
differentiated macrophages, requiring this protein to accomplish 
their defensive and scavenging roles in vivo. Uninduced HL60 cells, 
when assayed for the secretion of lysozyme by the method described in 
Chapter II, 2, E, (i), do not produce any of this protein. However, 
during the course of TPA induction, lysozyme protein secretion could 
be detected as early as 2 h following the addition of inducer to the 
culture medium. The level of secreted lysozyme protein increased 
rapidly throughout the first 24 h of induction, reaching a peak 
between 24-48 h (Figure 13). Interestingly, DMSO and RA induced HL60 
cells were found to secrete some lysozyme protein but at a
concentration of approximately 5-10 fold less than that of TPA 
induced cells.
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Figure 13 Change in the level of lysozyme protein secretion during 
induced differentiation of HL60 cells.
Samples of medium were removed from uninduced HL60 cell cultures and 
from HL60 cell cultures treated with TPA, RA and DMSO at time points 
throughout the period of induction. The amount of lysozyme protein 
secreted in to the growth medium was measured and expressed as 
units/10 cells. ( a  ) , TPA induced HL60 cells; (O), RA induced HL60
Cells; (■)f DMSO induced HL60 cells; (•), uninduced HL60 cells.
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b2) Intracellular lysozyme protein
To determine if lack of secretion of lysozyme from uninduced and RA 
or DMSO induced HL60 cells was due to a block in the secretion 
process, the level of intracellular lysozyme protein present in these 
cells was examined. HL60 cells were harvested and washed thoroughly
to remove all traces of medium. The cells were then lysed in a small
volume of 0.2% (v/v) triton X-100 and the lysozyme protein content
measured as described previously. The results from this analysis are 
shown in Table 2. No lysozyme protein was found internally in RA 
induced, DMSO induced or uninduced HL60 cells*, however a small amount 
was present in TPA induced cells. Therefore, it appeared that the 
stimulation of lysozyme protein during TPA treatment of HL60 cells, 
was the result of a change in gene expression initiated by the 
induction stimulus and not the release of protein already present in 
the uninduced cell prior to treatment.
b3) Lysozyme mRNA
To examine lysozyme gene expression, total RNA from uninduced and 
induced HL60 cells were fractionated by electrophoresis on a
denaturing agarose gel and then used to prepare a Northern blot. This 
was hybridised to P-labelled lysozyme cDNA. The lysozyme probe, 
available in our laboratory, is a full-length cDNA of chick lysozyme 
and therefore only bears approximately 40% homology to the human 
lysozyme sequence (Land et al, 1981). This low homology determined 
that care had to be taken when washing the blot; it was washed at 
42°C and in low stringency wash buffers. The results of this analysis 
are given in Figure 14. This probe should detect a 0.8 kb RNA in the 
human system.
At the region around 0.8 kb, the size of the lysozyme mRNA, 
hybridisation was detected in total RNA from 24 h and 3 day TPA 
treated HL60 cells and in RNA isolated from normal human monocytes. 
After 3 days of TPA treatment a larger transcript of 3.8 kb was also 
apparent. It is interesting to note that this transcript was also 
present in normal monocyte RNA. A very strong hybridisation signal 
was detected in uninduced HL60 cells but these transcripts were 
longer than 0.8 kb. Interestingly, RA induced HL60 cells also 
appeared to contain high levels of homologous RNA to lysozyme,
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HL60
Induction
Units of Lyso7yme/106ce!ls
Intracellular Ptotein Secreted Ptotein
Uninduced 0 2
3 day DMSO 0 5
5 day DMSO 0 8
3 day RA 0 8
5 day RA 0 9
,3 day TPA 6 5 7
Table 2 Intracellular lysozyme protein compared to secreted lysozyme 
protein in unlnduced and induced HL60 cells.
1 x 106 cell samples of uninduced and induced HL60 cells were lysed 
and the amount of intracellular lysozyme protein determined. Secreted 
lysozyme protein was determined by analysis of the amount of lysozyme 
protein present in the growth medium (see Figure 13).
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Figure 14 Northern blot analysis of lysozyme transcripts in 
uninduced and in induced HL60 cells.
30 pg of total cellular RNA from uninduced and induced HL60 cells 
were subjected to electrophoresis on a denaturing agarose gel. The 
RNA was then blotted on to nitrocellulose membrane. The
nitrocellulose membrane was hybridised with 32^"labelled probes for 
(A), lysozyme; (B) , B2 -microglobulin. a, uninduced HL60; b, 5 day 
RA induced HL60; c, 16 h TPA induced HL60, d, 24 h TPA induced HL60; 
e, normal macrophage.
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however, the hybridisation signal covered an area relating to
1.0-2.0 kb therefore no exact size could be calculated for these 
transcripts. From these results it could be concluded that uninduced 
and RA induced HL60 cells, although not possessing lysozyme protein, 
did appear to contain RNA species homologous to the lysozyme cDNA
sequence; this is discussed in Chapter IV, 3, B.
To determine that a uniform RNA concentration was used in each sample 
the blot was stripped and rehybridised to radioactively labelled
B2-microglobulin cDNA (Figure 14).
C) Comparison of the Timing of Events Leading to Terminal 
Differentiation of HL60 Cells
i) TPA induction
Comparisons, made between self-renewal parameters and commitment or 
differentiation characteristics, suggest that HL60 cells cease to 
divide at approximately the same time as the appearance of overt 
differentiation features. Almost 90% of TPA induced cells ceased to 
proliferate after 16-24 h of treatment. This is concomitant with an 
increase in the percentage of cells which exhibited differentiated 
characteristics, such as the appearance of NSE positive cells, 
maximum production of lysozyme protein and the occurence of almost 
100% adherent cells. The timing of the decline in c-myc RNA preceded 
these events by a number of hours. However, there does appear to be a 
direct relationship between cell proliferation and loss of detectable 
c-myc RNA. These results are summarised in Figure 15.
ii) DMSO induction
Decline of self-renewal in HL60 cells, treated with DMSO, also
occurred concomitant to the appearance of committed, terminally
differentiated cells. In a similar fashion to TPA induction, the loss 
°f c-myc RNA occurred very rapidly after addition of DMSO to the cell 
culture medium, within 1 h of treatment. This event preceded any 
other differentiation related response, in DMSO induced cells, by 
16-24 h. It is interesting to note that although c-myc transcripts
were not detectable after 1 h of induction, DMSO induced cells still
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proliferated, infact these cells cycled 2-3 times before arresting in 
G0/G1 at approximately 72-96 h of treatment. These results are 
summarised in Figure 16.
iii) RA induction
When used to treat HL60 cells, RA did not result in an efficient
differentiation response. c-Myc RNA was detected up until 72 h of 
induction, FACS analyses (Figure 9) and cloning potential assays
showed that 40-50% of HL60 cells were still capable of proliferation
at this time. In addition, histochemical analysis revealed that a 
similar percentage of cells did not stain positively in an NBT test, 
a positive result revealing the cells ability to produce superoxide 
which is a characteristic of mature cells of the myeloid lineage. 
This is summarised in Figure 17. Although c-myc transcripts were not 
detected following 5 days of RA treatment, this might be due to the 
accumulation of quiescent cells, as the culture medium was not
replenished throughout the induction period.
Chapters 2 and 3 give results obtained from the screening of cDNA 
libraries, constructed from total poly(A)+ RNA isolated from RA 
induced HL60 cells. The results described above have considerable 
bearing on the origin of the cDNAs used to construct this library as 
it appears that the poly(A)+ RNA used as a template for cDNA 
synthesis was isolated from a mixed population of cells, containing 
both RA induced and uninduced HL60 cells.
D) c-Myc Expression and HL60 Differentiation
A general trend throughout induced differentiation of HL60 cells is 
the loss of self-renewal capacity followed by the appearance of overt 
differentiation characteristics, c-myc RNA levels decrease prior to 
this, suggesting that the loss of this message may determine when 
HL60 cells become committed to a specific differentiation pathway, 
the loss of c-myc transcripts being a prerequisite in preparing HL60 
for terminal differentiation. Evidence is now gathering to support 
this and is discussed in Chapter IV, 2, B.
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Figure 15 A summary of the results obtained from assays to assess 
the differentiation status of HL60 cells during a 3 day 
period of TPA treatment.
The results displayed measure (■), cloning potential of TPA induced
HL60 cells; (□), NSE activity in TPA induced HL60 cells; (O), cell
adherence; (•), c-myc expression. All percentages were calculated by 
taking the value obtained for the uninduced cell (cloning potential
and c-myc) or the fully induced cell (NSE and adherence) as 100%. The
results for c-myc expression were obtained from densitometric 
scanning of the Northern blot in Figure 10.
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Figure 16 A summary of the results obtained from assays to assess 
the differentiation status of HL60 cells during a 5 day 
period of DMSO treatment.
The results displayed measure (■), cloning potential of DMSO induced 
HL60 cells; ( □ ) , the occurence of NBT positive cells during DMSO 
induction and (•) , c-myc expression. All percentages were calculated 
by taking the value obtained for the uninduced cell (cloning 
potential, c-myc) or the fully induced cell (NBT) as 100%. The 
results for c-myc expression were obtained from densitometric 
scanning of the Northern blot in Figure 11.
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Figure 17 A summary of the results obtained from assays— to asses_s 
the differentiation status of HL60 cells during a 5 day 
period of RA induction.
The results displayed measure (■), cloning potential of RA induced 
HL60 cells; ( □ ) , the occurence of NBT positive cells during RA
induction and (•) , c-myc expression. All percentages were calculated 
by taking the value obtained from the uninduced cell (cloning 
potential, c-myc) or the fully induced cell (NBT) to be 100%. The 
results for c-myc expression were obtained from densitometric 
scanning of the Northern blot in Figure 12.
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2 IDENTIFICATION OF SEQUENCES WHICH CHANGE IN ABUNDANCE FOLLOWING 
THE INDUCED DIFFERENTIATION OF HL60 GF.T.T.S
A) Library Construction
Prior to my arrival at this laboratory, HL60 cDNA libraries had been 
constructed from uninduced and induced HL60 cellular RNA, by the
method of Wickens et al (1978). Briefly, total RNA was isolated from
HL60 cells (in the case of the library I screened, the RNA was 
prepared from HL60 cells following 5 days exposure to RA and was 
therefore called the RA5 library). Poly(A)+ RNA was isolated from 
the total RNA by passing through an oligo d(T) cellulose column (Aviv 
and Leder (1972)). The poly(A)+ RNA was used as a template for the 
oligo d(T) primed synthesis of a single stranded cDNA in the 5'-3' 
direction, catalysed by reverse transcriptase. Following this, the 
mRNA-cDNA first strand hybrids were denatured by boiling. The second 
cDNA strand was then synthesised in a 5'-3' direction by DNA 
polymerase I, utilising the hair-pin loop, formed at the 3' end of 
the first strand cDNA, as a primer for this reaction. This resulted
in the formation of a double-stranded cDNA, joined by a
single-stranded hair-pin loop, which is variable in length and 
location. To remove this the cDNA was digested by SI nuclease and the 
ends then repaired by DNA polymerase I. The cDNAs were blunt-end 
ligated into the Sma I site of pUC8. No size selection of cDNAs was 
carried out before ligation. The resulting recombinant plasmids were 
used to transform E.coli JM83 cell. Figure 18 depicts the library 
construction procedure in a schematic form.
B) Library Screening
The RA5 library had initially been screened to isolate those clones 
which contained sequences present in high abundance in RA induced 
HL60 cells. Grunstein-Hogness Colony Hybridisation (Grunstein and 
Hogness (1975)) and DNA dot blot screening had been employed. This 
had reduced the number of recombinants to be analysed from 10 000 to 
190. These 190 positively scoring clones were inoculated into 2 
"composite" 96 well culture dishes.
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Figure 18 Schematic representation of the construction of the cDNA 
library representing polvCAl RNA from 5 day. RA induced 
HL60 cells.
Briefly, double-stranded DNA was synthesised from a poly(A)^ RNA 
template, using an oligo(dT) primer, this was blunt end ligated in to 
the Sma I site of pUC8.
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Firstly, I had to confirm that the 190 recombinants were represented
in RA induced HL60 cells and, from the results obtained, select those
recombinant plasmids which appeared to represent sequences showing
changes in abundance during differentiation. To accomplish this the
Grunstein-Hogness colony screening method was used. Filters were
prepared in triplicate from each "composite" plate. These were then 
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hybridised to P-labelled cDNAs, reverse transcribed from
poly(A)+ RNA which had been isolated from the total cellular RNA of 
uninduced, TPA induced and RA induced HL60 cells. Recombinant
plasmids were selected by comparison of the intensity of
hybridisation signal gained from each of the probes, the signal was 
estimated from a number of different autoradiographic exposure times. 
To confirm the results obtained from the analyses described above, 
the experiment was then repeated using freshly prepared filters. The 
results from both rounds of screening were then compared and only 
those clones which gave consistant results were chosen to enter the 
next round of selection assays.
Selection criteria were :-
a) signal increase :- increase in abundance following induction of
differentiation. An example of this can be seen in Figure 19A, A9. 
This recombinant plasmid appeared to represent a sequence which was 
highly abundant in TPA induced HL60 cells but not present in
uninduced or RA induced cells.
b) signal decrease :- decrease in abundance following induction of
differentiation. An example of this can be seen in Figure 19B, A6. 
This recombinant plasmid appeared to represent a sequence which was 
abundant in uninduced HL60 cells but not present in either RA or TPA 
induced cells.
c) a hybridisation signal was detected with each probe but the degree 
of hybridisation varied, being high with one probe but low with one 
or both the others. An example of this can be seen in Figure 19A, A6. 
This recombinant plasmid appeared to represent a sequence which was 
highly abundant in RA induced HL60 cells, present in uninduced cells, 
but barely detectable in TPA induced cells.
d) the same degree of hybridisation signal intensity was gained with
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Figure 19 Grunstein-Hogness screening of the cDNA library
representing RNA from 5 day RA induced HL60 cells.
Impressions were taken of the colonies containing recombinant
plasmids. These were cultured, in triplicate, on nylon membranes. The
membranes were then hybridised to P-labelled cDNA reverse
transcribed from poly(A)+ RNA isolated from uninduced, 5 day RA
induced and 3 day TPA induced HL60 cells. (A) represents recombinants
from "composite plate 1; (B) represents recombinants from "composite
plate 2.
136
each probe. An example of this can be seen in Figure 19A, A3 This 
recombinant plasmid appeared to represent a sequence that was highly 
abundant in uninduced, RA induced and TPA induced HL60 cells.
Of the 190 clones analysed in this round of screening most were 
in categories a) , c) and d) . The results from this experiment are 
summarised in Table 3. It appeared that the majority (55%) of the 
clones represented sequences which were found in RA induced or in 
both RA induced and uninduced HL60 cells. This would be expected as 
the recombinant plasmids were constructed from cDNA produced from 
poly(A)+ RNA of RA induced HL60 cells. It can therefore be surmised 
that, during the induced differentiation of HL60 by RA, a large 
proportion of the cellular RNA is specific to that differentiation 
pathway. The large proportion of clones which hybridised to probes 
produced from poly(A)+ RNA from uninduced HL60 cells is also not 
surprising as results from Chapter III, 1, B revealed that following 
5 days of RA treatment 40-50% of an HL60 cell culture still retain 
uninduced cell characteristics.
To ensure that a similar plasmid copy number existed in each 
transfectant, the filters from the analyses described above, were
n r\
then stripped of hybridised probe and rehybridised to P-labelled, 
nick-translated pUC8 cDNA.
From this first analysis 25 recombinant plasmids were selected which 
appeared to represent sequences which were highly abundant in RA 
induced HL60 cells when hybridised to the reverse transcribed probes 
from HL60 poly(A)+ RNAs. These clones were again screened by the 
Grunstein-Hogness colony hybridisation method. This third round of
screening showed little variation in results from the first or
second. At this stage glycerol stocks were made of each of the 25
recombinant plasmids. Each glycerol stock was prepared from a single 
colony to ensure that it represented only 1 recombinant plasmid.
These stocks also ensured that each time a fresh batch of plasmid DNA
was prepared, it originated from the initial isolate.
The colony hybridisation technique has two main disadvantages. 
Firstly, results are dependent on growth of the cells once
transferred on to the nylon filter, which consequently affects
plasmid copy number and poses problems when comparing individual
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Signal with 
Probes from:-
Number from 
190 Clones
Percentage
RA induced cells 
only
56 29.5 %
Uninduced cells 
only 20 10,6 %
TPA induced cells 
only 2 1.0 %
All cells 28 14.8 %
TPA+ Uninduced 
cells 26
13.7 %
RA+ Uninduced 
.cells 48
25.2%
TPA+RA induced 
cells
4 2.0 %
No Signal 6 3.2 %
Table 3 Summary of initial sreening results from the cDNA library.
The percentage of recombinant plasmids which appeared to contaii 
sequences found in uninduced, 3 day TPA induced and 5 day RA inducec 
HL60 cells were calculated from screening data.
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colonies. Secondly, the efficiency of the lysis and denaturing
processes affect the degree of hybridisation between the plasmid DNA
and the labelled probe. In order to overcome these problems, DNA from
the 25 recombinant plasmids, selected previously, were prepared using
the small-scale plasmid DNA preparation method described in Chapter
II, 2, K. (iii) . The DNA was dot-blotted on to nitrocellulose membrane
32and hybridised to P-labelled probes reverse transcribed from
poly(A)+ RNA isolated from total cellular RNA of uninduced, TPA
induced and RA induced HL60 cells. Weak hybridisation signals were
obtained during this experiment which was probably due to low DNA
concentrations used in each DNA dot. However, the intensity of signal
improved with longer autoradiographic exposure enabling comparisons
to be made between filters hybridised to the three different probes.
Very few recombinant plasmid DNAs hybridised to probes from uninduced
or TPA induced HL60 poly(A)+ RNA (Figure 20). Filters hybridised
with labelled cDNA from RA induced HL60 poly (A)+ RNA also gave a
poor signal, however with very long exposure times of upto 2 weeks,
almost all of the recombinant plasmid DNAs gave a weak hybridisation
signal with this probe (Figure 20) . Figures 20 (d) and (e) show the
control filter for this analysis, which was hybridised to 
32P-labelled pUC8 cDNA, and the filter plan describing the position 
of each clone.
The recombinant plasmids have been named after the vector, pUC8, plus 
the position that the plasmid occupied in the initial "composite" 
plate. Therefore pUC8C3 is a recombinant pUC8 plasmid found at 
position C3. The cDNA of each clone is named after the position only, 
dropping the pUC8 prefix, therefore the pUC8C3 cDNA insert would be 
called C3. The RNA homologous to the C3 sequence would be termed C3 
RNA.
When the results from both screening methods were compared, 10 clones 
were chosen. These appeared to represent sequences which changed in 
abundance following HL60 differentiation. The results from the 
screening analyses, for the 10 recombinants are summarised in Table 4
(A). Almost all of the clones appeared to represent RNA sequences 
that were highly abundant in RA induced HL60 cells, with the 
exception of pUC8C2, which appeared to be homologous to an RNA 
abundant in TPA induced HL60 cells. pUC8A3 was selected to act as a 
control in further analyses, as the cDNA insert present in this
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Figure 20Tdentification of recombinants homologous to sequences 
which change in abundance during HL60 differentiation,.
Small scale preparations of plasmid DNA were made from 25 colonies
which were selected from the cDNA library representing poly(A) RNA
from 5 day RA induced HL60 cells. These preparations were used o
prepare three nylon membranes. The membranes ”®>-e y rl ^  , ,
P- labelled cDNA transcribed from poly(A)+ RNA from ^induced 
HL60 cells, 5 day RA induced HL60 cells and 3 day TPA in uc 
cells. This figure shows the results of autoradiographs of these
membranes. The filters were then s c r i p p e  o y ri that an
rehybridised to radioactively labelled pUC8 cDNA to ensure that an
equivalent amount of plasmid DNA was present in eac ' .
the membranes, giving the position and n a m e  of the 2 re ^
also displayed. a),TPA probed, b),RA proDeo, c; , f
of plate; e),pUC8 probed plasmid DNA.
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Table 4 Summary of the data obtained for the 10 recoiqbiqants selected 
following screening of the cDNA library containing; sequences 
present in 5 day RA induced HL60 cells.
(A) The abundance of the sequences represented by each recombinant was 
established from a number of autoradiographic exposures from the 
membranes in Figures 19 and 20. (++) > very abundant; (+), moderately 
abundant; (-), not detected.
(B) The sizes of the cDNAs from each of the recombinants was determined 
by Eco RI + Bam HI restriction digestion of the plasmid DNAs followed 
by fractionation on a 1.5% (w/v) agarose gel. The sizes were calculated 
by comparison to DNA size markers which were run simultaneously on the 
same gel. These were 0X174 DNA digested with Hae III.
(A)
Plasmid UNI RA TPA
pUC8A3 + + + + + +
p UC8 B 1 - + + -
pUC8B4 + + + -
PUC8C2 + + + +
plies ce + + + +
pUC8E1 + + + + +
p UC8E4 + + + +
p UC8F6 + -t- + -
p UC8F10 + + + -
P UC8G6 + +• + -
Plasmid Size of cDNA
pUC8A3 1250
p(JC8B1 600,120
PUC8B4 180
- PUC8C2 180
pUC8C6 220,190,160
pUC8E1 -
PUC8E4 230
pUC8F6 550
PUC8F10 210
pUC8G6 310, 250
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plasmid hybridised almost uniformly to probes from induced and 
uninduced HL60 cells.
C) Calculation of the Sizes of the cDNA Inserts from the 10 Clones 
Selected Following: the Screening Process of the RA5 cDNA Library
During construction of the cDNA library, derived from poly(A)+ RNA 
from 5 day RA induced cells, the Sma I restriction digestion site 
within the pUC8 multicloning site was utilised as the cloning site 
for the blunt end ligation of the cDNAs into pUC8. To isolate the 
cDNAs from the recombinant plasmid required restriction digestion
with Eco RI and Bam HI. This is shown diagramatically in Figure 21. 
Therefore, to estimate the size of the cDNAs, from the 10
recombinants selected following screening of the RA5 library, 1 ug of 
each plasmid DNA was restriction digested with Eco RI + Bam HI, then 
fractionated by electrophoresis on a 1.5% agarose gel (Figure 22). 
The sizes of the cDNAs (Table 4 (B)) were calculated by comparison 
to Hae III restriction digested 9X174 DNA markers, run simultaneously 
on the same gel. At this stage, one recombinant plasmid, pUC8El, did
not appear to contain any cDNA and was therefore discarded.
Generally, the cDNAs were small, the largest being A3 of 1250 bp in 
length. A3, Bl, C 6 , F6, and G6 cDNAs gave multiple fragments
following Eco RI + Bam HI digestion of the recombinants. This was
indicative of an internal restriction site in the cDNA sequence.
Another possibility was that these recombinant plasmids were 
conjugate, consisting of two plasmids ligated end to end with either 
the same or different cDNA inserts. Eco RI + Bam HI restriction 
digestion of such a plasmid would also reveal two cDNAs. From 
previous work in our laboratory conjugate plasmids had been
discovered.
The smaller of the potential cDNAs detected in lanes 1 and 8 of
Figure 22, corresponding to pUC8A3 and pUC8F6, were not clearly 
defined bands on the gel which was indicative of some form of
contaminant in the DNA preparation. This could have been caused by 
contaminating RNA co-purified in the initial preparation of the
plasmid DNA. Therefore the plasmid DNAs were further purified by 
centrifuga t i on at high speed through a sucrose gradient. Re-analysis
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* HaeH
pUC 8
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Haett1.5
HaeH
Inserts
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MCS: EcoRI, S m a l, Bam H I
Xm al
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Figure 21 Diagram nf the plasmid cloning.,.vector pUC,_
f t-hp Hae XX restriction digest 
This diagram shows the position ot cDNAs were
sites and also the sites in the mu tic ° removal from the plasmid
cloned in to the Sma I ^ s w eEco°RI +hBam Hrrestriction digestion
vector could be accomplished by &co m
of the recombinant plasmid DNA.
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Figure 22 Sizing the cDNAs from the 10 selected recombinants^
Each recombinant was digested with the restriction enzymes Eco RI + 
HI. The digested plasmid DNAs were electrophoresed in a 1.5% 
agarose gel. Hae II digested & X 174 DNA was also loaded alongside, 
Providing size marker DNA bands. The figure^ shows the resulting 
ethidium bromide stained gel visualised by UV light. Lane 1, pUC A , 
Lane 2, pUC8Bl; Lane 3, pUC8B4; Lane 4, pUC8C2; Lane 5, pUC8C , 
Lane 6, pUC8El; Lane 7, pUC8E4; Lane 8, pUC8F6; Lane 9, pUC8F10; Lane 
10, pUC8G6.
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Restriction enzvme digestign of pUC8B1 . pUC8C6 . and pUC8G6 
DNAs .
1 Mg of plasmid DNA was digested with Eco RI, Bam HI or Eco RI + 
m HI. xhe digested DNA samples were then fractionated by 
6 ^ tf°P^oresis on a 1.5% agarose gel. The figure shows the resulting 
e^di u m  bromide stained gel visualised by UV light. Hae II digested 
DNA was also loaded alongside to provide DNA size markers.
ane 1, pUC8 DNA; Lane 2, pUC8 DNA / Eco RI; Lane 3, pUC8C6 DNA;
ane 4, pUC8C6 / Eco RI; Lane 5, pUC8C6 DNA / Bam HI; Lane 6, pUC8C6 
NA / Eco RI + Bam HI; Lane 7, pUC8Bl DNA; Lane 8, pUC8B / Eco RI; 
J^ane 9, pUC8Bl DNA / Bam HI; Lane 10, pUC8Bl / Eco RI + Bam HI;
DNa6 111 PUC8G6 °NA; Lane 12, pUC8G6 DNA / Eco RI; Lane 13, pUC8G6
NA / Bam HI; Lane 14, pUC8G6 DNA / Eco RI + Bam HI.
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of pUC8A3 and pUC8F6 DNAs following this revealed only one cDNA
fragment for each plasmid.
To determine if pUC8Bl, pUC8C6 and pUC8G6 were conjugate plasmids, 
the plasmid DNAs were digested with Eco RI, Bam HI or Eco RI + Bam HI 
and fractionated on an agarose gel. The results showed that these 
plasmids did not appear to be conjugate (Figure 23). When linearised 
each plasmid appeared as a single band of slightly larger size than 
linearised pUC8. If indeed they had been conjugate plasmids, it might 
have been expected that the linearised DNA would run as a doublet.
The extra fragments were also unlikely to be the result of a
contaminating plasmid. Purification by colony-selection, followed by 
Eco RI + Bam HI digestion, still revealed an identical restriction 
pattern. Thus, it appeared that Bl, C6 and G6 contained internal 
Bam HI or Eco RI digestion sitesj the fragments generated from these 
sites, however, were not detected, even when a large -concentration of 
plasmid DNA was analysed (Figure 23).
3 EXAMINATION OF RNAS HOMOLOGOUS TO THE cDNAs OF THREE RECOMBINANTS 
SELECTED FOLLOWING SCREENING OF THE cDNA LIBRARY
Following the screening of the RA5 library, 10 cDNAs had been 
selected which appeared to represent sequences that were expressed in 
high abundance during HL60 induced differentiation by RA. 3 of these 
cDNAs, F6, F10 and C6, and the RNAs homologous to the sequences the
cDNAs represented were then studied in detail.
A) Characterisation and Identification of the F6 cDNA Sequence
Initial results obtained from screening analyis indicated that the F6 
cDNA was homologous to RNA which was abundant in both RA and 
uninduced HL60 cells. To confirm this further analyses were carried 
out to determine the size and relative abundance of F6 RNA. Results 
from these analyses, when compared to those obtained from other cDNAs 
would also determine if the F6, F10 and C6 cDNAs represented
different sequences.
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i) Southern Blot Analysis
To determine the restriction fragment lengths homologous to F6 in 
genomic DNA, total cellular DNA from HL60 cells was digested with the 
restriction endonucleases Eco RI, Bam HI and Hind III. These enzymes 
were chosen because they cleave DNA relatively infrequently and so 
should yield simple restriction patterns. A Southern blot was
prepared following electrophoresis of the digested DNA which was then 
hybridised to radioactively labelled F6. The results from this
analysis are shown in Figure 24. F6 cDNA was unusual in that it 
hybridised in a non-specific manner to the DNA. The hybridisation
signal was not resolved by increasing the washing time of F6 
hybridised filters at high temperatures and in high stringency wash 
buffers. This pattern is representative of those corresponding to 
highly repetitive sequences, which occur frequently throughout the 
genome.
ii) Analysis to Determine the Relative Abundance of F6 RNA in HL60 
Cells
To determine the relative abundance of F6 transcripts in HL60 cells, 
quantitative analyses were carried out. RNA doubling dilution dot 
blots were prepared from total RNA from uninduced, 3 day TPA induced 
and 5 day RA induced HL60 cells, then hybridised with radioactively 
labelled F6 cDNA. The results are shown in Figure 25. F6 hybridised 
strongly to uninduced HL60 cellular RNA. By measuring the end-point 
of titration for each RNA sample, it was calculated that RNA 
homologous to F6 was of 4-fold greater abundance in uninduced HL60
cells than in RA induced cells, and 32-fold more abundant than in TPA 
induced HL60 cells.
To confirm that the same amount of RNA was present in each series of 
RNA dots, the dot blot was stripped and rehybridised to
32P-labelled pHR28-l, a probe for human 28S ribosomal RNA
sequences. The results, shown in Figure 25, confirm that a uniform 
concentration of RNA was present in corresponding dots from each 
series.
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Figure ?4 Southern analysis of HL60 DNA hybridised to labelled 
F6 cDNA.
30 fig of HL60 total cellular DNA were restriction digested with 
Eco R I  t g a m  o r  n i n d  i n  then fractionated by electrophoresis on a 
(w/v) agarose gel. The DNA was transferred to nitrocellulose 
^mbrane by blotting. The nitrocellulose membrane was hybridised with 
P-labelled F6 cDNA. (B), Bam HI; (R), Eco RI; (H), Hind III.
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Figure ?5 Determination of the abundance of F6 RNA in HL60 cells.
20 i^g of total RNA isolated from uninduced, 5 day RA induced and 3 
day TPA induced HL60 cells were dotted in a doubling dilution fashion 
on to nitrocellulose membrane. The nitrocellulose membrane was then 
hybridised with radioactively labelled probes for (A), F6 sequences 
and (B) , human 28S ribosomal RNA sequences. (R) , 5 day RA induced 
HL60 RNA; (T) , 3 day TPA induced HL60 RNA; (U), uninduced HL60 RNA.
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iii) Northern Blot Analysis
To discover the size of the RNA transcript(s) homologous to F6, a 
Northern blot was prepared from total cellular RNA from uninduced, 
3 day TPA induced and 5 day RA induced HL60 cells. The blot was then 
hybridised to 32P-labelled F6. The results from this analysis are 
shown in Figure 26. The transcript sizes were calculated by 
comparison to RNA size standards, run simultaneously, ranging from
9.5 kb - 0.3 kb.
The F6 cDNA hybridised to an area covering 4.0 kb - 1.0 kb. Although 
no specific RNA species could be determined, the hybridisation signal 
was strongest in total RNA from uninduced and RA induced HL60 cells 
but did not appear in high abundance in TPA induced cells. The
results from this analysis suggested that the F6 cDNA contained a 
repetitive element, in agreement with those obtained from Southern 
analysis.
To ensure that the RNA analysed by Northern blotting was not degraded 
and that the concentration of RNA analysed from each sample was 
uniform the blot was stripped and reprobed with radioactively
labelled B2-microglobulin cDNA. The results, displayed in Figure 26 
confirm this.
The results obtained for the size of RNA homologous to F6, from 
Northern blot analysis and the relative abundance of the F6 
transcripts following HL60 differentiation, are summarised in Table 
5.
iv) Cell Compartments Containing F6 RNA
a) Poly(A)+ RNA
During the initial characterisation of F6 cDNA, total cellular RNA 
had been analysed. To determine if F6 transcripts were present in 
Poly(A)+ RNA in HL60 cells, and hence representing mRNA in these
cells, poly(A)+ RNA was isolated from uninduced, TPA induced and RA 
induced HL60 cells by the method of Aviv and Leder (1972). The
Poly(A)+ RNAs were then used to prepare Northern blots which were 
hybridised to 32P-labelled F6. The results are given in Figure 27.
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cDNA F6
Size of Hind III smear
DNA Fragments Eco RI smear
(kb) Bam HI smear
RI /  B 1 smear
Size of \
RNA Transcripts (kb) 1.0-4.0
Relative Abundance Uni 1
of Transcripts RA 0.25
TPA 0.0625
DMSO ND
Table 5 Summary . of the results of Northern and Southern 
blotting analyses of F6 sequences.
These results were gathered from a number of analyses. The values 
calculated for the relative abundance of F6 RNA are averages of 
results from a number of different inductions.
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Figure 26 Determination of the size of RNA homologous to F6 by 
Northern blotting.
20 i^g of total RNA isolated from uninduced, 5 day RA induced and 
3 day TPA induced HL60 cells were fractionated by electrophoresis on 
a denaturing, agarose gel. The RNA was then transferred on to 
nitrocellulose membrane by blotting and the membrane hybridised 
to radioactively labelled probes for (A), F6 sequences and (B), 
B2-microglobulin. (R), 5 day RA induced HL60 RNA; (T), 3 day TPA
induced HL60 RNA; (U), uninduced HL60 RNA.
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Figure 27 Determination of the presence of F6 RNA in polyCA’)* RNA 
isolated from HL60 cells.
5 x^g of poly(A)+ RNA isolated from uninduced, 5 day RA induced and 
3 day TPA induced HL60 cells were fractionated by electrophoresis on 
a denaturing, agarose gel. The poly(A)+ RNA was then transferred on 
to nitrocellulose membrane by blotting. The nitrocellulose membrane 
was then hybridised with P-labelled probes for (A), F6 sequences 
and (B), B2-microglobulin. (U), uninduced HL60 poly(A)+ RNA; (T), 
3 day TPA induced HL60 poly(A)+ RNA; (R), 5 day RA induced HL60 
Poly(A)+ RNA.
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Although much of the smearing, which was present when analysing total 
RNA, was lost, F6 did not hybridise to any specific mRNA. The 
intensity of hybridisation was again strongest in poly(A)+ RNA from 
uninduced and RA induced HL60 cells. The smeared results observed 
when Northern blots were hybridised with F6 suggested that the cDNA 
contained a non-coding element, supporting the conclusion reached 
following Southern blotting analysis which resulted in the
QO
non-specific hybridisation of P-labelled F6 cDNA to all sizes of 
DNA.
To determine that the poly(A)+ RNA used in this analysis was not 
degraded and that a similar concentration had been assayed from each 
sample, the Northern blot was stripped and rehybridised to 
■^P-labelled B2-microglobulin cDNA (Figure 27).
b) The abundance of F6 transcripts in Nuclear and Cytoplasmic RNA of 
HL60 cells
None of the analyses involving the characterisation of F6 RNA had 
revealed a distinct size of transcript. This led to the conclusion 
that F6 did not represent a coding sequence but might be a component 
of hnRNA. To discover if this were true the distribution of RNA 
homologous to F6 was examined in the different cellular compartments. 
The cellular compartment to which F6 RNA was localised, in HL60 
cells, was discovered by determining the relative abundance of these 
transcripts, by Northern blotting and RNA dot blot analysis, in total 
cytoplasmic and nuclear RNA isolated from uninduced HL60 cells. The 
results from these experiments are given in Figure 28. From the RNA 
dot blot analysis, cytoplasmic RNA did not hybridise efficiently to 
F6 but a strong signal was obtained from nuclear RNA. Therefore it
appeared that RNA homologous to F6 was 8-10 fold more abundant in 
nuclear RNA isolated from uninduced HL60 cells than in cytoplasmic
RNA. A similar conclusion could be drawn from Northern blot analysis
(Figure 28 (ii)). Again considerable smearing occurred but clearly F6
transcripts were more abundant in nuclear RNA. These results 
suggested that F6 RNA did not contribute to the cytoplasmic RNA pool, 
was unlikely to represent mRNA and therefore did not contribute to 
the protein complement of HL60 cells.
The northern blot was stripped and rehybridised with radioactively
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Figure 28 (i) Determination of the abundance of F6 transcripts in 
total nuclear RNA and total polysomal RNA isolated 
from uninduced HL60 cells.
5 jag of total cytoplasmic RNA and 5 jug of total nuclear RNA isolated 
from uninduced HL60 cells were dotted on to nitrocellulose membrane 
in a doubling dilution fashion. The nitrocellulose membrane was then 
hybridised with P-labelled probes for (A), F6 sequences and (B), 
human 28S ribosomal RNA sequences. (N), total nuclear RNA; (C), total 
cytoplasmic RNA.
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(ii) Northern blotting analysis of F6 RNA in nuclear and
cytoplasmic RNA isolated from uninduced HL60 cells.
5 pg of total cytoplasmic RNA and total nuclear RNA isolated from 
uninduced HL60 cells were fractionated by electrophoresis on a 
denaturing, agarose gel. The RNA was then transferred to
nitrocellulose membrane by blotting and subsequently hybridised to
radioactively labelled probes for (A), F6 sequences and (B),
B2-microglobulin. (N), nuclear RNA; (C), cytoplasmic RNA.
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labelled probe for B2-microglobulin to ensure that the RNA from 
each sample was at a uniform concentration and not degraded. (Figure 
28,ii) confirms this. The RNA dot blot was stripped and rehybridised 
to a probe for human 28S ribosomal sequences to confirm that a 
similar concentration of RNA was used in comparable dots from 
different series (Figure 28,i).
c) Examination of the Translation Potential of RNA Transcripts 
Homologous to F6
From examination of polysomal fractions obtained from the cytoplasmic 
extract of fractionated uninduced and induced HL60 cells, it became 
clear that RNAs homologous to F6 were not translated. The cytoplasmic 
extract, of uninduced, TPA induced and RA induced HL60 cells was 
centrifuged through a sucrose gradient which separated the polysomes, 
plus associated RNA, from free ribosomes. The gradient was then 
unloaded and collected in 1ml aliquots from which an RNA dot blot was 
prepared. The RNA dot blots were hybridised with radioactively 
labelled F6, the results are shown in Figure 29. A greater intensity 
of hybridisation was detected in those fractions relating to free 
ribosomes than to those representing polysomes. This was found to be 
the case in the samples isolated from uninduced HL60 cells and from 
that of RA induced and TPA induced cells.
v) Sequence and Identification of the F6 cDNA
Southern blot and Northern blot analyses revealed that F6 hybridised 
in a non-specific manner to total cellular DNA and to total cellular 
RNA and poly(A)+ RNA isolated from HL60 cells. Analysis of the 
location of F6 homologous transcripts in HL60 cells determined that 
these transcripts were abundant in the cell nuclear compartment. It 
was also shown that F6 RNA is unlikely to be translated as most of 
the F6 homologous RNA transcripts did not appear to be associated 
with polysomes. These results led to the conclusion that F6 contained 
a non-coding, repetitive element. To clarify the situation, the F6 
cDNA was sequenced by the Sanger "dideoxy" sequencing method 
described in Chapter II, 2 (S) . The F6 sequence is displayed in
Figure 30. The sequence obtained was then compared to recorded 
sequences in the Genebank Sequence Data Bank.
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Figure 29 RNA dot blot of polysomal RNA isolated from HL60 cells
hybridised to F6.
Polysomal fractions from uninduced, 5 day RA induced and 3 day TPA 
induced HL60 cells were centrifuged through neutral sucrose gradients 
to separate polysomes plus associated RNA from free ribosomes. 1 ml 
fractions were removed sequentially from the gradients and RNA was 
prepared from the samples. 5 jig of RNA from each sample were then 
dotted on to nitrocellulose membrane and then hybridised with 
radioactively labelled F6 cDNA. (U), uninduced HL60 RNA; (T), 3 day 
TPA induced HL60 RNA; (R), 5 day RA induced HL60 RNA.
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F6 GT CCAGCTCCTA GGGTAAGAAC GTCAAAAGTC TACTTAGGGT
B13
F6 ACGTTTAATT TCCCAAACTC TGTCTCAGGC CGAGAACAAC
B13
kkkkkk
AAACTC
kk kkkk
TGCCTCAAAG
kkkkkkkkkk
CGAGAACAAC
F6 CAACGGCACC TCACGTCACC GTGTCAGAGC CGAGTGACGT
*** kkkkkk kkk kkkkk kkkkkkkkkk
B13 GGGTCCGACC TCACGTTACC ACACTAGAGC CGAGTGACGT
F6 TTGGAGACGA ACGATCCAAG CTCACTAAGA GGGCTGG
* -k * * * * * kk
B13 TGTAGACGGA GGGCCCAAGT TCGCTAAGAG GACGAGGTCG
F6
B13 GAGTCGGAGT CCTCATCGAC CCCGATGTCC GTACGCGGTG
F6
B13 GTGCGGGCCG ATTAAAACAC
ATCATG
AAAAATCATC
CTCTACCCCA
kkk k
TCAACCCCAA
F6 AAGCGGATCA CCGCTCCGAC CAGAGCTTGA GGACTGGAGT
k k k kkk kkkkkk kkkk kkkkk kkkkkk k k
B13 AACGGTACAA CCGGTCCGAC CAGAACTTGA GGACTGAATT
F6 CCACTACACC GGTGGAGCTA TAGGGTTTCA CGGCCCTAAT
kkkkk kkkk kkkkk k kk kkkkkkk
B13 TCACTAGGTG AACGGAGTCG GAAGGTTTGA CGACCCTAAT
F6 GTAAGCAGTT TAATTTCCAA AACTAACACT ACTTTTTGTG
B13
F6
G
TGTATTTTAG CTAGTCGAAG TAGTAAAATT CACATATAAA
B13
F6 GTTCATCACA ATTTAAAAAA GTACGATAAC ACTTTGTGTA
B13
F6 GAGGCCTTGG AAAAGTAGAA d
Figure 30 Diagram representing the F6 cDNA sequence compared to that 
of Blur 13. a human Alu repetitive element.
The sequence of F6 cDNA was found to share approximately 80% homology 
to Alu repetitive elements. The Blur cDNAs are sequences which 
represent members of the Alu family of short, interspersed repetitive 
elements. This diagram indicates the regions of homology between F6
and Blur 13 by (*).
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Of the 550 bp of F6 cDNA, the sequence of 400 bp was obtained. From 
this it became apparent that F6 consisted of almost 300-400 bp of Alu 
sequence. These are short, interspersed repetitive DNA elements found 
in eukaryotes and present in the human genome in approximately 
500 000 copies per haploid genome (Jelinek et al. 1980). In fact
almost all of the F6 sequence shared 80-90% homology to known human 
Alu repetitive elements. However, 130 bp, at the 3' end of the F6 
cDNA did not share any homology to Alu sequence and also bore no 
similarity to any other recorded sequence in the Genebank Sequence 
Data files. Attempts to find a suitable restriction digest site which 
would allow the isolation of this 130 bp unique region, and therefore 
allow its separation from the Alu element, were not succesful.
Figure 30 also illustrates the regions of homology between F6 and 
another Alu family member Blurl3. The region for which no sequence 
was determined in F6 cDNA lies between two stretches of Alu 
homologous regions, which, when compared to other Alu clones, can be 
mapped 70-80 bp apart. It therefore seems reasonable to assume that 
this sequence would also be Alu. Although F6 cDNA did not represent a 
mRNA species, it is interesting to note that expression of Alu 
repetitive element RNA varied following induced differentiation of 
HL60 cells.
B) CHARACTERISATION OF F10 cDNA AND ITS HOMOLOGOUS RNA
From initial screening analyses of the RA5 cDNA library, the RNA 
transcripts homologous to F10 appeared to be highly abundant in 5 day 
RA induced HL60 cells. To establish this and to determine the size of 
F10 RNA a number of analyses were carried out.
i) Southern Blot Analysis
To determine the restriction fragment lengths homologous to F10 in 
DNA, total cellular DNA, from HL60 cells, was digested with the 
restriction endonucleases Eco RI, Bam HI and Hind III. The DNA was 
then used to prepare a Southern blot which was subsequently 
hybridised to radioactively labelled F10 cDNA. The results of this 
analysis are shown in Figure 31. F10 hybridised to discreet DNA
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Figure 31 Southern analysis of HL60 DNA hybridised with 
P-labelled F10 cDNA.
30 of HL60 total cellular DNA were restriction digested then
fractionated by electrophoresis on a 1% (w/v) agarose gel. The DNA 
was then transferred on to nitrocellulose membrane by blotting. The 
nitrocellulose membrane was hybridised with radioactively labelled 
probe for F6 sequences. (R), Eco RI digested DNA; (H), Hind III 
digested DNA, (B), Bam HI digested DNA; (R/B), Eco RI + Bam HI 
digested DNA.
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fragments. Comparison of the sizes of the restriction fragment 
lengths obtained from F10 and those of F6 and C6 indicated that F10 
represented a unique sequence. The sizes of the restriction fragments 
homologous to F10 are summarised in Table 6.
ii) Quantitative Analysis of the abundance of F10 RNA Following HL60 
Differentiation
To analyse quantitatively the abundance of transcripts related to 
F10, RNA doubling dot blot dilution assays were carried out.
Using total cellular RNA, isolated from uninduced, RA induced and TPA 
induced HL60 cells, blots were prepared and then hybridised to 
radioactively labelled F10 cDNA. The results from this assay are 
shown in Figure 32. Results from the doubling dot blot displayed in 
Figure 32 indicated that F10 RNA was 16 fold more abundant in RA 
induced HL60 cells than in uninduced and TPA induced HL60 cells.
However, a number of analyses were carried out using RNA prepared 
from cells from different inductions. From these results, and those 
obtained from densitometric scanning of autoradiographs of F10 probed 
Northern blots, it was concluded that the F10 RNA is 6-10 fold more 
abundant in 5 day RA induced cells and 3 fold more abundant in 5 day 
DMSO induced cells, than in the uninduced HL60 cellular counterpart. 
Table 6 summarises the relative abundance of F10 RNA following HL60
induction.
Rehybridisation of the RNA doubling dilution dot blot with a
■^P-labelled 28S ribosomal RNA probe, pHR28-l, confirmed that a
similar amount of RNA was present in each of the RNA dot series 
(Figure 32).
iii) Northern Blot Analysis
To discover if the sequence represented by F10 hybridised to a single 
RNA species and to determine the size of the transcripts homologous 
to F10, total RNA isolated from uninduced, 3 day TPA induced, 5 day
RA induced, and 5 day DMSO induced HL60 cells was used to prepare a
O O
Northern blot. This was subsequently hybridised to P-labelled F10 
cDNA. The results obtained are shown in Figure 33. F10 cDNA
hybridised to a single RNA transcript of 2.3 kb. Results from this 
initial analysis suggested that the F10 RNA was highly abundant in
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Figure 32 Determination of the abundance of F10 RNA in uninduced. 5 
day RA induced and 3 day TPA induced HL60 cells.
20 u^g of total RNA isolated from uninduced, 5 day RA induced and 
3 day TPA induced HL60 cells were dotted on to nitrocellulose 
membrane in a doubling dilution fashion. The nitrocellulose membrane 
was then hybridised with radioactively labelled probes for (A), F10 
sequences and (B) , human 28S ribosomal RNA sequences. (T) , 3 day TPA 
induced HL60 RNA; (R) , 5 day RA induced HL60 RNA; (U) , uninduced HL60 
RNA.
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cDNA F10
Size of Hind III 12.9
DNA Fragments Eco RI 7.0
(kb) ' Bam HI 3.7
RI /  Bl 3.2
Size of
RNA Transcripts (kb) 2.3
Relative Abundance Uni 1
of Transcripts RA 6
TPA 2
DMSO 3
Table 6 SummarJU   of the results of Northern and Southern blot
analyses of F10 sequences in HL60 cells.
The values calculated for the relative abundance of F10 RNA are 
average values calculated from a number of different inductions. 
Densitometric scanning of Northern blots of total HL60 cellular RNA 
hybridised with radioactively labelled F10 cDNA were also used to 
determine the relative abundance of F10 RNA following induction of 
HL60 cells.
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Figure 33 Determination of the size of RNA homologous to F10 cDNA 
by Northern blotting.
30 fsg of total whole cell RNA isolated from 3 day TPA induced, 5 day 
RA induced, 5 day DMSO induced and uninduced HL60 cells were 
fractionated in a denaturing, agarose gel. The RNA was transferred on 
to nitrocellulose membrane by blotting and then hybridised with 
P-labelled probes for (A), F10 sequences and (B) ,
B2-microglobulin. (R) , 5 day RA induced HL60 RNA; (T) , 3 day TPA
induced HL60 RNA; (U) , uninduced HL60 RNA; (D) , 5 day DMSO induced 
HL60 RNA.
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HL60 cells induced to differentiate down the granulocytic pathway.
The smearing detected below F10 RNA was not due to degradation of the 
RNA samples. This was shown by stripping and rehybridising the 
filters with radioactively labelled B2-microglobulin cDNA which
hybridises to a distinct 1.1 kb RNA (Figure 33).
iv) Analysis of HL60 Poly(A)+ RNA
To determine if the 2.3 kb F10 RNA was present in the poly(A)+ RNA
fraction of HL60 cells, poly(A)+ RNA, isolated from total cellular
RNA of uninduced, 3 day TPA induced and 5 day RA induced HL60 cells,
was used to prepare a Northern blot which was subsequently hybridised 
32
to P-labelled F10 cDNA. The results from this experiment are 
displayed in Figure 34. F10 poly(A)+ RNA was found to be abundant
in RA induced HL60 cells, however very little hybridisation was
detected in the TPA induced or the uninduced poly(A)+ RNA samples. 
The blot was stripped of hybridised probe and rehybridised to
radioactively labelled B2_niicroglobulin cDNA to ensure that a
similar concentration of RNA had been used in each sample during the 
analysis (Figure 34).
v) Examination of F10 Expression Throughout the Induced 
Differentiation of HL60 Cells to Granulocytes
To discover when the increase in the relative abundance of F10 RNA 
occurred during the course of HL60 granulocytic differentiation, 
total RNA was prepared from HL60 cells following periods of time 
throughout the 5 days required for RA and DMSO induction. These RNAs 
were fractionated by electrophoresis then used to prepare Northern 
blots which were subsequently hybridised to radioactively labelled 
F10 cDNA. The results from these analyses are displayed in Figure 35 
(a). In both RA and DMSO induced differentiation of HL60, the 
increase in the relative abundance of F10 RNA was a late event. 
During DMSO treatment, this increase occurred between days 1-5 of 
induction, a similar pattern was observed during RA treatment; the 
level of F10 RNA increased steadily from 24 h of induction to reach a 
peak between 3-5 days. Densitometric scanning analysis of the
autoradiographs from these experiments, showed that the level of F10 
RNA did not rise steadily throughout the induction period of both RA
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Figure 34 Determination of the presence of F10 RNA in poly(A)+ RNA 
isolated from uninduced and induced HL60 cells.
5 jag of poly(A)+ RNA isolated from uninduced and induced HL60 cells 
were fractionated on a denaturing, agarose gel and the RNA then 
transferred on to nitrocellulose membrane by blotting. The membrane 
was then hybridised to  ^ P-labelled probes for (A), F10 sequences 
and (B), B2 -microglobulin. (U), uninduced HL60 poly(A)+ RNA; (T), 
3 day TPA induced HL60 poly(A)+ RNA; (R), 5 day RA induced HL60 
poly(A)+ RNA.
165
and DMSO, but dropped at early times of treatment. The results from 
the densitometric scan are displayed graphically in Figure 35 (b).
The relative abundance of the 2.3 kb transcript reached a minimum 
between 16-24 h in DMSO and RA induced HL60 cells. However, after 
this time the level of F10 RNA increased to a value 3-6 fold of that 
obtained in uninduced cells, to reach a maximum between days 3-5 of 
induction. It is interesting to note that, as described in Chapter 
III, 1, b the appearance of HL60 cells displaying myeloid 
cell-specific differentiation markers, occurs after 24 h of treatment 
by inducer, and the number of terminally differentiated cells is 
maximal at day 5 of both RA and DMSO treatment. The timing of these 
events correlates exactly with the increase in the level of F10 RNA 
during HL60 granulocytic induction.
The pattern of F10 RNA relative abundance, observed during
granulocytic induction, was not due to variation in the RNA
concentrations of the different samples used throughout these 
experiments. The filters were stripped and rehybridised with
"^P-labelled B2-microglobulin cDNA (Figure 35 a ). The levels of
this transcript were constant for each sample. This indicated that 
no variation in concentration arose in the RNAs isolated from HL60.
vi) Examination of the Range of Human Tissues that Express F10 RNA
From the results ' of previous analyses it appeared that F10 RNA was
highly abundant in mature myeloid cells produced by induced
differentiation of HL60 cells. The range of distribution of F10 RNA 
expression was examined by preparing RNA dot blots from total
cellular RNA isolated from a number of human tissues; bone marrow, 
peripheral white blood cells, normal kidney, normal liver and normal
O O
mucosa. The blots were hybridised with P labelled F10 cDNA, the 
results are given in Figure 36. A very weak hybridisation signal was 
detected in the series of RNA dots corresponding to peripheral white 
blood cell total RNA, however even after a long period of exposure
this signal was not improved. No hybridisation was apparent to any of
the other samples assayed. It could be surmised from these results
that the F10 RNA is restricted to expression in mature haemopoetic
cells, but is found in greatest abundance in 5 day RA induced HL60 
cells.
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Figure 35 (a) Northern blot analysis of F10 transcripts during 
granulocytic differentiation of HL60 cells.
30 jug of total cellular RNA isolated from cells harvested at time 
points throughout the 5 day course of DMSO and RA induction of HL60 
cells were electrophoretically fractionated on a denaturing, agarose 
gel. RNA was then blotted from the gel on to nitrocellulose membrane. 
The nitrocellulose membrane was hybridised with radioactively 
labelled probes for (A(l) and B(1)), F10 sequences and (A(2) and
B(2)), B2-microglobulin. a) 0 h; b) 1 h; c) 2 h; d) 4 h; e) 8 h; f) 
16 h; g) 24 h; h) 72 h; i) 120 h treatment with inducing agent.
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Figure 35 (b) Graphic display of the results from the Northern 
analyses in Figure 35 (aO .
The Northern blots in Figure 35 (a) were densitometrically scanned to 
quantify the abundance of F10 RNA throughout HL60 differentiation to 
granulocytes. (O), RA induced HL60 cells; (■), DMSO induced HL60 
cells.
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Fieure 36 Determination of the range of human tissues that contain 
F10 RNA.
20 jjg of total cellular RNA isolated from a number of different human 
tissues, were dotted on to nitrocellulose membrane in a doubling 
dilution fashion. The nitrocellulose membrane was then hybridised 
with P-labelled probes for (A), F10 sequences and (B), human 28S 
ribosomal RNA sequences. (a.), uninduced HL60; (b) , 5 day RA induced 
HL60; (C), normal human bone marrow; (d), normal human peripheral 
white blood cells; (e) , normal human kidney; (f), normal human liver; 
(g) , normal human mucosa.
k,
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The blot was stripped and rehybridised to radioactively labelled 
pHR28-l cDNA (Figure 36). This confirmed that a similar concentration
of RNA was present in each series of RNA dots.
vii) Cell Compartments Containing F10 RNA
To discover in which cellular compartment F10 RNA was found in HL60
cells, a comparison was made between the relative abundance of this 
transcript in nuclear RNA and total cellular RNA prepared from
uninduced and induced HL60 cells. Total RNA was prepared from whole
cells and from nuclei isolated from uninduced and induced HL60 cells.
The nuclear and total RNAs were prepared from cells from the same
culture. These RNAs were then used to prepare Northern blots, which 
were hybridised to "^P-labelled F10 cDNA. Results from this
analysis are given in Figure 37. It was found that RNA homologous to
F10 was very abundant in the nuclear RNA from uninduced HL60 cells, 
but almost undetectable in the total RNA isolated from uninduced 
whole cells. In the case of RA induced HL60 cells, very little 
hybridisation occurred to the nuclear RNA but 2.3 kb transcripts were
detected in the total, whole cell RNA. From these data it could be
concluded that F10 RNA was present in the cytoplasmic RNA fraction of 
RA induced HL60 cells, but not in uninduced HL60 cells where it was 
detected in the nuclear RNA fraction. The hybridisation signal from 
the Northern blot, prepared from total RNA was weak because only 3 ug 
of RNA was used in each sample.
The F10 cDNA probe did not hybridise to a single RNA species in the 
uninduced cellular nuclear RNA but to an area covering 2.3 kb to very 
small sizes. This was not due to non-specific degradation of the RNA 
as is shown in Figure 37. The blots were stripped and rehybridised 
with radioactively labelled B2 -microglobulin cDNA. This hybridised 
to a single RNA species of 1.1 kb.
viii) Analysis of the Half-Life of the F10 RNA
Throughout Northern analysis of F10 transcripts,, the smearing effect 
below the 2.3 kb RNA was apparent. From work carried out in. this 
laboratory, examining e-mye RNA, smearing beneath the 2,4 kb -
2.2 kb c-i»yc transcripts has been explained by the rapid turnover of 
these RTTAs . 71 liar,: been reported by others that e-wye SWA has. a
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Figure 37 Determination of the cell compartment(s) containing F10 
RNA.
3 fig of total cellular RNA and 3 yxg of total nuclear RNA isolated 
from uninduced, 5 day RA induced and 3 day TPA induced HL60 cells 
were fractionated by electrophoresis in a denaturing, agarose gel. 
The RNA was then transferred on to nitrocellulose membrane by 
blotting. The nitrocellulose membrane was then hybridised with 
radioactively labelled probes for (A (1) and B(l)), F10 transcripts 
and (A(2) and B(2)), B2-microglobulin. (R), 5 day RA induced HL60; 
(T) , 3 day TPA induced HL60; (U) , uninduced HL60.
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half-life of 10-15 min (Dani e_t al, 1984). To examine the half-life
of F10 RNA, HL60 cells were cultured in the presence of actinomycin
D, an RNA polymerase II transcription inhibitor. The cells were then 
harvested, total RNA was prepared, which was then analysed by 
Northern blotting, hybridised to 32P-labelled F10 cDNA (Figure 38 
(a)). The autoradiographic results obtained from this experiment were 
scanned on a densitometer, to give results which could be analysed 
quantitatively (Figure 38(b)). F10 RNA did not appear to have a very 
short half-life, when compared to c-myc. After 120 min treatment with 
actinomycin D, the level of F10 RNA had only decreased by 40%. By 
extrapolation from the graph in Figure 38 (b), if can be concluded 
that F10 RNA would have a half-life of 2.5-3 h in the uninduced HL60
cell whereas c-myc transcripts appeared to have a half-life of only
15-20 min.
Figure 38,(a) shows the results from the controls from this analysis.
To ensure that actinomycin D did inhibit transcription, the filter
3 7was stripped and rehybridised to a P-labelled probe for c-myc RNA 
(pMC41-3RC). The level of c-myc transcripts rapidly decreased , to 
become undetectable after only 30-60 min of actinomycin D treatment. 
The filter was then stripped and rehybridised a second time with 
radioactively labelled -microglobulin, to check the uniformity of 
the RNA concentrations for each sample.
ix) Analysis of the Proportion of Cells in HL60 Cell Cultures That 
Express F10 RNA
Only 50-60% of an HL60 cell culture terminally differentiate with RA 
treatment, however, these cells appeared to contain approximately 
twice the amount of F10 RNA that was detected in DMSO treated HL60 
cells. DMSO induction results in almost 90% of the cells displaying 
terminally differentiated cell characteristics. Therefore, it was of 
interest to determine what proportion of the HL60 cells undergoing RA 
induction actually expressed F10 RNA. To discover if the increase in 
F10 RNA occurred in all the cells exposed to the RA induction 
stimulus, the technique of in situ hybridisation was used. The 
results from this analysis are shown in Figure 39. When uninduced 
HL60 cells were hybridised to 33S labelled F10 cDNA, virtually no 
hybridisation signal was detected. (Figure 39 (A)). However, when 5 
hay RA induced cells were examined, the F10 probe hybridised strongly
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Figure 38 (a) Determination of the half-life of F10 RNA.
30 jag of total cellular RNA from uninduced HL60 cells treated with
fractionated by 
The RNA was then 
by blotting. The 
hybridised with 
(B), human c-myc 
min; b, 15 min;
actinomycin D for periods of time were
electrophoresis on a denaturing, agarose gel. 
transferred on to nitrocellulose membrane
nitrocellulose membrane was subsequently 
P-labelled probes for (A), F10 sequences;
(pmc41-3RC); (C), B2-microglobulin. a, 0
c> 30 mm; 
treatment.
60 min; e, 90 min; f, 120 min of actinomycin D
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Figure 38 (b) Graph to determine the half-life of F10 RNA.
Results from the autoradiographs in Figure 38 (a) were scanned on a 
densitometer to quantitate the abundance of F10 transcripts during 
the period of treatment with actinomycin D. (•) , F10 RNA;
(□), c-myc RNA.
to a large proportion of the cells (Figure 39 (B)). Therefore, it 
appeared that F10 RNA transcription was increased in almost all RA 
induced HL60 cells. Following in situ hybridisation, the cells had 
been stained with May-Grunwald and Giemsa stains to enable viewing by 
light microscopy. This also enabled the cell morphology to be 
determined. When a comparison was made between mature cell morphology 
and hybridisation of 35S-labelled F10 cDNA to individual cells it 
appeared that those cells displaying a morphology attributed to 
banded and segmented neutrophils, terminally differentiated myeloid 
cells, did not hybridise efficiently to F10 and indeed in a few 
examples no hybridisation was detected at all in these cells. 
Interestingly, only a small proportion (35%) of 5 day DMSO induced 
HL60 cells hybridised to 35S-labelled F10 cDNA despite the fact 
that almost 90% of the DMSO induced HL60 cells appeared terminally 
differentiated. These results are summarised in Table 7.
x) Investigation of the Effects of RA Treatment on F10 RNA Expression 
in HL60 Cells
It has been reported that retinoids exert a hormone-like control on 
cell proliferation or cell differentiation (Roberts and Sporn, 1984). 
This could have had considerable bearing on the results obtained from 
analysis of F10 RNA levels throughout HL60 differentiation and from 
those obtained from in situ hybridisation analyses of uninduced, RA 
induced and DMSO induced HL60 cells. From examination of a number of 
granulocytic differentiation markers, it was found that by day 5 of 
an HL60 RA induction only 50-60% of the cell population had appeared 
to terminally differentiate to mature myeloid cells. However, at a 
comparable time during DMSO induction, over 90% of the cells were 
found to express mature granulocytic characteristics (Figures 16 and 
17). Results from previous Northern analyses (Figure 35), suggested 
that F10 RNA was a mature myeloid cell-specific transcript. However, 
the fact that RA treatment, leading to the highest levels of this 
transcript, also resulted in the smallest number of terminally 
differentiated cells, contradicted this conclusion. Therefore, the 
F10 sequence in the HL60 genome, may not have responded to RA 
stimulation in a "differentiation” capacity but could have responded 
to a "vitamin / hormonal " effect of the retinoid on the cells.
To try and determine which effect resulted in the increase in F10
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AFigure 39 Uninduced and 5 day RA induced HL60 cells following in 
situ hybridisation with S-labelled F10 cDNA.
2 x 10^ cells were sampled from uninduced and 5 day RA induced HL60 
cell cultures. The cells were cytocentrifuged on to glass slides and 
hybridised to ^S-labelled probe for F10 RNA. Following 
hybridisation the slides were coated in emulsion; after 5-7 days 
exposure the slides were fixed and the cells stained with 
May-Grunwald and Giemsa stains so that the cells could be viewed by 
light microscopy. (A) Represents uninduced HL60 cells and (B) 5 day 
RA induced HL60 cells hybridised to ^S-labelled F10 cDNA.
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HL60 INDUCTION
TIME OF 
INDUCTION UNINDUCED DMSO RA TPA
3 DAYS 0% 70% 40% 0%
5 DAYS 0% 35% 90% 0%
Table 7 Tabulation of the percentage of HL60 cells which
hybridised to radioactively labelled F10 cDNA during in 
situ hybridisation.
2 x 10"* cells were sampled from HL60 cell cultures and
cytocentrifuged on to glass slides. These cells were then hybridised 
to S-labelled F10 cDNA. The slides were then covered in emulsion. 
Following exposure the cells were fixed and stained with May-Grunwald 
and Giemsa stains so that the cells could be viewed by light 
microscopy. Hybridisation of F10 probe to the cells could be detected 
by black dots on the cell indicating exposure of the emulsion by the 
isotope. 200 cells were scored for hybridisation. This was repeated 
three times and the average of the three counts taken as the 
percentage of HL60 cells containing F10 RNA.
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RNA, in the HL60 cell system, another cell line capable of induced 
differentiation was used, U937. U937 is a human, histiocytic
lymphoma cell line with monoblast-like characteristics (Sunstrom and
Nilsson, 1976). These cells differentiate into morphologically mature 
macrophage-like cells after treatment with a number of chemicals, 
including RA (Olsson and Breitman, 1982). U937 cells were chosen
because RA treatment induces differentiation to monocytic cells, not 
granulocytes as is the case in the HL60 model system. F10 RNA was
almost undetectable in monocytic cells produced following 3 days of
TPA treatment of HL60 cells. Therefore, if the increase in F10 RNA,
in RA induced HL60 cells, was due to RA acting in a "hormonal" 
fashion only, these transcripts would also increase in the U937 cells 
incubated with RA, irrespective of the differentiation end point of
the cells.
Total RNA was prepared from uninduced U937 cells and cells following
3 days and 5 days treatment with RA. The RNA was used to prepare
37Northern blots which were then hybridised to P-labelled F10 cDNA. 
The results of this analysis are shown in Figure 40. The level of 
F10 RNA did not increase with increasing time of exposure of U937 
cells to RA. Densitometric scanning of the autoradiographs revealed
that the abundance of the F10 transcripts actually decreased 3 fold 
during 5 days of RA treatment. At this time the U937 cells had begun 
to show some of the morphological characteristics attributed to 
monocytes; the cells had begun to clump together but did not adhere 
to the tissue culture flask surface, as reported by others, (Olsson 
and Breitman, 1982) . It can therefore be concluded that the increase
in F10 RNA levels observed during RA induction of HL60 cells was a
consequence of the differentiation stimulation of this agent and not 
due to a "hormonal" effect.
The Northern blot of U937 total cellular RNA was stripped and 
rehybridised to "^P-labelled B£-microglobulin cDNA to determine 
that the concentration of the RNAs used during this analysis was 
uniform. The results of this analysis are shown in Figure 40.
xi) The F10 cDNA Sequence
The sequence of F10 was determined using the Sanger "dideoxy 
sequencing method (Chapter II, 2, (S)). The sequence data is given in
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Figure 40 Determination of the presence of F10 RNA in U937 cells by 
Northern blotting.
30 jug of total cellular RNA isolated from uninduced, 3day TPA induced 
and 5 day RA induced U937 cells were fractionated by electrophoresis 
in a denaturing, agarose gel. The RNA was transferred on to 
nitrocellulose membrane by blotting and then hybridised with 
radioactively labelled probes for (A) , F10 RNA and (B) ,
&2-microglobulin. a) uninduced U937; b) 3 day RA induced U937; 
c) 5 day induced U937.
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F10
5'
GGACCTAGGC CCAGCCCCTA GCCTGATTGG AGCCCCTGAA GACAGTCCCA
End End End
CCCACTTTAT GGCCTATTGA CATGATCGAT CCTGCTGTGT GTCCTGTTCA
End
TGTTCGGTTC ATCAAATAAT TTGGAAAAAA .........
End
3'
Figure 41 Diagram of the F10 cDNA sequence.
The sequence of F10 cDNA was determined and compared to sequences 
stored in the Genbank Data System. The underlined sequences represent 
stop codons.
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Figure 41. F10 did not share any significant homology to any of the
sequences in the Genebahk Data System. The cDNA therefore represents 
an as yet unknown gene. The non-polyadenylated region has a 
considerable number of stop codons which indicates that the sequence 
represented by F10 may be a 3' non-coding region.
C) INVESTIGATION AND CHARACTERISATION OF C6 cDNA
From initial results obtained from the screening of the RA5 library, 
C6 appeared to represent a sequence which was expressed in high 
abundance in 5 day RA induced HL60 cells. To confirm this and to 
investigate the RNA homologous to C6 cDNA further analyses were 
carried out.
i) Southern Blot Analysis
To determine the sizes of restriction fragments homologous to C6 in 
HL60 DNA, total cellular DNA from HL60 cells was restriction digested 
with Eco RI, Bam HI and Hind III. The DNAs were fractionated on a 1% 
agarose gel which was used to prepare a Southern blot. This was 
subsequently hybridised to radioactively labelled C6 cDNA. The 
results from this analysis are shown in Figure 42. During the early 
stages of analysis of C6 cDNA, all 3 fragments generated from an Eco 
RI + Bam HI digest of the recombinant plasmid were pooled and used as 
a template for a single hybridisation probe. Figure 44 (A) depicts a 
restriction digest of pUC8 which clearly shows these multiple 
fragments. From the restriction digest pattern obtained from Southern 
blot analysis it was apparent that C6 represented a unique sequence. 
The sizes of the restriction fragments homologous to C6 are 
summarised in Table 8.
ii) Northern Blot Analysis
To discover the size of RNA homologous to C6 a Northern blot was 
prepared from total cellular RNA isolated from uninduced, 3 day TPA 
induced, 5 day DMSO induced and RA induced HL60 cells. The blot was 
then hybridised to ^P-labelled C6 cDNA. Figure 43 shows the 
results obtained from this analysis. Two clearly distinguishable RNA 
transcripts hybridised to C6 of 1.3 kb and 2.4 kb respectively. From
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Figure 42 Southern analysis of HL60 DNA hybridised to 
— P-labelled C6 cDNA.
30 fig of total cellular DNA isolated from HL60 cells were digested 
with Eco RI, Bam HI, Hind III and Eco RI + Bam HI. The DNAs were 
fractionated by electrophoresis, transferred to nitrocellulose
membrane and this was hybridised to radioactively labelled probe for 
06 sequences. (B) , Bam HI, (H), Hind III; (R), Eco RI; (R/B), Eco RI 
+ Bam HI.
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Figure 43 Determination of the size of RNA homologous to C6 by 
Northern blotting.
30 ug of total RNA isolated from uninduced, 5 day RA induced, 5 day 
DMSO induced and 3 day TPA induced HL60 cells were fractionated by 
electrophoresis on a denaturing, agarose gel. The RNA was then 
transferred on to nitrocellulose membrane and subsequently hybridised 
to P-labelled probes for (A), C6 sequences and (B),
B2-microglobulin. (D) , DMSO induced HL60; (U), uninduced HL60; (R), 
RA induced HL60; (T), TPA induced HL60.
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this initial analysis it appeared that both transcripts were highly 
abundant in HL60 cells induced down the granulocytic pathway.
To ensure that a similar concentration of total RNA was assayed from 
each sample the blot was stripped and rehybridised to radioactively 
labelled B2-microglobulin. The result of this experiment, displayed 
in Figure 43 confirmed this.
iii) Further Investigation of the Recombinant Plasmid pUC8C6
The initial Northern blot analysis of total HL60 RNA, hybridised to 
32P-labelled C6 cDNA, resulted in the resolution of two RNAs of
distinct sizes (Figure 43). However, the template for the
hybridisation probe used in the initial experiments had consisted of 
3 fragments, generated from Eco RI + Bam HI digestion of pUC8C6. This 
restriction digest should have resulted in the isolation of the C6
cDNA, however, fragments of 220 bp, 190 bp and 160 bp were produced. 
The initial digestion analysis of pUC8C6 had not revealed any
evidence to suggest that it was a conjugate plasmid. However the
results from Northern blotting contradicted this conclusion.
Therefore further restriction digestion analyses were carried out on 
the recombinant plasmid pUC8C6 DNA to try and clarify the
situation.
a) Analysis of pUC8C6 by Hae II digestion
pUC8 contains three Hae II restriction sites (Figure 21) which give 
rise to three fragments of 1870 bp, 370 bp and 430 bp, on digestion 
of plasmid DNA with Hae II. However, on ligation of a cDNA into the 
multi-cloning site, Hae II digestion of the recombinant pUC8 plasmid 
gives a 1870 bp and a 370 bp fragment, as previously, but the 430 bp 
fragment, which contains the multi-cloning site, increases in size in 
direct proportion to the ligated cDNA. To investigate the construct 
of pUC8C6 further, plasmid DNA was restriction digested with Hae II 
and the DNA fractionated on a 1.5% agarose gel. The results from this 
experiment are displayed in Figure 44(B). Hae II digestion of pUC8C6 
revealed the 1870 bp and the 370 bp (plasmid) fragments, however the 
430 bp fragment was replaced by what appeared to be a doublet of 
800 - 740 bp. This was indicative of :-
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Figure 44 (A) pUC8C6 DNA digested with Eco RI + Bam HI.
3 jag of pUC8C6 DNA were restriction digested with Eco RI + Bara HI and 
fractionated on a 1.5% (w/v) agarose gel.-00(174 DNA digested with
Hae III was used as DNA size markers. The gel was then stained with 
ethidium bromide and the DNA visualised by exposure to UV light.
(B) Hae II digestion of pUC8C6 DNA.
3 jag of pUC8 DNA or pUC8C6 DNA were digested with Hae II or Eco RI 
and fractionated on a 1.0% (w/v) agarose gel. The gel was then
stained with ethidium bromide and the DNA visualised by exposure to 
UV light. £  X174 DNA digested with Hae II was used as DNA size 
markers. Lane 1, pUC8; Lane 2, pUC8 digested with Eco RI; Lane 3, 
pUC8 digested with Hae II; Lane 4, pUC8C6; Lane 5, pUC8C6 digested 
with Eco RI; Lane 6, pUC8C6 digested with Hae II; Lane 7, pUC8C6
digested with Eco RI + Bam HI.
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1) two cDNA inserts, and therefore a conjugate plasmid, or
2) a large cDNA with internal Hae II restriction sites.
It was unlikely that the multiple fragments obtained following Eco RI 
+ Bam HI digestion of pUC8C6 were the result of a contaminating 
plasmid. pUC8C6 had been subjected to two colony purification 
procedures to ensure that only one recombinant plasmid was isolated 
prior to preparation of plasmid DNA.
b) Examination of pUC8C6 by electron microscopy
From the results of the previous experiment no conclusion could be 
reached about the construction of the recombinant plasmid pUC8C6. To 
examine the size(s) of the C6 cDNA it was decided to view the plasmid 
DNA directly by electron microscopy. Initial analysis of the plasmid 
DNA, in closed-circle form, did not reveal any unusually sized 
plasmid, as might have been expected if pUC8C6 had been conjugate. 
However, it was difficult to calculate sizes because of the
supercoiled state of the DNA. Therefore all further analysis was 
carried out on pUC8C6 which had been linearised by Sac I digestion. 
Homoduplex analysis, of Sac I digested pUC8C6 hybridised to self, did 
not reveal any unusual plasmid fragments. However, heteroduplex 
analysis, pUC8 hybridised to pUC8C6, revealed small loops or eyes, 
regions of non-homology between the plasmids. These were measured and 
the size calculated to be approximately 200 bp. No evidence was 
discovered to indicate that pUC8C6 was conjugate. The results of this 
experiment therefore suggested that C6 cDNA was of approximately 
200 bp long. Figure 45 gives the results of the analysis of pUC8 DNA 
by electron microscopy.
iv) Analysis of the Individual cDNA Fragments Generated Following 
Digestion of pUC8C6 by Eco RI and Bam HI
a) Northern Blot Analysis
The experiments carried out to examine the construction of pUC8C6 had 
heen inconclusive so it was decided to isolate each of the fragments 
generated from the Eco RI + Bam HI digestion of pUC8C6 and use each 
one as a hybridisation probe. It was hoped that this would result in
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Figure 45 Analysis of pUC8C6 DNA by electron microscopy.
pUC8 DNA and pUC8C6 DNA were restriction digested with Sac I then 
hybridised together to determine the regions of homology between the 
two plasmids. (A) represents pUC8 / pUC8C6 heteroduplexes.
(B) represents pUC8C6 / pUC8C6 homoduplexes.
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the identification of which cDNA fragment was homologous to which RNA 
(either the 2.4 kb or the 1.3 kb species). The expression of each of 
these RNAs could then be analysed separately. This, of course, 
assumed that pUC8C6 was conjugate, containing at least two different 
cDNAs of almost identical size.
The fragments were isolated by fractionation of restriction digested 
pUC8C6 DNA on a 2% low-melting point agarose gel. The cDNAs, once 
purified, were used as probes to hybridise to Northern blots prepared 
from total cellular RNA from HL60 cells. The results from this 
experiment are given in Figure 46. All 3 fragments hybridised to two 
RNAs of 2.4 kb and 1.3 kb. The RNAs also appeared more abundant in RA 
and DMSO treated cells, in an identical fashion to initial analyses 
using the pooled fragments as a single hybridisation probe. 
Therefore, it appeared that the C6 cDNA fragments corresponded to 
exactly the same sequence, or regions of the same sequence.
b) Examination of the Role of DNA Secondary Structure in Determining 
the Size of C6 CDNA
If the assumption that all three C6 cDNA fragments are similar, was 
true, then the difference in size, as seen during fractionation by 
electrophoresis, could have been the result of some form of secondary 
structure which was present in the cDNA. This may have resulted in 
some C6 fragments maintaining a constrained configuration, following 
digestion, whilst others would take on a more relaxed, open
structure. This would lead to the DNA running at apparently different 
sizes during electrophoresis.
To determine if this were true, two experiments were carried out. 
Firstly, prior to electrophoresis, Eco RI + Bam HI restriction
digested pUC8C6 DNA was heated to 90°C for 10 min which should 
denature the DNA (Figure 47 (A)). However, when the DNA was
electrophoresed on a 2% agarose gel, then stained with ethidium
bromide to visualise the DNA fragments, the same pattern of C6 cDNA 
fragments was found in both heated and unheated DNA samples. 
Secondly, digested pUC8C6 DNA was electrophoresed on a denaturing, 
agarose gel, (55mM NaOH) . Following staining of this gel with 
ethidium bromide, it was found that the pattern of digested C6 
fragments had not altered (Figure 47 (B)). These results dismissed
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Figure 46 Northern blot analysis of C6 transcripts following
differentiation of HL60 cells, using each of the C6 cDNAs 
as a hybridisation probe.
30 pg of total RNA isolated from uninduced, 5 day RA induced, 5 day 
DMSO induced and 3 day TPA induced HL60 cells were fractionated by 
electrophoresis in a denaturing, agarose gel. The RNA was then 
transferred by Northern blotting on to a nitrocellulose filter which 
wes subsequently hybridised with radioactively labelled probes 
produced from (A) 220 bp C6 cDNA fragment; (B) 190 bp C6 cDNA
fragment; (C) , 160 bp C6 cDNA fragment. (U) , uninduced HL60; (R) 5
d*y RA induced HL60; (D) , 5 day DMSO induced HL60; (T) , 3 day TPA
induced HL60.
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Figure 47 Examination of secondary structure in C6 cDNA.
(A) 3 /ug of pUC8C6 DNA were digested with Eco RI + Bam HI. Prior to
fractionation in a 1.5% (w/v) agarose gel the plasmid DNA sample was 
heated at 90°C for 10 min to destroy any DNA secondary structure. 
Following electrophoresis the gel was stained with et^dium bromide 
and the DNA visualised by exposure to UV light. Lane 1, pUC8C6 
digested DNA; Lane 2, boiled pUC8C6 digested DNA.
(B) 3 jug of Eco RI + Bam HI restriction digested pUC8C6 DNA was 
fractionated by electrophoresis in a denaturing (55mM NaOH) 1.5% 
(w/v) agarose gel. This should destroy any DNA secondary structure. 
Following electrophoresis the gel was stained with ethidium bromide 
and the DNA visualised by UV light.
the theory that secondary structure played any role in determining 
how C6 cDNA ran during electrophoresis.
v) Sequence of the Three C6 cDNA Fragments
To determine if the 3 C6 cDNA fragments were similar, it was finally 
decided to reclone each one into bacteriophage M13 and sequence each 
of the cDNAs. This procedure would eliminate any contamination by 
other fragments (this could have happened when the fragments were 
isolated from agarose) as only one cell clone would be used from 
which the template would be prepared for the sequencing reaction. A 
comparison of the sequences obtained would give a clear indication of 
the degree of homology between the cDNAs.
However, before religation into Ml3 could be accomplished the 
termini of the C6 cDNAs had to be established. Although an Eco RI + 
Bam HI restriction digest had produced the C6 fragments it was
unclear if they possessed an Eco Rl-end and a Bam HI- end. To
determine this, the technique of end-labelling was used. Following an 
Eco RI or a Bam HI restriction digest of pUC8C6 DNA, the termini! of
O O
each fragment produced was labelled with P-dCTP, using the Klenow 
fragment, of E.coli DNA polymerase I. The reaction mixes were then 
halved, one half was retained while the DNA in the remainder was 
subjected to a further digestion, which would result in a Eco RI + 
Bam HI cut fragment. Following this, all the DNA samples were 
fractionated by electrophoresis on a 3.5% polyacrylamide gel. The gel 
was then autoradiographed for short periods of time. By comparing the 
size of the fragments generated by Eco RI + Bam HI and the single
digested DNA samples it was determined that all 3 C6 cDNAs had Eco RI
and Bam HI termini and could therefore be successfully ligated into 
M13 (Figure 48).
Using the Sanger ' dideoxy' sequencing method , all 3 C6 cDIA 
fragments were sequenced. The results are given in Figure 48. Only 85 
bp of unique sequence existed, this sequence was found in all of the 
C6 fragments. The remainder of each cDNA consisted of thymidine 
residues. Interestingly the only difference determined between each 
°f the cBMAs was the number of thymidine residues, this varied by 
30-40 nucleotides between the different fragments. It was therefore 
concluded that the C6 cBIAs represented the same sequence. ®o
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C6 ____________________________________
5'
TTCCTGACAC AGTGAAACAC CTTCCTCAAC CCAGGCGGGT GGACAGGGTC
CCCTGTGGTC CAGCAGTAAA AACCATGGTC CCCCCAAAAA
3'
FiEure 48 Sequences of the C6 cDNA fraements.
(A) Autoradiograph from end-labelling analysis of pUC8C6 DNA Eco RI +
Bam HI restriction digested the labelled with P-dCTP to determine
the terminii of the separate fragments. Lane 1, Bam HI digested
PUC8C6 DNA; Lane 2, Eco RI digested pUC8C6 DNA; Lane 3, Eco RI 
followed by Bam HI digested pUC8C6 DNA; Lane 4, Bam HI followed by 
Eco R I  digested pUC8C6 DNA.
(B) The 85 bp sequence common to all 3 C6 cDNA fragments is
illustrated. The Poly(A) sequence has been omitted for convenience.
0.220 > 
0.190 > 
0.160 >
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homology was found between the 85 bp region of sequence common to all 
the cDNAs and those stored in the Genebank Data system, available in 
this laboratory. The C6 cDNAs therefore appear to represent the 3' 
non-coding region of an as yet unidentified sequence.
vi) Quantitative Analysis of C6 RNA Abundance Following HL60 
Differentiation
Having established that all 3 C6 cDNA fragments were identical 
the analysis of the RNA species homologous to this sequence could be
continued. The relative abundance of C6 RNA in HL60 cells was 
calculated by an RNA doubling dilution dot blot prepared from total 
cellular RNA from uninduced, 3 day TPA induced and 5 day RA induced 
HL60 cells. The hybridisation probe was synthesised using the 220 bp 
C6 cDNA fragment as a template. However it must be noted that the 
figures calculated from this analysis were the sum of both the 2.4 kb 
and the 1.3 kb transcripts. The results from this experiment are 
shown in Figure 49, and summarised in Table 8.
To determine that a similar concentration of RNA was present in each
series of RNA dots, the dot blot was stripped and rehybridised to 
32P-labelled pHR28-l (Figure 49).
Results from the RNA dot blot in Figure 49 indicated that C6 RNA was
8 fold more abundant in RA induced cells than in uninduced HL60
cells. RA induced HL60 cells also contained 4 times the amount of C6 
RNA detected in TPA induced cells. However a number of different
analyses were carried out on RNAs isolated from different inductions. 
A value was calculated for the abundance of C6 RNA in uninduced and 
induced cells by taking the average of the results from the different 
experiments. These are shown in Table 8.
vii) Analysis of HL60 Poly(A)+ RNA
To determine if both the 2.4 kb and the 1.3 kb C6 RNAs were present 
in the poly(A)+ RNA fraction of HL60 cells, poly(A)+ RNA, 
isolated from uninduced, 3 day TPA induced and 5 day RA induced HL60 
cells, were used to prepare a Northern blot which was subsequently 
hybridised to 32P-labelled C6 cDNA (220 bp fragment). The results 
from this experiment are displayed in Figure 50. The 1.3 kb C6 RNA
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cDNA C6
Size of Hind III 15.0
DNA Fragments Eco Rl 11.0
(kb) Bam H| >21.5
Rl /  Bl 7.0
Size of
RNA Transcript(s) (kb) 2.4 and 1.3
Relative Abundance Uni 1
of Transcripts RA 8
TPA 2
DMSO 10
Table 8 Summary. _ of the results of Northern and Southern blot
analyses of C6 sequences in HL60 cells.
The values calculated for the relative abundance of C6 RNA are 
average values calculated from a number of different inductions. 
Densitometric scanning of Northern blots of total HL60 cellular RNA 
hybridised with radioactively labelled C6 cDNA were also used to 
determine the relative abundance of C6 RNA following induction of 
HL60 cells.
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Figure 49 Determination of the abundance of C6 RNA in HL60 cells..
20 ug of total RNA isolated from uninduced, 5 day RA induced and 
3 day TPA induced HL60 cells were dotted in a doubling dilution 
fashion on to nitrocellulose membrane. The nitrocellulose membrane 
was then hybridised with P-labelled probes for (A), C6 sequences 
and (B), human 28S ribosomal RNA sequences. (U), uninduced HL60; (T), 
TPA induced HL60; (R), RA induced HL60.
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Figure 50 Determination of the presence of C6 transcripts in 
poly(A) RNA isolated from HL60 cells.
5 yg of poly(A)+ RNA isolated from uninduced, 5 day RA induced and
3 day TPA induced HL60 cells were fractionated by electrophoresis in
a denaturing, agarose gel. The RNA was then transferred by blotting
°n to a nitrocellulose filter which was subsequently hybridised with
radioactively labelled probes for (A), C6 sequences and (B) , 
'Hiicroglobulin. The lanes of the gel were (T), TPA induced HL60; 
(R), RA induced HL60; (U), uninduced HL60.
B
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was found to be abundant in poly(A)+ RNA isolated from 5 day RA 
induced HL60 cells, however very little hybridisation was detected in 
the TPA induced or the uninduced poly(A)+ RNA samples. It is 
interesting to note that the 2.4 kb C6 transcript appeared less 
abundant in poly(A)+ RNA isolated from HL60 cells induced to 
differentiate to granulocytes than was observed during analysis of 
total RNA.
To ensure that a similar concentration of poly(A)+ RNA had been 
analysed from each sample the blot was stripped and rehybridised to 
radioactively labelled B2-microglobulin. The results shown in 
Figure 50 confirm this.
viii) Examination of C6 Expression Throughout the Induced 
Differentiation of HL60 Cells to Granulocytes
The previous analyses of C6 RNA had established that following 5 days
of RA or DMSO treatment of HL60 cells these transcripts had increased
in abundance. To determine when this increase occurred during
differentiation, Northern blots were prepared from total cellular RNA
isolated from HL60 cells at time points throughout DMSO and RA
32induction. The Northern blots were then hybridised to P-labelled 
C6 (220 bp) cDNA, however, similar results were obtained using the 
190 bp and 160 bp C6 fragments as hybridisation probes. Figure 51 
shows the results from these analyses.
The Northern blots from the experiments described above were stripped 
and rehybridised to ^^P-labelled B2-microglobulin cDNA to confirm 
that each sample analysed was of a uniform RNA concentration (Figure
51 ).
To analyse the results quantitatively, the autoradiographs were 
scanned on a densitometer. The 1.3 kb and the 2.4 kb transcripts were 
scanned separately as they appeared to display different patterns of 
expression during HL60 differentiation. The results from the scanning 
analyses are displayed graphically in Figure 52.
a) DMSO Induction
The level of the 1.3 kb transcript in uninduced HL60 cells was low,
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Figure 51 Northern blotting analysis of C6 transcripts during 
granulocytic differentiation of HL60 cells.
30 n g of total cellular RNA isolated from cells harvested at time
points throughout the course of DMSO and RA induction of HL60 cells 
were fractionated by electrophoresis in a denaturing, agarose gel. 
The RNA was then blotted from the gel on to nitrocellulose membrane. 
The nitrocellulose membrane was hybridised with radioactively 
labelled probes for (A(l) and B(l)), C6 sequences and (A(2) and 
B2-microglobulin sequences. a) 0 h; b) 1 h; c) 2 h; d) 4 h;
e) 8 h; f) 16 h; g) 24 h; h) 72 h; i) 120 h of treatment with
inducer.
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however the 2.4 kb RNA was almost undetectable. During the first 24 h 
of DMSO treatment both C6 RNA levels fluctuated, however the sharp 
decrease observed at 24 h appeared to be artifactual as was shown in 
the control blot probed with B2-microglobulin cDNA (Figure 51 (b)).
It appeared that the 24 h DMSO sample had less RNA present than the 
others that were analysed. Nevertheless, the general trend with both 
the 2.4 kb and the 1.3 kb transcripts was a dramatic increase in 
abundance following 24 h of DMSO treatment. A 3-fold increase was 
estimated for the level of the 1.3 kb transcript in 5 day DMSO 
induced HL6}0 cells compared to their uninduced counterparts. However 
the level of the 2.4 kb RNA increased 18-fold during DMSO induction 
of HL60 cells.
b) RA Induction
As in DMSO treatment, the 2.4 kb C6 transcript was undectable in RA 
induced HL60 cells till almost 16-24 h of induction, however the
1.3 kb RNA was present in uninduced cells. Again, as described above, 
the levels of the C6 transcripts were highly variable during early 
times of treatment but the general trend was a dramatic increase in 
abundance of C6 RNA by day 3 of RA induction. This increase was 2-3 
fold for the 1.3 kb transcript, comparing uninduced HL60 cell levels 
to that of 3 day RA induced cells. However, unlike DMSO, 5 day RA 
induced HL60 cells displayed a decrease in the level of 1.3 kb C6 RNA
between days 3-5. This was not mimicked by the larger transcript; the
level of the 2.4 kb C6 RNA increased dramatically from 4 h of RA 
treatment to become 6 fold more abundant in the 5 day RA induced 
cells than in the uninduced HL60 cell (Figure 52) .(^ee Note on page facing 1
From these experiments it could be concluded that the increase 
observed in the level of the 2.4 kb C6 RNA, during HL60 
differentiation, was of a much greater magnitude than that of the
1.3 kb RNA. The increase in the levels of both transcripts, was also
a relatively early event during induction, initiating between 4-24 h 
of treatment. Unlike the cDNA (F10) discussed previously, C6 cDNA 
hybridised to RNA species which were more abundant in DMSO induced 
HL60 cells. It should be noted that the abundance of C6 transcripts 
showed some degree of variation between inductions carried out at 
different times throughout this project. The discrepancies were 
small, probably due to slight variations in cell clones which were
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Figure 52 Graphical display of results obtained from densitometric 
scanning of the autoradiographs from the Northern blots 
in Figure 51.
(A) Graph of results obtained from densitometric scanning of
autoradiographs from Northern blots of HL60 total RNA isolated from 
times throughout a 5 day DMSO induction period. (O), represents the
2.4 kb C6 RNA; (■) , represents the 1.3 kb C6 RNA.
(B) Graph of results obtained from densitometric scanning of
autoradiographs from Northern blots of HL60 total RNA isolated from 
times throughout a 5 day RA induction period. (O), represents the 2.4 
kb C6 RNA; (■), represents the 1.3 kb C6 RNA.
Note : The results plotted on graphs (A) and (B) are average figures
obtained from densitometric scanning of Northern blots of HL60 total
RNA. The RNAs used during these analyses were prepared from different 
clones of cells and from different RA and DMSO inductions.
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Figure 53 Determination of the range of human tissues that contain 
C6 RNA.
20 |ig of total cellular RNA, isolated from a number of different 
human tissues, were dotted on to nitrocellulose membrane in a 
doubling dilution fashion. The nitrocellulose membrane was then 
hybridised with radioactively labelled probes for (A), C6 sequences 
and (B), human 28S ribosomal RNA sequences, (a), uninduced HL60; (b), 
5 day RA induced HL60; (c), normal human bone marrow; (d), normal
human peripheral blood leukocytes; (e), normal human kidney; (f), 
normal human liver; (g), normal human mucosa.
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nuclear and total RNA, isolated from uninduced, 3 day TPA induced and
5 day RA induced HL60 cells were used to prepare Northern blots which
39
were then hybridised to P-labelled C6 cDNA (220 bp). As discussed
previously, the total RNA and the nuclear RNA were isolated from 
cells of the same culture. The results of this experiment are shown 
in Figure 54.
Both C6 transcripts were clearly detectable in total RNA from RA
induced HL60 cells, however, only the 2.4 kb RNA could be detected in
the nuclear RNA from these cells. Very little hybridisation was found 
to the uninduced and 3 day TPA induced HL60 RNAs. From these results 
it could be deduced that the C6 2.4 kb RNA was highly abundant in the 
nuclear RNA of RA induced HL60 cells. Although total RNA was 
analysed, it can be assumed that the 1.3 kb C6 RNA if not present in
the nuclear fraction must have been in the cytoplasmic RNA pool.
These results provided evidence to support the conclusion that the
2.4 kb C6 RNA is a precursor of the 1.3 kb mRNA.
The Northern blots were stripped and rehybridised to radioactively 
labelled B2-microglobulin cDNA to determine that a similar RNA 
concentration was present in each of the RNA samples assayed (Figure 
54).
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ff^ure~~54~ Determination of the cell compartment(s) containing C6
RNA.
3 i^g of total cellular RNA and 3 jug of total nuclear RNA isolated 
from uninduced, 5 day RA induced and 3 day TPA induced HL60 cells 
were fractionated by electrophoresis in a denaturing, agarose gel. 
The RNA was then transferred on to nitrocellulose membrane by 
blotting. The nitrocellulose membrane was hybridised with 
radioactively labelled probes for (A (1) and B(l)), C6 sequences and 
(A(2) and B(2)), B2-microglobulin. (R), 5 day RA induced HL60; (T), 
3 day TPA induced HL60; (U), uninduced HL60 cells.
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1 MYELOID CELL DIFFERENTIATION
A) Use of Cell Lines as Model Systems
Many cell lines exist which can be induced to differentiate in 
culture and which have been used as model systems for
differentiation. These include myogenic cell lines, embryonic cell 
lines and haematopoietic cell lines (Collins et al, 1977; Marks and 
Rifkind; 1978; Strickland and Mahdavi, 1978; Blau and Epstein, 1979). 
Study of the processes which occur during induced differentiation of 
these cell lines not only sheds light on the events leading up to 
terminal differentiation in the individual systems but can also be 
used to give a general over-view of differentiation in all systems.
There are, however, certain advantages and disadvantages in the use 
of cell lines to study differentiation. Cne main advantage is that
cell lines allow the isolation of relatively homogeneous, clonal cell 
populations of differentiated cells, not available in vivo. As a 
result, these systems also enable the differentiation process to be 
monitored easily as the differentiating cells are not surrounded by a 
background of other cell types or cells at vastly different
differentiation stages. Cell lines which can be induced to 
differentiate also offer the opportunity to study commitment to 
differentiation since variant cell lines are available which are 
resistant to differentiation (Toksoz et al, 1982). Furthermore, large 
amounts of material for analysis, for example RNA and DNA, are easily 
obtainable. It would prove difficult to obtain similar quantities
from animal donors; therefore cell lines are attractive for 
laboratory use. An added advantage of using a haematopoietic cell 
line to study differentiation is that the haematopoietic system has
been well studied in vivo and the cell biology of the differentiation 
processes well characterised.
Haematopoietic cell lines, and almost all other cell lines, are 
however derived from tumour cells and therefore are transformed and 
aberrant. Aberrant gene expression is known to occur in transformed 
cells therefore it is uncertain if control of gene expression is 
equivalent in these cells and their normal cellular counterparts 
(Cairns, 1981). Cell lines are also capable of culture in vitro, and
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are established hence adaption to tissue culture may also result in
aberrant gene expression. The culture conditions may not reflect that 
of the natural in vivo environment of the cell which may be required 
for normal growth.
The inducing agents used to initiate differentiation of cell lines 
are often either non-physiological chemicals, such as DMSO, 
or are used at concentrations far greater than would commonly be 
found in vivo. These agents are therefore unlikely to reflect a
normal differentiation signal. Furthermore, the mechanisms of action
of these agents have not been determined in many cases. Therefore, it 
is unknown if induction of differentiation by chemical agents occurs 
by similar patterns of gene expression as are found in vivo. Cell 
lines are also immortal, with unlimited proliferative capacity, 
unlike normal cells. During induction of differentiation, cell lines 
become committed to a specific course of differentiation. This is 
followed by a change from immortality to mortality. Therefore, many 
of the changes in gene expression observed during induction of 
differentiation may result from a shift from immortality to mortality 
and need not necessarily represent changes important in the
differentiation process. Changes in gene expression during induced 
differentiation may also be due to cessation of proliferation and 
therefore could be considered secondary to the differentiation 
process.
B) HL60 as a Model for Differentiation
i) Advantages of Studying Differentiation of HL60 Cells
The HL60 cell line (Collins et al, 1977) has been used as a model 
system in which to study the biochemical and molecular events 
necessary for the processes leading to terminal differentiation. The 
use of haematopoietic, established cell lines has provided a 
continuous supply of apparently "maturation arrested" cells which can 
be cultured easily and indefinitely. These cells can also be induced 
to differentiate by readily available agents, and the progress of
differentiation can be monitored by readily assayable
characteristics.
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In choosing a system in which to study control of changes in gene 
expression during differentiation it is important to select a system 
which allows not only the opportunity to study the mechanisms behind 
gene regulation, but, also one which affords the chance to observe 
the co-ordination of events which must occur during the
differentiation process. HL60 is therefore an important model for
differentiation. Comparison of gene expression between uninduced 
cells and induced cells will allow the determination of changes in 
gene expression due to differentiation, as in other cell systems.
However, there is also good evidence that HL60 is bipotent, therefore 
these cells also provide the opportunity to investigate the 
mechanisms that govern the differentiation of progenitor cells down 
different cellular pathways (Fontana et al, 1981; Fischkoff et al,
1984). This provides interesting possibilities for the study of 
commitment to differentiation and also to determine gene expression 
patterns specific to one lineage which could lead to the 
determination of control mechanisms which operate to co-ordinate gene 
expression.
The HL60 cell line is also a useful tool for the study of "maturation 
arrest" in leukaemic disorders. These cells provide an insight into 
the nature of the leukaemic lesion and are therefore useful as a 
means of analysing the changes between normal and transformed cells. 
It is interesting to note that the drugs which are most effective in 
the treatment of patients with acute myelogenous leukaemia, such as 
anthracyclines, are also inducers of HL60 differentiation (Schwartz 
and Sartorelli, 1981). It can be speculated that the effectiveness of 
these drugs may be due in part to their ability to promote leukaemic 
cell differentiation and partly to their cytocidal effect on
malignant cells.
ii) A Comparison Between Uninduced HL60 Cells and Normal 
Promyelocytes
HL60 cells were established from the peripheral blood leukocytes of a 
patient with acute promyelocytic leukaemia (Collins et al, 1977). 
Hence, these cells represent leukaemic cells and are abnormal. 
Nevertheless, studies have shown that despite an abnormal karyotype, 
HL60 cells exhibit many of the functional characteristics of normal 
promyelocytes (Collins et al, 1977; Gallagher et al, 1979). Studies
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involving antisera and monoclonal antibodies directed against normal 
myeloid cell surface antigens have also demonstrated that HL60 cells 
possess surface markers equivalent to those found in normal human 
promyelocytes. For example, HL60 cells react with antiserum directed 
against cells further down the granulocytic pathway than myeloblasts
but not with neutrophil-specific antiserum, hence it has been 
proposed that HL60 cells are relatively mature myeloid cells (Mulder 
et al, 1981). Uchanska-Zeigler (1982) has also shown, using a wide 
range of monoclonal antibodies directed against myeloid cells, that 
HL60 cells exhibit many of the cell surface antigens associated with 
cells of the myeloid lineage. However, variation between different
HL60 sublines from different laboratories have also been reported.
These variations are both karyotypic and biochemical (Gallagher et 
al, 1985; Graham et al, 1985; Peyman and Sullivan, 1987). The 
biochemical variations observed between different HL60 sublines from 
different laboratories may reflect differences in cell culturing 
techniques. The fact that HL60 cells are established, and therefore 
can be maintained for long periods of time in culture, could also 
result in selection and outgrowth of clones of cells which may vary 
from the initial cell isolate. Genotypes of transformed cells must be 
less stable than those of normal cells to allow for progression of
tumo .rigenesis in vivo, hence, the longer these cells are maintained
in culture the more likely that genotypic variations could arise. 
This highlights the problems of using cell lines as care has to be 
taken when comparing results from different laboratories and between 
in vitro systems and that which occurs in vivo.
iii) Heterogeneity of HL60 Cell Populations During Induction
Uninduced HL60 cell cultures are relatively heterogeneous, consisting 
of 90% promyelocytes with 10-15% more mature cells of both the 
granulocytic and the monocyte / macrophage lineages (Chapter III, 1) 
(Collins et al, 1977). Following addition of the inducing agent to
the growth medium and during the differentiation process, the cell
population becomes more heterogeneous. The whole HL60 cell population 
undergoes a programmed differentiation. However, during the course of 
treatment with inducing agents, cells can be found distributed 
throughout the many stages of the myeloid cell lineages leading to 
mature granulocytes or macrophages (Boyd and Metcalf, 1984). I have 
also detected intermediates between promyelocytes and granulocytes
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during induction with DMSO or RA and monocytic cell intermediates 
during TPA induction. The cell morphologies closely reflect the 
morphologies observed during in vivo differentiation of myeloid 
cells. At the completion of differentiation however, the majority of 
cells resemble mature, terminally differentiated myeloid cells (see 
Chapter 111, 1 of this thesis; Breitman et al. 1980; Boyd and
Metcalf, 1984).
Heterogeneity of an HL60 cell population, during the course of 
differentiation, may be the result of lack of synchrony between cells 
both in the position of individual cells in the cell cycle and also 
in the stage of differentiation of each cell at the time the 
induction stimulus was added. This may result in variation in the
timing of the appearance of overt differentiation between individual
cells. Therefore, when interpreting data pertaining to 
differentiation of HL60 cells the proportion of fully differentiated 
cells has to be determined and the fact that a proportion of cells
will always be relatively undifferentiated has to be noted.
iv) Comparison between Induced Differentiation and Normal 
Differentiation
Following differentiation of HL60 cells, the cells acquire some of 
the morphological and functional characteristics of normal 
granulocytes or macrophages (see Chapter III, 1 of this thesis; 
Tsiftsoglou and Robinson, 1985). These changes are accompanied by 
changes in gene expression which is reflected by changes in the 
protein content of the induced cell (Reyland et al, 1986). 
Differentiating HL60 cells have been shown to undergo many of the 
phenotypic changes known to occur during normal myeloid 
differentiation from promyelocytes to granulocytes (Collins et al, 
1978; Breitman et al, 1980). Hence, many of the normal programmed
changes in gene expression during myelopoiesis, which give rise to 
the fully differentiated phenotype, must also take place during HL60
differentiation despite the fact that they are transformed cells. It
can therefore be surmised that HL60 differentiation may be very 
similar to that of the normal myeloid differentiation system.
Nevertheless, results from Skubitz and August (1983), who have 
studied changes in 125I-labelled surface antigens after induction
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of HL60 cells, have reported that although surface antigen
characteristics of mature granulocytes could be detected on HL60 
cells, they represented only a small proportion of the total 
population of cell-surface antigens found on these cells. However,
the composition of RA induced cell populations reported by Shubitz 
and August differed from that of others (Breitman et al, 1980) and 
they did not demonstrate that these cells had undergone full
induction. They also did not take into account the heterogeneity of 
the HL60 cell population. Ferrero et al (1983) also reported that
HL60 differentiation is defective. Although they report that over 90% 
of the HL60 cells appeared morphologically differentiated they did 
not present data giving the percentage, in cell types, of the final
population. Others have demonstrated alterations in polypeptide 
synthesis down the granulocytic differentiation pathway (Yokota et 
al, 1984). They showed that, although some of the changes observed 
were consistent with the normal differentiation process, induction of 
differentiation of HL60 cells may yield partial or incomplete 
differentiation since the protein pattern observed from induced HL60 
cells was not identical to the normal cell counterpart. From much 
earlier studies, Gallagher et al (1979) reported that DMSO induced 
HL60 cells do not synthesise lactoferrin and alkaline phosphatase, 
markers of mature granulocytes, which also suggests that HL60 
differentiation may not be complete. However, different inducing 
agents were used in these experiments which may contribute to some of 
the conflicting results. It has been demonstrated that some inducing 
agents are more effective than others in HL60 cell induction
(Breitman et al, 1980) . I have also demonstrated this when comparing 
the proportion of cells which appear terminally differentiated 
following RA or DMSO induction (Chapter III, 1 of this thesis).
Conflicting results have also been reported about the extent of 
monocyte / macrophage differentiation observed following TPA
induction of HL60 cells. TPA induced HL60 cells are phenotypically 
very different from uninduced cells or HL60 cells induced to
differentiate to granulocytes. I have also shown this (Chapter III,
1). However, Ferrero et al (1983) have reported that, although TPA
induced HL60 cells did possess some myelomonocytic cell markers, 
others could not be detected. These cells were also found to retain 
some antigens known to be characteristic of granulocytes. Others have
shown that TPA induced HL60 cells do express a number of
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membrane-bound proteins predominately synthesised by human 
macrophages (Todd et al, 1981; Feuerstein and Cooper, 1984; Yokota 
et al, 1984). Therefore, although induced HL60 cells may not be
identical to their normal cellular counterparts, the evidence 
available suggests that DMSO or RA induced HL60 cells are 
granulocytic and TPA induced HL60 cells are monocyte / 
macrophage-like.
Classification of haematopoietic cells at specific stages of 
differentiation is commonly carried out by morphological 
similarities. However, sub-groups could exist which, although very 
similar morphologically, could differ phenotypically. This could lead 
to slight variations in cell-surface antigen expression and 
functional changes. However, HL60 cells are derived from a cloned 
cell population, hence comparison of antisera reactivity of HL60 
cells with that of normal, haematopoietic cells, an uncloned cell 
population, may be misleading. Furthermore, HL60 cells are grown in 
culture which means that they are not influenced by 
microenvironmental stimuli encountered by normal, differentiating,
haematopoietic cells in the bone marrow. Bentley (1982) has proposed 
that contact between differentiating haematopoietic cells and bone 
marrow cells may influence the direct administration of appropriate 
regulatory factors to the differentiating cells. It is not clear how
the different inducing agents effect differentiation of HL60 cells or 
how closely they may mimic in vivo factors. Therefore, it is possible 
that these agents are not capable of eliciting a full differentiation 
response from HL60 cells. This would result in phenotypic differences 
between HL60 in vitro differentiation and normal haematopoietic 
differentiation in vivo.
It has been reported that leukaemogenesis involves the uncoupling of 
the mechanisms regulating differentiation and proliferation (Sachs,
1980). Since HL60 cells were derived from a leukaemic source they 
must therefore be aberrant in this respect. McCulloch (1983) has
proposed that a leukaemic clone consists of cells which are
"maturation arrested" at a stage similar to a differentiation stage 
in normal haematopoiesis. Addition of inducing agent to cultures of
HL60 cells may allow the cells to overcome the block in maturation 
and allow progress towards terminal differentiation. It is possible
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that the original ancestors of the leukaemic clone which gave rise to 
HL60 progressed along a differentiation pathway which may have only 
mimicked the normal course of differentiation. This suggests that 
HL60 differentiation may only closely resemble the normal, myeloid 
differentiation pathway, but may actually proceed down a parallel 
leukaemic differentiation pathway. This could explain the 
inconsistencies arising from comparison of the characteristics of 
normal haematopoietic cell and HL60 cells.
v) Classification of HL60 Cells
Studies involving the in vitro growth of normal bone marrow cells
have suggested that the myeloid and monocytic lineages share a common 
ancestor in haematopoietic differentiation. This proposal was based 
on studies which indicated that colonies grown in semi-solid media,
consisting of both granulocytes and macrophages, developed from a 
normal haematopoietic colony-forming unit (Pluznick et al, 1965). It 
has also been supported by the ability of myeloid leukaemia cells to 
differentiate to granulocytes and macrophages following an induction 
stimulus (Fibach et al, 1973). HL60 cells are bipotent, which has led
to the proposal that they represent an early cell which is common to
both monocyte and macrophage differentiation pathways. If this is 
correct, and HL60 cells are early progenitor cells, this raises 
doubts about the classification of this cell line as promyelocytic.
Figure 3 represents the proposed lineages leading to mature 
granuloytic and monocytic differentiation. Promyelocytes are 
positioned past the branch point at which these lineages diverge.
This would indicate that promyelocytes are committed to differentiate 
to granulocytes. However, HL60 cells are apparently not committed to 
one particular lineage as they can differentiate to granulocytes or 
macrophages. It is unlikely that HL60 cells reverse commitment to
granulocytes then become re-committed to monocytic differentiation.
Therefore, it can be speculated that the position of the branch point 
on the differentiation pathway to mature granylocytic and monocytic 
differentiation may need to be reviewed. However, HL60 cells are 
derived from leukaemic cells therefore they are not "normal,,. 
Although they possess promyelocytic features they may represent a 
cell type which is neither on the granulocytic nor the monocytic 
pathway but somewhere in between, an example of lineage infidelity. 
This would then suggest that HL60 differentiation parallels normal
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myeloid differentiation but progresses along a separate "leukaemic 
lineage" which shares both granulocytic and monocytic features. 
Alternatively, HL60 bipotency may reflect transdifferentiation of
these cells in response to an induction stimulus. 
Transdifferentiation is the term given to conversion from one
distinct cell type to another developmentally related type. This 
results in expression of proteins in cells which would normally not
contain these products (Wyllie et al, 1982). Transdifferentiation of 
pigmented and neural epithelium to lens tissue has been reported 
(Clayton, 1982). It would appear that certain conditions, both in
cell culture and in cell-cell contact, have to be met before 
transdifferentiation occurs in this system. Therefore, it could be 
suggested that the induction stimulus allows HL60 cells to 
transdifferentiate to monocytic cells with the expression of certain 
characteristics specific to normal monocytes.
2 INDUCTION OF DIFFERENTIATION AND COMMITMENT
A) Comparison of Inducing Agents
The most commonly used inducing agents for stimulating granulocytic 
differentiation in HL60 cells are RA and DMSO. TPA and
1,25-dihydroxyvitamin Dg are commonly used to induce monocyte /
macrophage differentiation. Many different parameters have been used 
to determine the differentiation status of induced HL60 cells, 
including morphological changes, histochemical changes, functional 
changes and changes in gene expression (Tsiftsoglou and Robinson,
1985) . From such analyses it has become apparent that differences can 
be observed not only between HL60 cells induced to macrophages and 
cells induced to granulocytes, but also between cells induced to the 
same differentiation end point with different chemical agents. This 
may indicate that not all agents are efficient inducers of
differentiation in HL60 cells. Alternatively, different inducing
agents may overlap in the patterns of gene expression they induce but 
may also act individually on other sets of genes. For example, it has 
been reported that TPA-responsive genes contain a 5' region, a 
TPA-responsive element, which recognises a specific protein which is 
expressed following TPA treatment of cells. Interaction of the
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protein and the TPA responsive element is thought to induce gene 
expression (Angel et al, 1987). Therefore, TPA may induce expression 
of genes in HL60 cells required for monocytic differentiation but may 
also stimulate expression of "TPA responsive genes" which may or may 
not be involved in the differentiation process.
Tsiftsoglou and Robinson (1985) have reported that RA is apparently 
more effective at inducing HL60 cells to terminally differentiate to 
granulocytes than DMSO. However, Skubitz et al (1982) have observed
that DMSO induced HL60 cells have a greater receptor activity for
formylated peptides than RA induced HL60 cells. Similarly, a report 
from Breitman and Keene (1982) demonstrated calcium ionophore 
activated production of leukotrienes was greater in DMSO induced 
cells, indicating that DMSO induced HL60 cells were more mature than 
RA induced HL60 cells. However, Hemmi et al (1982) demonstrated RA
induced HL60 cells appeared morphologically more mature at an earlier 
stage during induction than DMSO induced HL60 cells. I have found 
that variation exists between RA and DMSO induction of HL60 cells. 
During analysis of differentiation parameters during RA induction, it 
became very clear that only 50%-60% of the cell culture expressed 
characteristics of mature myeloid cells at the completion of the 5 
day RA induction period (see Chapter III, 1).
There appears to be great variation in the extent of differentiation 
of HL60 cells with different inducing agents as reported from 
different laboratories. The concentrations of the inducing agents 
used are all very similar therefore it seems reasonable to assume 
that these results arise through differences in the HL60 sublines 
from the various laboratories and differences in cell culturing 
technique (see Section 1 of this chapter) . Many different HL60 
sublines have been isolated which display varying degrees of 
resistance to induced differentiation (Gallagher et al, 1985). 
However the mechanism(s) responsible for resistance is unknown. It is 
therefore possible that the HL60 cell line used in this laboratory 
contains a population of cells incapable of responding to RA. 
Alternatively, RA may only induce HL60 partly along the granulocytic 
differentiation pathway. At the initiation of induced differentiation 
the HL60 cells are not synchronous in relation to phase of cell cycle 
and possibly stage of differentiation, hence this could result in 
some cells responding quickly to the induction stimulus whilst others
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have a delayed response. Therefore, at the end of a 5 day induction 
period those cells which respond early in the treatment period would 
display mature cell characteristics but those cells which were later 
in responding would still be at a very early stage on the 
granulocytic differentiation pathway and would retain uninduced cell 
characteristics. I observed that following 5 days of treatment with
RA, 50-60% of the cells resembled granulocytes both morphologically 
and biochemically. However, 30-40% of the cells still resembled
uninduced HL60 cells or myelocytes. Cell proliferation could still be 
observed in the HL60 cell culture, supporting the evidence that a
proportion of cells still remained undifferentiated. Interestingly, 5 
day RA induced HL60 cells invariably appeared less mature, 
morphologically, than 5 day DMSO induced HL60 cells (see Chapter III, 
1) .
Others have also reported differences in the abilities of TPA and
1.25-dihydroxyvitamin Dg to induce monocyte / macrophage
differentiation in HL60 cells. Most reports on HL60 cells induced by 
TPA state that the majority of the cells terminally differentiate and 
express morphological, functional and biochemical changes associated 
with mature macrophages (Rovera et al, 1979). I also found that 
approximately 90% of HL60 cells terminally differentiated when
induced by TPA (see Chapter III, 1). However, others have reported 
differences in the proportion of terminally differentiated HL60 cells 
found in cultures treated with 1,25-dihydroxyvitamin . For 
example, it has been reported that almost 80%-90% of
1.25-dihydroxyvitamin Dg induced HL60 cells become terminally 
differentiated (Daniel et al, 1987). However, others report that as 
few as 30% of the cells showed differentiated characteristics 
(Studinski and Brelvi, 1987).
B) The Commitment event
The nature of the cellular signal(s), which effects a cellular 
programme whereby cells yield terminally differentiated progeny, is 
an outstanding question in leukaemogenesis as well as regulatory 
biology. Due to its differentiation properties the HL60 cell line has 
been used to determine the order of events before the appearance of 
overt differentiation and the timing of the commitment event during
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HL60 monocytic and granulocytic differentiation.
From my analyses of terminally differentiated cell characteristics, 
it appears that the commitment event occurs between 8-24 hours of TPA 
treatment, and during 48-96 hours of DMSO treatment. At these times 
the majority of cells display reduced cell cloning ability, are 
arrested in G0/G1 phase of the cell cycle and display both
morphological and histochemical characteristics of mature myeloid 
cells. Removal of the cells from the induction stimulus before this 
time resulted in the cells maintaining their immature cell 
characteristics.
These results are in agreement with those reported by Fibach et al
(1982) and Fontana et al (1981). They proposed that 48-96 hours were 
required to irreversibly commit HL60 cells induced by DMSO to 
granulocytic differentiation and that 8-12 hours were required for 
commitment to monocytic differentiation. Data from these workers was 
derived from analysis of mature cell morphology and histochemical 
markers of differentiation displayed by HL60 cells exposed for
periods of time to inducing agents then cultured in the absense of 
any induction stimulus. The proportion of cells which became 
terminally differentiated throughout the period of culture, without
any differentiation stimulus, were counted as committed. This was 
identical to the method I applied to assess cell cloning potential 
during HL60 differentiation. They determined that after the critical 
period the presence of inducer in the growth medium was no longer 
required for completion of the differentiation programme. However, 
cells removed from the differentiation stimulus before this time 
showed reversal of mature cell characteristics and the reappearance 
of those characteristics associated with uninduced HL60 cells. This 
was also demonstrated during clonal analysis; before the commitment 
event cells continued to grow indefinately with only a small 
proportion unable to self renew. During and after the critical time 
the number of cells incapable of self renewal increased with a 
concomitant increase in those cells displaying mature cell
characteristics.
During these analyses HL60 cells were not synchronous with respect to 
phases of the cell cycle. It is unlikely that all cells will respond 
simultaneously to the induction stimulus, therefore, the time of
218
exposure required for individual cells to become irreversibly 
committed would vary. This would explain why the estimated time of 
the commitment event in HL60 cells, after induction, spans a number 
of hours.
Two models have been proposed for the mechanism of commitment to 
terminal differentiation, the stochastic model proposed by Till and 
McCulloch (1964) and the instructive model by Trentin (1967) (see 
Chapter I, 1, A(ii)). It has been reported that HL60 cells become
committed to terminal differentiation in a manner consistent with a 
stochastic model (Tarella et al, 1982). According to this model 
commitment events occur randomly in the population with a particular 
probability. A similar model is also proposed for induced
differentiation of erythroleukaemia cells (Guesella et al, 1976). 
However, it would appear difficult to separate entirely the 
stochastic model from the instructive model. It has been reported
that HL60 cells do not respond to inducing agents in a synchronous
manner therefore these cells do not respond to chemical agents
instructively (Tarella et al, 1982). However, others have reported 
that cells respond to induction stimuli at specific stages of the
cell cycle (Yen and Albright, 1984). Therefore HL60 cells would have
to reach that particular stage before becoming committed and 
expressing terminally differentiated cell characteristics. This would 
mask the fact that these cells were responding in a manner consistent 
with the instructive model. I have found that TPA induction of HL60 
cells results in the majority of the cells expressing terminally 
differentiated characteristics after only 24 hours of treatment. This 
indicates that these cells responded to the induction stimulus within 
the time required for the cells to undergo one round of cell 
division. This would suggest that these cells responded to TPA in a 
manner consistent to the instructive model. However, DMSO induction 
of HL60 cells required 3-4 days before the majority of cells were 
found to express terminally differentiated cell characteristics (see 
Chapter III, 1). This indicates that the cells had the opportunity to 
divide 2-3 times before becoming terminally differentiated and could
be consistent with a stochastic model for commitment to 
differentiation.
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C) Commitment and the Cell Cycle
Using fluorescence-activated cell sorting, to analyse the 
distribution of HL60 cells around the cell cycle, I found that TPA 
and DMSO treatment caused a progressive accumulation of cells in GO / 
G1 phase of the cell cycle and a concomitant decrease in the 
proportion of cells found in S and M phases. The subsequent 
inhibition of growth demonstrated by decrease in cell cloning ability 
may be attributed to a reduction in the percentage of cells capable 
of DNA synthesis. Arrest in G0/G1 occurred early in TPA induction, 
after 24 hours almost 95% of the cells were localised at this stage 
of the cell cycle. Others have also reported this (Rovera et al,
1980) . Treatment with DMSO resulted in G0/G1 arrest following 
72-96 hours of treatment. Similar results have also been reported by 
Yen et al (1985) but using RA as the induction stimulus. Many other
mammalian cell types in advanced stages of differentiation have a DNA 
content corresponding to the G0/G1 phase of the cell cycle and are no 
longer capable of proliferation (Prescott, 1976). Therefore this 
appears to be a normal event in the differentiation process.
It has been proposed that inducing agents transiently block cells in
one particular phase of the cell cycle where the probability of 
spontaneous differentiation is high. This block has been proposed
from observations that analogues of purines and pyrimidines, which 
inhibit DNA synthesis, can induce the differentiation of HL60 cells 
(Munroe et al, 1984; Griffin et al, 1982). Analysis of induced
differentiation in synchronised HL60 cell populations has suggested 
that HL60 cells become responsive to RA induction during S phase (Yen 
et al, 1984). Indeed evidence suggests that pretreatment with agents
which disrupt DNA synthesis accelerates the onset of terminal 
differentiation. For example, Yen et al (1987) demonstrated that 
pretreatment of HL60 cells with hydroxyurea followed by exposure to 
RA resulted in accelerated HL60 cell differentiation when compared to 
RA alone. They propose that hydroxyurea induces a precommitment state 
in HL60 cells. It is proposed that precommitment is a labile, early 
stage which may be activated specifically in S phase of the cell
cycle. Occurence of precommitment is also associated with nuclear
structural changes (Yen et al, 1985) . Others have reported that early 
changes in cell cycle kinetics, during differentiation of murine 
erythroleukaemia cells, resulted in prolongation and finally arrest
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at G0/G1 phase of the cell cycle (Terada et al, 1977). My results
indicate a progressive decrease in the proportion of HL60 cells found 
in G2/S phase during early times of TPA induction which could 
indicate prolongation of the G1 phase.
If induction was facilitated by the cells being in a specific phase
of the cell cycle at the time of addition of the inducer, then it
could be suggested that cell cycling is a necessary element in the
lead up to terminal differentiation. However, it has been 
demonstrated that commitment to differentiation and indeed the onset
of HL60 terminal differentiation does not require DNA synthesis or
cell division (Ferrero et al, 1982; Rovera et al, 1980). Hence there 
is confusion about the importance of the cell cycle in relation to
HL60 differentiation.
During commitment of differentiation in normal "stem cells" only one 
daughter cell becomes committed, the other must retain its ability to 
produce multipotent daughters to maintain the stem cell pool. In this 
respect HL60 commitment to differentiation is different. Quite 
clearly the majority of cells become committed to terminal 
differentiation. HL60 cells are classified as promyelocytic therefore 
these cells are committed to differentiation down the myeloid
differentiation lineages (Collins et al, 1977). They therefore 
represent late stages in haematopoiesis and are far removed from 
early progenitor stem cells. HL60 cells can proliferate but on 
receiving an induction stimulus it appears that all cells respond
unlike stem cells.
D) The Role of c-mvc During HL60 Differentiation
It has been suggested that cellular oncogene sequences may encode
products that control growth and differentiation. This has been 
supported in part by study of cellular oncogene expression during the 
induced differentiation of tumour cell lines in vitro. For example, 
HL60 cells possess amplified c-myc sequences which has led to the 
proposal that c-myc may have had a role during the leukaemogenic 
event from which the cells arose (Dalla Favera et al, 1982a) . It has 
previously been demonstrated that c-myc RNA is undetectable in 
terminally differentiated HL60 cells (Westin et al, 1982, Reitsma
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1983). To determine when c-myc transcripts became undetectable 
I examined the presence of c-myc RNA at time points throughout HL60 
differentiation.
During the course of induced differentiation of HL60 cells, c-myc RNA 
was undetectable after very short periods of treatment with either
TPA or DMSO: following 4 hours of TPA treatment and after only 1 hour
of DMSO treatment. c-Myc transcripts then remained undetected
throughout the period of induction. A similar decrease in detectable 
c-myc transcripts, following DMSO induction of HL60 cells, has been 
reported by Eick and Bornkamm (1986) and has also been observed 
during Friend erythroleukaemia cell differentiation (Lachman and 
Skoultchi, 1984).
From the parameters I measured during HL60 differentiation, decrease 
in c-myc RNA was the earliest change detected during granulocytic and 
monocytic differentiation. The loss of c-myc RNA appeared to precede 
the commitment event, the loss of the potential to self renewal,
arrest at G0/G1 and the appearance of overt differentiation. These 
events occurred a number of hours after c-myc transcripts became 
undetectable. This is in agreement with results reported by Filmus 
and Buick (1985). They observed a similar pattern of events during 
DMSO induction of HL60 cells. I observed that HL60 cells also 
appeared to stop proliferating before expressing differentiated cell 
characteristics. It has been postulated that c-myc has a role in cell 
proliferation and differentiation' however, is decrease in c-myc 
expression in HL60 cells due to the cessation of growth or due to the 
differentiation event?
i) c-Myc, a Role in Cell Proliferation
Evidence that myc sequences may be involved in cell proliferation was 
initially proposed from observations that c-myc expression was 
induced following serum or growth factor stimulation of quiescent 
fibroblasts and mitogenic stimulation of lymphocytes (Kelly et al, 
1983; Reed et al, 1985). DNA synthesis was also induced when 3T3 
cells were transfected with c-myc DNA under the control of the mouse 
mammary tumour virus promoter and the cells then cultured in the 
presence of glucocorticoids (Armelin et al, 1984). c-Myc sequences 
have also been demonstrated to co-operate with other sequences in the
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transformation of primary cells (Land et al, 1983). It has been 
suggested that c-myc protein is a competence factor, it is required 
for transition from GO to G1 of the cell cycle but other progression 
factors are needed for entry into S phase (Bravo et al,1985; Lee et 
al, 1985; Kaczmarek et al, 1985). Therefore, it has been proposed 
that c-myc has a role in establishment of cells which enables them to 
grow continuously in culture.
It was initially believed that c-myc expression was restricted to G1 
phase of the cell cycle. This followed reports that serum stimulation 
of quiescent fibroblasts or activation of lymphocytes by 
phytohaemaejcjLutinin resulted in proliferation of the cells and 
induction of c-myc RNA (Kelly et al (1983); Campisi et al, 1984). It 
was reported that the level of c-myc transcripts increased 20-fold 
shortly after cells were stimulated to proliferate and then declined 
before the onset of DNA synthesis. It was inferred from these data
that c-myc expression may be specific to G1 phase of the cell cycle.
However, it became apparent that the interpretation of these results 
had been misleading. Shortly after these data had been published
others reported that c-myc is rapidly induced upon the cell's
transition from a resting to a growing state* however, observation of 
the cells following stimulation, as they progressed round the cell 
cycle, indicated that c-myc RNA was present in cells at all phases of 
the cell cycle (Thompson et al, 1985). It has also been demonstrated 
that c-myc protein is present in nuclei of cells isolated from phases 
throughout the cell cycle (Hann et al, 1985). Therefore, in the light 
of this evidence, it would appear difficult to assign a role for 
c-myc in cell proliferation. However, it has been proposed that c-myc 
expression may reflect a cell's competence to enter and progress 
through the cell cycle but the c-myc gene is not expressed at any 
particular phase (Thompson et al, 1985).
During my analyses of levels of c-myc transcripts throughout TPA 
induction of HL60 cells, c-myc expression was undetectable after only 
4-8 hours of treatment. Following this event the majority of cells 
(>90%) arrested at GO / G1 of the cell cycle within the time 
estimated for one cell division (24 hours) . This indicates that with 
addition of TPA to the growth medium, those cells which had embarked 
on the cell cycle completed it but did not enter a second. It can 
therefore be proposed that loss of c-myc during monocytic
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differentiation of HL60 cells appears to reflect the cell's lack of 
ability to continue cycling. This would support the proposal that 
c-myc expression reflects a cell's ability to proliferate. However,
loss of c-myc RNA during TPA induction of HL60 cells also occurred
concomitant to the appearance of mature cell characteristicswhich 
indicates a direct link between levels of c-myc RNA and the
differentiation process.
From data generated from the analysis of c-myc expression during HL60 
induced differentiation by DMSO, I reported a loss of detectable 
c-myc transcripts within only one hour of treatment. However, from 
fluorescence activated cell sorting analysis and from observation of 
cell cloning potential during DMSO induction, it appears that these 
cells still divide 2-3 times following addition of inducer to the 
growth medium, before arrest at GO / G1 and the appearance of overt 
differentiation characteristics. This suggests that in DMSO induced 
HL60 cultures the cells are capable of proliferation without the 
presence of detectable c-myc RNA. Loss of c-myc transcipts also 
occurs approximately 24-48 hours before the appearance of mature cell 
characteristics which indicates that the commitment event occurs at a 
time when the level of c-myc RNA has been negligable for many hours.
Therefore, unlike the TPA induction, it is difficult to determine a 
direct link between c-myc expression and the loss of cell cycling 
potential and the appearance of overt differentiation in DMSO induced
HL60 cells.
ii) c-Myc, a Role in Differentiation Processes
I demonstrated that the steady-state levels of c-myc RNA dramatically 
diminish during differentiation of HL60 cells down both the 
granulocytic and the monocytic differentiation pathways. c-Myc 
expression has also been reported to decrease during differentiation 
of many other cell lines. During induction of differentiation of the 
teratocarcinoma cell line, F9, to parietal and visceral endoderm, 
c-myc RNA becomes undetectable following only 9-12 hours of treatment 
with RA (Griep and DeLuca, 1986). c-Myc RNA is also diminished at an 
early stage of induced differentiation of WEHI-3B cells (a murine 
myeloid leukaemia cell line) to monocyte / macrophages and a very 
early biphasic response is observed of c-myc transcripts when murine
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erythroleukaemia cells are induced to differentiate to mature 
erythroid cells (Gonda and Metcalf, 1984; Lachman and Skoultchi,
1984). During the induced differentiation of erythroid cells a 5-15 
fold drop in c-myc RNA levels occurred within 1-2 hours. The c-myc 
RNA then recovered to pretreatment levels by 12-18 hours and then
continued to fall off gradually as terminally differentiated cells
accumulated. Therefore, decrease in c-myc RNA levels is observed
during differentiation of many different cell lines which could 
indicate that this is a common event during the differentiation 
process.
Evidence to suggest that c-myc expression is an important factor in 
differentiation processes has come from a number of different
sources. It has been demonstrated that the continuous presence of
c-myc RNA prevents differentiation in many systems. Transformation of 
embryonic quail myogenic cells with avian v-myc myelocytomatosis 
virus MC-29 resulted in irreversible suppression of their competence 
for terminal differentiation (Falcone et al, 1985). Furthermore, the 
constitutive expression of c-myc sequences, as a result of
transformation of murine erythroleukaemia cells with v-myc sequences, 
under the control of the SV40 promoter, resulted in inhibition of
erythroid differentiation (Coppola and Cole, 1986). Similar results 
have been reported by Prochounik et al (1986) and Dmitrovsky et al 
(1986). Lachman et al, (1986) reported a similar experiment where 
alterations in the timing of the reappearance of c-myc RNA, during 
the biphasic response observed during induced differentiation of
murine erythroid cells, was demonstrated to change the timing of
commitment. For example, introduction of exogenous c-myc sequences
reduced the time of reappearance of c-myc transcripts during murine 
erythroleukaemia cell induction. This resulted in the appearance of 
committed cell characteristics at earlier times than observed in the 
parent line. However, transformation of the erythroid cells with
anti-sense c-myc sequences resulted in delayed reappearance of c-myc 
transcripts and a delay in the accumulation of committed cells. From 
these results it has been proposed that c-myc may have a regulatory 
role during commitment to differentiation.
However, contradictory evidence has also been reported which suggests 
that in certain systems the loss of c-myc RNA is not an important
event during differentiation. For example, induction of the human
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monocytic leukaemia cell line THP-1 showed no decrease in the level 
of c-myc transcripts when induced to differentiation to functional, 
adherent macrophages (Lee et al, 1987). Similarly, BC3H1 cells, a 
myogenic cell line which can be induced to differentiate, showed only 
partial inhibition of terminal differentiation when transfected with 
c-myc sequences under the control of the SV40 promoter. This 
maintains the abundance of c-myc RNA at levels comparable to that of 
undifferentiated myoblasts (Schneider et al, 1987). Therefore 
contradictory opinions exist about the role c-myc plays during 
differentiation. However, it is widely believed that c-myc does have 
a role to play in both differentiation and proliferation. The fact 
that some cell lines demonstrate a requirement for regulation of 
c-myc sequences while others do not, may reflect the nature of the 
original transforming event which initiated the establishment of the 
various cell lines. It has been proposed that transformation is the 
result of de-regulation of the processes of differentiation and 
proliferation hence some established cell lines may not reflect the 
events which occur during normal proliferation and differentiation 
(Sachs, 1980).
I observed that differences existed between DMSO and TPA induction of 
HL60 cells in respect to c-myc expression. This may reflect 
differences in the mode of operation of DMSO and TPA in inducing the 
differentiation process. TPA treatment alters lipid metabolism 
thereby altering membrane-mediated processes. For example, Cabot et 
al (1980) have reported enhanced stimulation of phospholipid
metabolism during treatment of HL60 cells with TPA. This has been
proposed to affect lipid microviscosity, alter lipid components 
present in the membrane and ion transport across the membrane, all of 
which could have substantial effects on intracellular processes 
(Sussman et al, 1985) Protein kinase C has been reported to be the 
membrane receptor for phorbol esters. Diglyceride, formed by a 
phospholipase C-catalysed hydrolysis of inositol phospholipids, is 
the physiological activator of protein kinase C; phorbol esters can 
substitute for diglycerides in this role. (Castagne ejt al, 1982).
Protein kinases have been implicated in transformation processes but 
are also believed to play a central role in normal growth regulation 
(Taylor, 1987). It is thought that they act as means of transmitting 
signals by phosphorylation events from the cell membrane to the cell 
nucleus (Taylor, 1987). It has recently been reported that the
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co-ordinate expression of TPA-responsive genes is implemented by a 
specific TPA-response motif in the 5' sequences of these genes. This 
motif appears to recognise a protein(s) which is abundant following 
TPA treatment (Angel et al, 1987). Thus, some changes which do or do 
not take place in response to treatment with TPA may be due to a 
direct effect of TPA on promoters of genes rather than a response to 
a differentiation programme.
DMSO is a bipolar molecule, with a high dielectric constant, which
has an enormous effect on permeability of membranes; this is
indicated by changes in ion movements across the membrane (Friend and
Freedman, 1978). Phase transition temperatures of phospholipids are
increased by DMSO treatment, causing reduced fluidity and increased 
membrane stability (Lyman et al, 1976). The importance of these
membrane changes on the induction of differentiation by DMSO has been
highlighted by treatment of murine erythroleukaemia cells with agents 
known to increase the fluidity of artificial and biological 
membranes. This treatment inhibits the induction of erythroleukaemia 
cells by DMSO (Papahadjopoulos et al, 1975; Poste et al, 1975).
However, the exact mechanisms through which DMSO operates are
unclear. Changes in membrane permeability could enhance 
differentiation by altering or enhancing transport or binding of 
certain "factors" which normally initiate differentiation.
Therefore, both TPA and DMSO appear to have a major effect on the 
membrane of cells* however the exact nature of the mechanism(s) 
through which they elicit their induction effects is unclear. To 
determine if different induction agents affect transcription of the 
c-myc gene by different mechanisms more would need to be determined 
about the intracellular processes leading to differentiation and the 
role c-myc plays in these processes.
Alternatively, c-myc transcription may still occur during DMSO 
induction but expression may be down-regulated to such an extent that 
it is below the levels of detectability by Northern blotting 
analysis. c-Myc sequences are greatly amplified in HL60 cells 
(Dalla-Favera et al, 1982a). The degree of c-myc transcription is 
directly proportional to the extent of amplification (Graham et al,
1985). Hence, it could be postulated that transcription is reduced to 
levels reflecting that from the normal allele which may be difficult
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to determine by the method I used. However, the abundance of c-myc 
protein has not been determined during HL60 differentiation. 
Therefore, despite the fact that c-myc RNA is undetectable after only 
one hour of treatment with DMSO, the protein could still be 
functional for some time. For this to occur in this situation, the 
c-myc protein would need to be stabilised as it has a short half life 
of only 15-30 minutes in normally cycling cells (Hann and Eisenman, 
1984).
3 CHANGES IN GENE EXPRESSION DURING HL60 DIFFERENTIATION
During induced differentiation of HL60 cells to granulocytes or 
macrophages, changes in morphological and functional characteristics 
are observed (see Chapter III, A of this thesis; Tsiftsoglou and 
Robinson, 1985). Changes in the expression of specific genes have 
also been reported, in particular c-myc (Westin et al, 1982; Reitsma 
et al, 1983) . Complex patterns of gene expression are thought to 
occur during differentiation; this is likely to involve regulation at 
many levels from the gene to the protein. Some aspects of this 
regulatory programme have been characterised by looking at changes in 
the population of mRNA or protein molecules synthesised by cells. 
From analysis of the availability of specific mRNA transcripts for 
translation in vitro, the extent of regulation of gene expression 
during HL60 differentiation has been evaluated. Reyland et al (1986)
reported that 17% of a mRNA population appeared to be differentially
regulated during DMSO induction of HL60 cells. Colbert et al (1983) 
have reported that almost 50% of the mRNA population are 
differentially regulated and have also observed differences in the 
translation products produced by HL60 cells induced to granulocytes 
compared to cells induced to monocytes / macrophages. In other
systems, during development of Dictyostelium for example, 25%-27% of
proteins synthesised in vivo have been shown to be regulated (Alton 
and Lodish, 1977). These results suggest that extensive changes in 
gene expression must occur during development and differentiation. 
From my data, gathered from screening analyses of a cDNA library 
constructed from poly (A)"*" RNA isolated from 5 day RA induced HL60 
cells (see Chapter III, B), it appears that almost 30% of the cDNAs 
represent sequences which are highly abundant in induced cells
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compared to uninduced HL60 cells and therefore appear to be 
differentially regulated. This is in agreement with the results of 
others from in vitro translation experiments.
I wanted to select sequences which changed in abundance during HL60 
differentiation, and to examine the expression of the genes these 
sequences represented during the induction period, particularly with 
respect to commitment. To identify the sequences I employed two 
methods. The first approach was to examine the expression of genes
which had been demonstrated to change during HL60 induction. This 
included c-myc and lysozyme, a macrophage-specific protein which is
frequently used as a marker of monocytic differentiation in HL60
cells. The second approach employed the use of cDNA libraries 
constructed from poly(A)+ RNA isolated from 5 day RA induced HL60 
cells. The library was screened to determine sequences which changed 
in abundance during differentiation. The cDNAs, representing these 
sequences could then be used as hybridisation probes to investigate 
the differential characteristics of the homologous RNA. Three mRNAs 
were selected for analysis by this method. This method has been used 
successfully by others to determine sequences which change in 
abundance due to differentiation or hormone stimulation (Goodfellow, 
1984; Fulton, 1985).
A) Potential Control Mechanisms for c-Mvc Expression During HL60 
Differentiation
C-Myc RNA has been shown to be undetectable following very short 
times of RA or DMSO treatment of HL60 cells (Bentley and Groudine, 
1986; Eick and Bornkamm, 1986). I have also observed a rapid loss of 
c-myc RNA following only 1 hour of treatment with DMSO. Similarly, I 
observed that only 2-4 hours of TPA treatment was all that was 
required to result in the loss of c-myc transcripts from HL60 cells 
(see Chapter III, A of this thesis).
Both transcriptional and post-transcriptional mechanisms appear 
responsible for alteration of c-myc expression in many systems. 
Recent studies of c-myc expression, following the addition of serum 
and defined growth factors to growth-arrested fibroblasts, have 
indicated that transient increases in c-myc RNA levels occur as a
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consequence of both increased transcription and enhanced transcript 
stability (Greenberg and Ziff, 1984; Blanchard et al, 1985). 
Inhibition of protein synthesis during mitogenic stimulation leads to 
"superinduction" of c-myc RNA, suggesting that c-myc mRNA levels may 
be regulated by a labile protein , a negative regulator (Kelly et al, 
1983). Lachman and Skoultchi (1984) also reported data to support 
this; early decline of c-myc RNA, during DMSO induced Friend 
erythroleukaemia cell differentiation, was delayed by protein 
synthesis inhibitors. The initial decrease in c-myc RNA levels during 
Friend erythroleukaemia cell differentiation is followed by 
re-expression of c-myc. From these data Lachman and Skoultchi (1984) 
also postulate that c-myc transcription is controlled by positive 
regulators which facilitate the biphasic response of c-myc to the 
induction stimulus.
Evidence is now gathering which indicates that control mechanisms may 
operate at the 5' regions of the c-myc locus. The repression of 
normal c-myc expression in transformed cells harboring c-myc 
chromosome translocations or c-myc retroviruses, has been proposed to
be an auto-regulatory phenomena. This may be mediated, by a
repressor, at the level of the first exon of the c-myc gene (Leder et
al, 1983; Rabbitts et al, 1984; Rapp et al, 1985). Indeed, control at
the first exon of c-myc has been supported by the discovery of a
cis-acting negative control element, with the opposite properties of
a transcriptional enhancer, which has been localised upstream of the 
murine c-myc locus (Remmers et al, 1986). The first exon of c-myc has 
also been reported as a site of anti-sense transcription which may
act as a mechanism for control of gene expression but has yet to be
demonstrated in vivo (Nepveu and Marcu, 1986).
Control of gene expression during HL60 differentiation also appears 
to operate at the level of the 5' regions of the c-myc locus. It has 
been reported that decrease in the levels of c-myc RNA during DMSO 
induction of HL60 cells is caused by a block in transcription, which 
may start immediately after addition of DMSO. Eick and BornKamm 
(1986) used nuclear run-on assays to determine when and where along 
the c-myc locus the block occurred. They demonstrated that the block 
in c-myc transcription was complete after only 30 minutes of DMSO 
treatment. From my results, using Northern blotting analysis to 
determine the steady state levels of c-myc RNA during HL60 induction
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by DMSO, transcripts were undetectable following only 1 hour of 
treatment. If the half-life of c-myc RNA is only 10-15 minutes in 
HL60 cells, as reported by Dani et al (1985), and transcription of 
the c-myc gene was abolished after only 30 minutes of treatment by 
DMSO, this would account for the rapid loss of c-myc RNA during DMSO 
induction. I have also found that the half-life of c-myc RNA in 
uninduced HL60 cells from this laboratory is only 15 minutes (see 
Chapter III, A).
The block in c-myc transcription has been localised to regions in the 
exon 1 / intron 1 boundaries. Interestingly, the first exon remains
transcriptionally active when the rest of the gene is silent (Eick 
and Bornkamm, 1986). In an attempt to detect the exon 1 transcripts, 
identified by nuclear run-on analysis, I prepared a Northern blot 
from total RNA isolated from HL60 cells harvested at different times 
following addition of DMSO to the growth medium. This was hybridised 
to a c-myc exon 1 probe, however no small RNAs homologous to this 
sequence could be detected. This has also been reported by others 
(Eick and BornKamm, 1986). They postulate that the c-myc transcripts, 
from exon 1, may be so unstable that they are rapidly degraded and 
therefore are undetectable by Northern blotting analysis.
Bentley and Groudine (1986) have reported that a similar blockage 
operates to control c-myc expression during RA induction of HL60 
cells. They report that the blockage is localised to an area similar 
to that defined by Eick and Bornkamm, at the boundary of c-myc exon 1 
/ intron 1. Eick and Bornkamm (1986) suggest that blockage of 
transcription is caused by DNA secondary structure at the exon 1 / 
intron 1 regions of the c-myc locus which results in transcriptional 
termination. They postulate that stem loop structures may facilitate 
the blockage in response to the induction stimulus. It is unknown if 
the same mechanisms operate to control c-myc expression during TPA 
induction of HL60 cells. However, it can be postulated that a
different mechanism may operate. Both Eick and Bornkamm (1986) and
Bentley and Groudine (1986) have reported that c-myc transcription is 
abolished in HL60 cell at very short times after the addition of DMSO 
or RA to the growth medium (see Chapter III, A). However, I found 
that TPA induced HL60 cells appeared to show a decrease in c-myc RNA
at later times than HL60 cells induced to granulocytes, after 2-4
hours instead of 1 hour. The difference in the timing of loss of
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c-myc transcripts may therefore indicate the operation of a different 
mechanism for control of c-myc expression during TPA induction of 
HL60 cells. Unfortunately RA did not induce a large proportion of my 
HL60 cells. This made it impossible to determine if and when c-myc 
transcripts became undetectable in the terminally differentiated 
cells. c-Myc RNA was detected throughout the first 3 days of RA 
induction. In the light of data from others this was probably 
produced from those cells which remained uninduced.
B) Lvsozvme Expression in HL60 Cells
Apart from their phagocytic role, mononuclear phagocytes synthesis 
and secrete a wide variety of biologically important products, some 
of which are constitutively expressed, some inducible (Gordon, 1980). 
Lysozyme is a constitutively secreted protein, unaffected by the 
activation status of monocyte / macrophage cells (Lappin et al,
1986) . Therefore this protein is a marker of mature macrophage 
differentiation and has been used to determine when HL60 cells become 
terminally differentiated to monocyte / macrophage cells during the 
course of induction (Reitsma et al, 1983; see Chapter III,A).
From analysis of lysozyme protein secretion during the three days 
required for TPA induced macrophage differentiation of HL60 cells, it 
appears that lysozyme protein is highly abundant in TPA induced HL60 
cells even at very early times following the addition of inducing 
agent to the growth medium. An increase in lysozyme protein secretion 
was detected after only 2 hours of TPA treatment; the amount of 
secreted lysozyme protein increased dramatically throughout the first 
48 hours of treatment but no further increase was observed during the 
final 24 hours of TPA induction. These results are supported by 
Reitsma et al (1983). They also reported very early increases in 
secreted lysozyme protein, between 6-12 hours, during HL60 induction 
to monocyte / macrophage differentiation by 1,25-dihydroxyvitamin 
D<j Polansky et al (1985) also report a similar pattern of lysozyme 
protein secretion following phorbol ester induction and Krystosek and 
Sachs (1976) have demonstrated that myeloid leukaemic cells also 
secrete lysozyme when induced to differentiate to monocyte / 
macrophages.
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The increase in abundance of extracellular lysozyme protein does not 
appear to be through stimulated release of intracellular protein by 
the inducing agent. The intracellular lysozyme protein content of 
uninduced and RA or DMSO induced HL60 cells was almost negligible. 
This is in agreement with data reported by Polansky et al (1985). 
Therefore, it can be deduced that the increase in lysozyme secretion 
observed by TPA induced HL60 cells is a consequence of changes in 
lysozyme gene expression (Chapter, III, A).
To determine the abundance of lysozyme RNA in HL60 cells, total RNA 
from uninduced and terminally induced HL60 cells were analysed by 
Northern blotting for the presence of lysozyme mRNA. Lysozyme 
transcripts were not clearly resolved but hybridisation was observed 
in both TPA induced and normal macrophage RNA samples. Interestingly, 
a very strong hybridisation signal was detected from total RNA 
isolated from RA induced and uninduced HL60 cells. This has also been 
reported by Polasky et al (1985) . They postulated that some 
post-transcriptional event may control lysozyme expression in HL60 
cells. Indeed Northern analysis reveals that transcripts homologous 
to the lysozyme probe, in uninduced and RA induced HL60 cells, are 
not of a specific size and appear larger than the normal lysozyme 
mRNA. This may indicate that control of lysozyme gene expression 
operates at the level of RNA processing.
Alternatively, the results from the Northern blotting analysis could 
be artifactual. The lysozyme probe was of chick origin and is thought 
to share only 40% homology with the human lysozyme sequence. Due to 
this the filters were washed in low stringency wash buffers. This 
could have resulted in non-specific binding of the hybridisation 
probe. Clearly investigation into the mechanism(s) controlling 
lysozyme expression in HL60 cells will require production of a human 
lysozyme probe.
C) F6 RNA Expression During HL60 Differentiation
i) Abundance of F6 RNA in HL60 Cells
F6 cDNA represents RNA which is highly abundant in uninduced HL60 
cells, moderately abundant in RA induced cells but barely detectable
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following TPA induction. Analyses of HL60 RNA by Northern blotting, 
revealed that F6 cDNA shared homology with a large range of RNA 
transcripts in both total whole cell RNA and in poly(A)+ RNA. Probe 
for F6 also hybridised in a non-specific manner to total genomic DNA. 
This pattern of hybridisation has been reported by others during the 
analysis of repetitive DNA elements (Kramerov et al, 1985).
By examination of the distribution of F6 RNA, in nuclear and 
cytoplasmic RNA fractions isolated from uninduced HL60 cells, it was 
found that F6 transcripts were highly abundant in nuclear RNA but 
barely detectable in cytoplasmic fractions. Repetitive sequences have 
frequently been associated with hnRNA but found at very low levels in 
cytoplasmic RNA. This has been demonstrated in HeLa cells, in cells
from Chinese hamster and also in murine cells (Ryskov et al, 1973;
Jelinek, 1978 and Elder et al, 1981).
F6 cDNA was conclusively proved to contain sequenceshomologous to
repetitive elements following sequencing of the cDNA. It was found 
that approximately 400 nucleotides of F6 bore 80% homology to the Alu 
family consensus sequence. Alu sequences make up 3-6% of the human 
genome, with approximately 500 000 copies per haploid genome. The Alu 
elements are dispersed throughout the DNA with no apparent clustering 
(Schmid and Jelinek, 1982).
ii) The Alu Repetitive Elements Compared to F6
Alu family members have highly conserved sequences with 
individual members differing by an average of only 10% from other 
members. Most of the variations are point mutations which appear 
randomly distributed throughout the length of the repeat unit 
(Deininger et al, 1981). Figure 30 represents the sequence of F6 c M A  
and that of another Alu family member Blur 13. Approximately 80%
homology exists between the two sequences and the variations consist 
of short sequences, as reported by others.
A stretch of unique sequence of approximately 130' nucleotides in 
length is associated with the Alu repeat element in F6. This stretch 
shared no homology with known sequences when compared with those in 
the Microgene Databank System. Alu repeats, as mentioned previously, 
are highly represented in hnRNA (Elder et al, 1981). They have been
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described in the intervening sequences of many genes, either in 
introns which are spliced out or in 3' non-coding regions. The 12 Kb 
c-sis gene contains three Alu family members (Dalla Favera et al, 
1981). Similarly, the 56 Kb stretch of human DNA encoding the 
epsilon, A-gamma, G-gamma, delta and beta globin genes have also been 
shown to contain seven Alu family members (Coggins et al, 1980). 
Others have reported the occurrence of Alu sequences in coding
regions. Zabarovsky et al (1984) described Alu repeat insertions in 
the coding region of the human c-mos pseudogene and Quattrochi et al 
(1986) have demonstrated Alu sequences in the mRNA transcripts of 
human cytochrome P-450. However, the Alu element present in F6 cDNA 
hybridises to a number of different sizes of transcripts making it 
impossible to distinguish the sequence specific to F6. In the light 
of the data described above it would appear that F6 originated from 
non-coding sequences. Procedures used to isolate the poly(A)+ RNA
transcripts prior to preparation of the cDNA library relied on
oligo(dT) recognition of the polyadenylated tail; F6 has a high 
adenosine content which may have led to the isolation of this 
sequence during oligo(dT) separation of poly(A)+ RNA. 
Alternatively, the F6 RNA could have been aggregated with poly(A)+ 
hnRNA and therefore was co-purified with poly(A)+ RNA.
iii) Repetitive Elements and Differentiation
The abundance of transcripts homologous to F6 cDNA were found to 
decrease dramatically following three days of TPA treatment. Others
have also reported inactivation of transcription of repeat sequences 
during terminal differentiation (Chou et al, 1984). This could 
indicate a general decrease in transcription in these cells. However,
Colbert et al (1983) reported no overall decrease in poly(A)+ RNA
isolated from TPA induced HL60 cells. This indicates that TPA induced 
HL60 cells do not contain reduced amounts of RNA. Therefore the loss 
of transcripts which share homology to F6 does not appear to be the 
result of a general mechanism operating on transcription but may 
indicate a function for these transcripts during the differentiation 
process.
It has been postulated that repetitive sequences may have a function
in the regulation of gene expression (Davidson and Britten, 1979).
The observation that short period interspersed repeats are found in
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close proximity to protein coding sequences in DNA and that their 
transcripts are found associated with nuclear RNA has been used to 
argue that they function either to regulate transcription or to 
regulate the processing of hnRNA to mRNA (Jelinek et al, 1980).
Others have described stimulation of transcripts containing sequences 
sharing homology to repetitive elements when quiescent mouse 
fibroblasts are stimulated with serum or epithelial growth factor and 
insulin (Hodgson et al, 1983; Edwards et al, 1985). Scott et al
(1983) have discovered a B2 sequence (the murine equivalent of the
human Alu sequence) in the 3' non-coding region of a class 1 major 
histocompatibility antigen which is induced in cells transformed by 
both viral and chemical agents. Murphy et al (1983) have analysed 
total foetal RNA at different stages of mouse embryogenesis and shown 
that transcripts homologous to B2 repeat sequences peak sharply at 
the 9-10 day stage indicating that these transcripts might have a
role during development. They also observed that a B2 probe detected 
a broad range of transcripts whose abundance decreased upon induction 
of differentiation of F9 teratocarcinoma cells by RA. These results
imply that the transcription of repetitive elements is regulated 
during development and differentiation.
It is interesting to draw a comparison between the transcripts
described in F9 teratocarcinoma cells by Murphy et al (1983) and 
those detected by F6 cDNA probes in HL60 cells. In both systems a
decrease in transcripts homologous to repetitive sequences has been 
demonstrated following differentiation. HL60 cells are believed to be 
representative of early progenitor cells on the pathway leading to
granulocytic differentiation. Therefore transcripts containing 
repetitive elements may be specific to immature cell types. Aberrant 
expression of developmentally significant genes has been proposed as 
an important factor in cancer and cellular transformation (Pierce et 
al. 1978). It is therefore interesting that the transcripts
homologous to repetitive sequences appear abundant in cell lines
derived from cancer cells, and also in normal murine development.
The fact that RA induced HL60 cells did not show total loss of 
transcripts homologous to F6, may be due to the high proportion of
cells which are apparently not terminally differentiated by this
agent (40%-50%). Uninduced HL60 cells were found to contain 4 times
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as much F6 RNA than RA induced HL60 cells and 16 times more F6 RNA 
than TPA induced HL60 cells. However, the correlation between 
decrease in transcripts which show homology to the Alu repetitive 
elements and increase in terminally differentiated cells during HL60 
induction by TPA may be casual rather than causal. It has been 
thought that Alu sequences are parasitic and that their occurence 
throughout the human genome has been by chance and not by design. It 
is proposed that Alu sequences have the ability to self-prime reverse 
transcription of their RNA transcripts (Jagadeeswaran et al, 1981). 
It has also been proposed that these sequences may share many of the 
characteristics attributed to bacterial insertion sequences, as they 
contain regions of homology to elements which appear to be required 
for transposition (Calos and Miller, 1980). Therefore, it has been 
postulated that, following reverse transcription, newly synthesised 
Alu cDNAs are capable of insertion into the genome. Insertion at some 
chromosomal loci could have severely disrupted the normal cellular 
physiological functions hence only those sequences which would not 
affect the cell phenotype would be tolerated by the cell. Alu 
repetitive elements have been preserved during recent primate
evolution with little change to their sequences (Sawada and Schmid,
1981). This has been postulated to indicate an important cellular 
function for these sequences. However, it has been argued that 
without any selective pressure put on Alu sequences the repetitive 
element would remain relatively stable. It is therefore unclear if 
Alu repetitive sequences have any function during differentiation and 
development.
D) C6 RNA Expression During HL60 Cell Differentiation
i) The C6 cDNA
The C6 cDNA represents transcripts which are highly abundant 
following granulocytic differentiation of HL60 cells. However, DMSO 
induced cells contain levels of C6 homologous RNA that are 
approximately 5 fold that detected in RA induced HL60 cells. 
Interestingly, C6 cDNA hybridises to two transcripts of 2.4 kb and
1.3 kb respectively, in total whole cell RNA from DMSO induced HL60 
cells. Only the smaller of the two transcripts can be clearly 
detected in uninduced cells.
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From initial analysis of the recombinant plasmid pUC8C6, following an 
Eco RI + Bam HI restriction digestion of the plasmid DNA, C6 cDNA was
demonstrated to yield three fragments of 220 base pairs, 190 base
pairs and 160 base pairs respectively. These fragments had not arisen 
from internal restriction digestion sites within the C6 cDNA 
sequence, or from a conjugate plasmid construct. Examination of the
recombinant plasmid DNA hybridised to pUC8, by electron microscopy, 
revealed only one region of non-homology between the two DNAs. This
region was estimated to be 200 - 300 base pairs in length. This
supported the evidence suggesting that pUC8C6 was not a conjugate of 
recombinant plasmids and also suggested that the C6 cDNA was only 
approximately 200 base pairs long. This indicated that the three 
fragments were not produced from restriction digestion of internal
Eco RI or Bam HI sites within a larger cDNA fragment.
From sequencing data, generated from the C6 fragments, it was
concluded that all the fragments contained a stretch of 85 
nucleotides in common. This was a unique sequence which bore no 
homology to sequences recorded in the Gene Databank system available 
in this laboratory. The only apparent difference between the
fragments was the length of thymidine residues, the 190 base pair
fragment was 30 nucleotides shorter and the 160 base pair fragment 60 
nucleotides shorter than the 220 base pair fragment. When used 
individually, as hybridisation probes, each fragment hybridised to 
the 2.4 kb and the 1.3 kb transcripts in RA and DMSO induced HL60 
total cellular RNA indicating the similarity between the fragments.
It is highly unlikely that the C6 fragments arose because of
contamination by another plasmid. During the preparation of the 
plasmid DNA the transfected cells containing pUC8C6 had been
colony-purified twice by selection of distinct cell colonies, which 
were well separated from other colonies. This eliminated any chance 
of cross-contamination. The fact that the cDNA fragments are 
identical, except for the length of thymidine residues, may therefore 
indicate that the fragments were initially derived from an ancestral
plasmid which may have undergone some recombination event during
early stages following the construction of the cDNA library. Plasmid
DNA was amplified by transfection and subsequent growth in E. coli
JM83 cells as recommended by Viera and Messing (1982). These cells 
are recA^ hence recombination events can occur (Messing, 1979).
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However, it is interesting to note that if these fragments were
generated by recombination events, the sites of recombination would 
appear very consistent as a similar fractionation pattern has been 
detected from a number of different pUC8C6 DNA preparations.
Alternatively, the fragments may have been generated by loss of
stretches of thymidine residues due to regions of instability along 
the length of the thymidine sequence. Certain combinations of
nucleotides are thought to be intrinsically unstable, for example GC
rich regions, but this has not been reported for stretches of A or T.
A role for secondary structure in the generation of these fragments
also seems unlikely. Fractionation of the fragments on denaturing
agarose gels did not alter the pattern observed when C6 cDNA was
fractionated normally which suggested that secondary structure was 
not a factor in producing the C6 cDNAs
C6 cDNA is highly unusual, not only because of the multiple fragments 
generated on Eco RI + Bam HI digestion of pUC8C6, but also because of 
the length of thymidine nucleotides detected following sequencing of 
these fragments. The initial synthesis of the cDNAs during the
construction of the cDNA library, followed the method of Wickens et
al, (1980). The synthesis of the single stranded cDNA from the 
poly(A)+ RNA template by Klenow fragment was oligo(dT) primed using
a 17mer. The primer was added to a concentration which would maximise 
binding along the length of the polyadenylated tails of the isolated 
mRNA molecules and which would, in turn, minimise the synthesis of
long stretches of thymidine nucleotides. However, the lengths of
thymidine nucleotides detected in the C6 cDNA fragments are very 
long, approximately 135 nucleotides in the 220 base pair fragment to 
75 nucleotides in the 160 base pair fragment.
ii) A Relationship between the 1.3 kb and the 2.4 kb C6 RNAs
Both transcripts detected by C6 cDNA must share the 85 base pair 
sequence found in all three C6 cDNA fragments in common. This 
suggested that these transcripts are related in some way. Southern 
blotting analysis of total cellular HL60 DNA hybridised to C6 probe 
indicated that the transcripts were derived from a unique DNA
sequence. Experiments to determine the location of the transcripts in 
the different cellular compartments revealed that only the 2.4 kb
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transcript could be detected in nuclear RNA isolated from RA induced
HL60 cells. Therefore, from this data, it can be tentatively proposed 
that the 2.4 kb transcript may be an unprocessed form of the 1.3 kb 
transcript. Since both transcripts can be detected in total whole 
cell RNA and the 2.4 kb transcript is detected in nuclear RNA it can 
be assumed that the 1.3 kb RNA must be located in the cytoplasmic 
cell fraction.
During the processing events leading from hnRNA to mRNA, evidence 
suggests that following transcription of the hnRNA these 
molecules are polyadenylated (Breathnach and Chambon, 1981). This 
event appears to precede splicing out of intron sequences, 
however the two processes of polyadenylation and splicing are not 
mechanistically coupled (Zeevi et al, 1981). It is therefore 
interesting to note that both the 2.4 kb and the 1.3 kb C6 RNAs are
present in poly(A)+ RNA isolated from RA induced HL60 cells. The
removal of introns from hnRNA containing multiple intron sequences 
does not appear to occur in a strict order. The order of removal is 
thought to be kinetically determined as excision of some introns is 
intrinsically faster than others. This would result in partially
spliced molecules with different intron patterns. This has been 
demonstrated by others. For example, Roop et al (1978) demonstrated 
that multiple species of ovalbumin RNA could be detected in chick
oviduct nuclei only. These RNAs ranged from 1.5 - 5 times larger than
the ovalbumin mRNA. Only the mRNA was detected in the cytoplasmic RNA 
fraction. Nordstrom et al (1979) reported similar results when 
analysing high molecular weight nuclear RNA for ovamucoid RNA. Hence 
it could be speculated that the 2.4 kb C6 RNA is the polyadenylated, 
unspliced precursor of the 1.3 kb transcript.
The half-life of introns within precursor RNAs can vary from only a 
few seconds to 10 - 20 minutes (Keohavong e_t al, 1982). Therefore,
the fact that the 2.4 kb C6 RNA can be detected by Northern blotting
analysis indicates that, if indeed a splicing event is involved in 
producing the 1.3 kb transcripts, the intron(s) must have a 
relatively long half-life.
Both C6 transcripts increased in abundance during granulocytic 
differentiation in HL60 cells, however the 2.4 kb RNA levels 
increased by a much greater proportion than that of the smaller
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transcript. For example, the level of the 2.4 kb RNA increased 5 fold 
during the 5 day RA induction period whereas the 1.3 kb RNA levels 
only doubled. During DMSO induction however the levels of the 2.4 kb 
RNA increased 18 fold during the 5 day induction period whereas the
1.3 kb transcripts doubled in abundance. It is interesting to note 
that although the level of the smaller RNA increased by a similar 
degree, during both DMSO and RA inductions, no similarity was found 
in the extent of increase of the 2.4 kb transcripts.
If the larger transcript is a hnRNA precursor of the 1.3 kb RNA, it 
is possible to explain the pattern of expression of both RNAs by 
slight modification of the simple kinetic model of mRNA splicing 
proposed by Pikielny and Robash (1985). They assumed that all 
reactions, during splicing, followed first order kinetics and that 
both precursor molecules and mature RNAs were at steady state. 
Briefly, they propose that if the rate of the splicing reaction is 
slower than the turn over of precursor molecules, most precursor RNAs 
will be degraded and the level of precursor RNA will be maximal and 
essentially independent of the rate of splicing. The level of mRNA 
would however be dependent on the rate constant of the splicing 
reaction. Conversely, when splicing is faster than the turn over of 
precursor RNA most precursor RNA would be spliced and the level of 
mRNA would be maximal. The amount of precursor RNA would then be 
inversely proportional to the rate of the splicing reaction. This 
model was based on data generated from observation of the abundance 
of precursor and mRNA molecules after specific mutations were 
introduced into the introns of yeast genes. It was observed that 
these mutations either increased or decreased the efficiency of the 
splicing reaction.
This model also indicates that threshold levels occur in splicing 
reactions and that the system can become saturated. The situation in 
the uninduced HL60 cell, in regard to splicing of the 2.4 kb C6 RNA, 
could be viewed hypothetically as a splicing reaction occurring under 
non-saturating circumstances. The production of 2.4 kb RNA would 
occur at a rate comparable to that of the splicing reaction producing 
the 1.3 kb transcripts. This would result in very low levels of the
2.4 kb transcripts but detectable levels of the 1.3 kb RNA. In 
effect, the rate of the splicing reaction would be greater than that 
of the transcription rate of the C6 gene. However, following
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induction of HL60 cells by RA or DMSO, it could be proposed that the 
transcription rate of the C6 gene is increased. As a result, the 
level of 2.4 kb RNA increases dramatically but the rate of the 
splicing reaction remains the same. A bottleneck would form at the 
splicing stage as the reaction reaches saturation. This would result 
in high levels of precursor RNA with a concomitant increase in mRNA 
levels which would depend on cytoplasmic stability and other factors 
which have been proposed to influence the concentration of mature
cytoplasmic RNAs.
Pikielny and Rosbash (1985) have also demonstrated that mutation in 
the sequence motifs in intron sequences in yeast genes could produce 
the effects described above. In many cases, however, such mutations 
did not result in reduction of cytoplasmic RNA but the sole effect 
was an increase in the level of nuclear precursor RNA. Therefore, the 
pattern of expression of C6 RNA observed during HL60 cellular
differentiation may not reflect a normal situation but may be the 
result of a mutation in HL60 cells which affects the splicing 
efficiency of the C6 RNA. The study of the defects in the alpha and 
beta-globin genes present in several forms of thalassemia has 
demonstrated many examples of natural splicing mutants (Treisman et 
al, 1983) . Alternatively, the abundance of the C6 RNAs may depend on
a number of other characteristics which control gene expression, such
as the stability of the precursor and mature RNA molecules and the 
rate of nucleo-cytoplasmic transport.
C6 RNA was detected in whole cell RNA isolated from a number of
different human tissues. Interestingly. all the tissues which 
expressed these transcripts did so at levels below those detected in 
HL60 cells. It would be interesting to see if both the 2.4 kb and the
1.3 kb C6 transcripts can be distinguished by Northern blotting 
analyses of these RNAs or is only one species detected. This would
indicate if the pattern of expression of C6 RNAs observed in HL60
cells reflected a normal rate limiting step in the splicing processes 
of C6 transcripts or if it is peculiar to HL60 cells.
RA induced HL60 cells did not contain such high levels of the 2.4 kb 
C6 RNA as their DMSO induced counterparts. However, the level of the 
smaller transcripts increased to a similar degree during treatment 
with both inducing agents. This probably reflects the differentiation
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status of RA induced HL60 cells. RA is apparently less efficient at
inducing granulocytic differentiation of HL60 cells during the 5 day 
period of treatment (see Chapter III, A). However, assuming the two 
C6 transcripts are related and that the relationship is that of 
unspliced precursor and mature transcript, it can be surmised that 
the rate of the splicing reaction must be similar in both RA and DMSO 
induced HL60 cells, hence the similar increase in 1.3 kb RNA 
abundance during the induction period. This would then indicate that 
the differences in the levels of the 2.4 kb transcripts at the
completion of the induction process may be the result of differences
in the rate of transcription of the C6 gene between RA and DMSO 
induced HL60 cells.
Obviously it will be of vital importance to prove categorically that 
the 1.3 kb C6 transcript is in the cytoplasmic fraction of DMSO and 
RA induced HL60 cells. It would also be interesting to determine the 
transcription rate of the C6 gene during HL60 granulocytic
differentiation to see if it is increased. It might also be worth 
while returning to the RA5 cDNA library to try and identify other
cDNAs representing C6 sequence. This would aid in the determination 
of the full length sequence of C6 and may shed light on the 
relationship between the 2.4 kb and the 1.3 kb transcripts.
E) F10 Expression During HL60 Cell Differentiation
i) The Effect of RA on the Levels of F10 RNA in HL60 and U937 Cells
F10 cDNA represents transcripts which become highly abundant during 
granulocytic differentiation of HL60 cells. From Northern analysis of 
total RNA isolated from HL60 cells harvested at different times
throughout the 5 day treatment period required for RA or DMSO
induction, F10 RNA was highly abundant during the final days of the
induction period. This indicated that these transcripts may represent 
a mRNA specific to mature granulocytes.
However, when a direct comparison was made between the levels of F10 
mRNA in 5 day RA induced HL60 cells and 5 day DMSO induced cells, the 
F10 transcripts appeared approximately 3 fold more abundant in RA 
induced cells. This was surprising since previous work, on the timing
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of commitment and the appearance of mature cell characteristics 
during HL60 differentiation, had demonstrated that only 60% of the 
cells responded to RA induction stimulus (see Chapter III, 1).
Retinoids are vitamin A derivatives. It has been demonstrated 
that this vitamin is required for normal vision, reproduction and 
maintenance of differentiated epithelium and mucous secretion in the 
whole animal (Goodman, 1984). It is also generally believed that 
retinoids play a basic role in control of differentiation and that 
these agents suppress the malignant phenotype (Lotan, 1980). 
Therefore it is suggested that retinoids exert a hormone-like control 
of either cell proliferation or cell differentiation (Sporn and 
Roberts, 1984). Assuming that the increase in F10 RNA was associated 
with the differentiation process, the inconsistency in the extent of 
terminal differentiation observed following RA induction and the
level of F10 RNA, could be explained if the expression of the F10 
gene was influenced not only by the differentiation stimulus of RA 
but also by a vitamin / hormone effect exerted by this agent. To 
examine this possibility the human histiocytic lymphoma cell line 
U937 was used. These cells express monoblast-like characteristics, 
possess receptors for RA and can be induced by this agent into 
morphologically mature macrophage cells (Sundstrom and Nillsson, 
1976; Olsson and Breitman, 1982). If the increase in abundance of F10
RNA, as seen during HL60 differentiation, was due in part to hormomal
stimulation, F10 RNA levels in U937 cells would also increase in 
abundance on exposure of these cells to RA irrespective of the 
differentiation end-point (macrophages during U937 induction and 
granulocytes in HL60 cell cultures following RA treatment).
U937 cells were found to express F10 RNA but the levels of this 
transcript decreased with the length of time the cells were exposed 
to RA. This decrease also occurred concomitant with the appearance of 
monocytic differentiation characteristics. Therefore, it appears that 
F10 RNA expression is decreased as a response to a differentiation 
stimulus to develop to monocyte / macrophage cells in U937 cells. 
Interestingly, the levels of F10 RNA are also decreased following 
induction of monocyte / macrophage differentiation in HL60 cells but 
increased during granulocytic differentiation. This indicates that 
increase in abundance of F10 RNA, in HL60 cells induced to
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granulocytes by RA treatment, was a differentiation response and not 
a response to hormone / vitamin effect of RA.
ii) F10 RNA, a Possible Differentiation Stage-Specific Transcript
In Chapter IV, (1), RA induction of HL60 cells was discussed. It was 
suggested that 5 days of treatment with this agent may not be 
sufficient to induce the majority of cells to terminally 
differentiate. When inducing agents are added to the growth medium 
the cells are not synchronous hence they do not respond to the 
differentiation stimulus simultaneously. Therefore, at early times 
following addition of the agent, some cells will have embarked on the 
pathway to terminal differentiation whilst others will not yet be 
committed. As the time of exposure to the induction stimulus 
increases more and more cells will terminally differentiate and 
ideally at the end of the induction period almost all the cells will 
express overt differentiation characteristics. However, if the 
induction is stopped at earlier times cells will be found distributed 
at different stages of differentiation, some will be terminally
differentiated but others will not have completed the developmental 
process. This model for cell differentiation in a population of
non-synchronous cells is displayed diagrammatically in Figure 55.
If it is assumed that 5 days of RA treatment is not sufficient to 
elicit a differentiation response from the majority of HL60 cells, 
the pattern of expression of F10 RNA can be explained if this 
transcript represents a stage-specific RNA of the granulocytic 
differentiation pathway. If F10 RNA was expressed by cells at late 
stages of granulocytic differentiation, but before terminal 
differentiation, this would suggest that at the completion of 5 days 
of treatment a large proportion of DMSO induced cells had passed this 
stage and had terminally differentiated ; hence lower levels of F10 
RNA would reflect fewer cells at the hypothetical stage of 
differentiation. However, in RA induced cells a large proportion of
cells may have just entered this stage and therefore would contain
large amounts of F10 transcripts. If this model is correct increasing 
the treatment time of HL60 cells with RA should lead to a decrease in 
F10 RNA.
Others have reported results which fit such a model for
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Figure 55 Schematic representation of a model for differentiation of 
non-synchronous HL60 cell populations.
The solid horizontal line represents a differentiation lineage; a, b, 
c, d, and e represent stages on the differentiation pathway, (a), 
uninduced or immature cells; (e), terminally differentiated cells, 
(b, c, d), are intermediate stages. Each diagram indicates the 
proportion of HL60 cells at each stage of differentiation after a 
period of treatment with a stimulus which induces the cells to 
differentiate, for example RA or DMSO. The majority of uninduced 
cells are found at very early stages of the differentiation pathway 
with very few cells at later stages, an almost homogeneous cell 
population. With induction to differentiate the proportion of cells 
at (a) diminishes with increasing time of treatment and the
population of cells become more heterogeneous and are found spread 
throughout the intermediate stages of differentiation (b, c and d). 
After 5 days of treatment with RA or DMSO the majority of cells 
should have terminally differentiated but a proportion will still 
remain at early stages.
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non-synchronous cell progression down a differentiation pathway. Boyd 
and Metcalf (1984) determined the progression of sodium butyrate 
induced HL60 cells along the monocyte / macrophage differentiation 
pathway during 7 days of treatment. Progression was determined by 
morphology, the expression of stage-specific antigens and changes in 
cell function. They demonstrated that at any one time following 
addition of the inducing agent to the growth medium cells were found 
at all stages of monocytic differentiation. With longer exposure to 
sodium butyrate more and more cells acquired mature cell 
characteristics but in a non-synchronous manner. For example, after 1 
day of treatment approximately 19% of the HL60 cells resembled 
monoblasts, 4% monocytes and the remainder appeared promyelocytic. 
However, by day 3, 41% of the cells were monoblastic, 56% monocytes 
and only 3% promyelocytic. By day 7 100% of the cells were classed as 
monocytic.
From in situ hybridisation analysis of HL60 cells it appeared that 
uninduced cells did not produce F10 RNA. However, when treated for 5 
days with RA, almost 90% of the cells hybridised to a radioactively 
labelled probe for F10 RNA. It was also found that approximately 30% 
of a 5 day DMSO induced HL60 cell culture hybridised to F10 cDNA but 
the remainder of the cells did not. A comparison was made between the 
degree of hybridisation of cells to F10 cDNA and the morphology of 5 
day RA induced cells to see if any correlation could be found. It 
appeared that virtually all the cells hybridised irrespective of 
morphology. However, 5-10% of those cells which displayed terminally 
differentiated morphology of banded and segmented neutrophils did not 
hybridise indicating that they did not express F10 transcripts. This 
could suggest that F10 is indeed a stage-specific transcript during 
haematopoiesis. Analysis of the distribution of F10 RNA in a number 
of different human tissues also revealed that this transcript was 
only detected in abundance in HL60 cells and in particular RA induced 
cells. The transcript was not observed in normal peripheral blood 
leukocytes or in normal bone marrow. F10 RNA was also barely 
detectable in normal granulocytes. These results support the proposal 
that F10 RNA represents a marker for a late stage during 
granulopoiesis. The identification of stage-specific transcripts is 
important. Not only do they allow cell differentiation to be 
monitored in vitro. for example, during HL60 differentiation, but
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they can also be used in conjunction with other methods to classify 
neoplastic tumours (Mills et al, 1987).
Many stage-specific markers have been determined for various 
differentiation systems. For example, Birnie et al (1983a) have 
reported a species of RNA, pCG14, which is localised to bone marrow
cells and in particular to myelocytes during normal haematopoiesis. 
However cells in the peripheral blood of patients suffering from CGL 
were also found to express this transcript (Birnie et al, (1983b). 
This reflects the stage at which the leukeaemic cells in CGL patients 
were maturation arrested. Similarly, Warnock et al (1985) have 
reported an RNA which may be an early monocyte marker.
Others have reported the appearance of proteins during myogenesis 
which are found specifically during or just prior to the onset of 
myotube formation. These proteins include myosin heavy chain, myosin 
light chain, B-actin and tropomyosin (Moss et al, 1981; Shani et al, 
1981; Garfinkel et al, 1982). Earlier stages in muscle cell 
differentiation do not produce these proteins but are found to 
produce non-muscle actin and other proteins which are not muscle 
specific (Schwartz and Rothblum, (1981).
During HL60 differentiation the classification of the terminally 
differentiated cells can be accomplished by the use of monoclonal 
antibodies which recognise membrane proteins which are specific to 
the terminal differentiated cell. For example, the monocyte specific 
monoclonal antibody FMC 17 occurs specifically after 3 days of
1,25-dihydroxyvitamin Dg treatment of HL60 cells. At this time the 
cells show many of the characteristics of monocytes (Daniel et al,
1986). Similarly, it has been reported that the pattern of expression 
of the major histocompatibility complex (MHC) class II antigens is 
tissue-specific and varies during differentiation (Amatruda et al,
1987). For example, the HLA-DR MHC antigen is expressed by 
approximately 80% of cells from cell lines with very immature 
phenotypes such as KG-1 which is believed to be myeloblastic in
origin (Koeffler and Golde, 1978). However HLA-DR expression is weak 
or absent from relatively mature cell lines such as HL60 or U937. 
Hence these antigens appear to be specific to very immature cell 
types during haematopoiesis.
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To determine which stage F10 RNA expression is related to during 
haematopoiesis it will be necessary to analyse F10 RNA levels in
populations of normal bone marrow cells. In situ hybridisation should 
enable a comparison to be made between cell morphology and 
hybridisation to F10 probe which will enable classification of the 
cell type(s) which express this transcript. It would also be 
necessary to determine the manner in which F10 RNA expression is 
regulated in HL60 cells. Initial analysis of the distribution of F10 
RNA transcripts in the different cellular compartments of HL60 cells 
revealed that F10 transcripts were found in the nuclear RNA from
uninduced HL60 cells but not in nuclear RNA isolated from RA induced 
HL60. In these cells the transcripts were present in the total whole 
cell RNA only. Therefore, it can be speculated that the F10 RNA is 
present in the cytoplasmic RNA of these cells but has to be proved 
categorically. If this is found to be the case F10 RNA may represent
a transcript whose expression is regulated at post-transcriptional
levels, possibly at the stage of nucleo-cytoplasmic transportation.
4 GENE EXPRESSION IN RELATION TO TIMING OF COMMITMENT IN HL60 CELLS
A number of different parameters were used to measure the proportion 
of committed or terminally differentiated cells during myeloid 
differentiation of HL60 cells (Chapter III, 1). From these results it 
is was deduced that 24-96 hours were required for the maximum number 
of cells to become committed to granulocytic differentiation in HL60 
cultures exposed to DMSO or 8-24 hours for commitment to macrophage 
differentiation. I have analysed the level of abundance of a number 
of different transcripts throughout induction of HL60 cells by TPA, 
DMSO and RA. Figure 56 and 57 represent graphs depicting the 
increase or decrease in the levels of these transcripts compared to 
the timing of commitment during HL60 differentiation. Only data 
generated from DMSO and TPA induced HL60 cells were used because of 
the difficulty in interpreting results from RA treatment.
A) TPA induction
The most striking feature during TPA induction of HL60 cells is the
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Figure 56 Comparison of the timing of commitment and the timing of 
changes in c-mvc and lvsozyme gene expression in TPA 
induced HL60 cells.
The timing of the changes in abundance of c-myc RNA and lysozyme 
protein have been compared to the timing of commitment in HL60 cells 
induced by TPA. This was 8-24 h, which is indicated by the dotted 
lines on the graph. The results are expressed as percentages 
calculated by taking the value for uninduced HL60 cells as 100%. (•) , 
c-myc RNA; (□), lysozyme protein; (■), cell cloning potential.
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Figure 57 Comparison of the timing of commitment and the timing of 
changes in c-mvc. F10 and C6 gene expression during DMSO 
induction of HL60 cells.
The timing of the changes in abundance of c-myc RNA, F10 RNA and C6 
RNA have been compared to the timing of commitment in HL60 cells 
induced by DMSO. This was 24-96 h, which is indicated by the dotted 
line on the graph. The results are expressed as percentages 
calculated by taking the value for uninduced HL60 cells as 100%.
(•), c-myc RNA; (■), F10 RNA; (O), 2.4kb C6 RNA; (□), 1.3kb C6 RNA.
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concomitant increase in lysozyme protein production with that of
decrease in cell cloning potential (Figure 56). Hence there appears
to be an inverse relationship between growth and differentiation in
HL60 cells induced to differentiate by TPA. Daniel et al (1987) have 
also demonstrated a correlation between growth and differentiation of 
HL60 cells induced to monocyte / macrophage differentiation. However, 
they used the chemical agent 1,25-dihydroxyvitamin D^.
c-Myc RNA becomes undetectable after only 4-8 hours of TPA induction 
of HL60 cells. It appears that loss of c-myc RNA bears an inverse 
relationship to differentiation but a direct relationship to
proliferation in HL60 cells induced by TPA. This indicates that c-myc 
may therefore be closely involved in both the processes controlling 
growth and differentiation in HL60 cells treated with TPA (see 
Chapter IV, 2).
B) DMSO induction
Figure 57 represents a graph summarising the timing of changes in the
levels of c-myc RNA, C6 RNA and F10 RNA compared to the timing of the
commitment event in HL60 cells induced by DMSO. It is interesting to 
note that the increase in the levels of F10 RNA and C6 RNA occurred 
at approximately 24 hours following addition of DMSO to the growth
medium. This correlates exactly with the timing of the commitment
event estimated for HL60 cells undergoing granulocytic 
differentiation. As the levels of C6 and F10 RNAs increased the 
cloning potential of the HL60 cells decreased concomitantly. 
Similarly, increase in NBT positively stained cells (a marker for 
mature myeloid cells) bore a direct relationship with increase in F10 
and C6 transcripts. ’
These results indicate that increase in F10 and C6 RNA levels bears 
an inverse relationship to parameters used to determine the
proliferative capacity of HL60 cells but a direct relationship to the 
timing of appearance of terminally differentiated cells. Therefore it 
can be proposed that both F10 and C6 gene expression is directly 
linked to differentiation.
However, c-myc RNA becomes undetectable after only 1 hour of DMSO
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treatment of HL60 cells. This event precedes both changes in growth 
and in differentiation of the cells. It would therefore appear that 
c-myc is not immediately and directly involved in the processes 
leading to induced differentiation of HL60 cells by DMSO. This is 
contradictory to the results obtained from TPA induced HL60 cells.
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